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Abstract 
 
BEHAVIORAL INSIGHTS INTO NOCICEPTOR FUNCTION:  
A SYSTEMATIC APPROACH TO UNDERSTANDING POSTSURGICAL 
AND NEUROPATHIC PAIN MECHANISMS IN RATS 
 
Max Allen Odem, M.S. 
 
Advisory Professor: Edgar T. Walters, Ph.D. 
 
Postsurgical and neuropathic pain are each clinically common, and often associated 
with ongoing pain. Ongoing pain has been linked to ongoing activity (OA) in human C-fiber 
nociceptors. Preclinical studies using rodent neuropathic models have concentrated on 
allodynia driven by OA generated in non-nociceptive Aβ fibers, but little attention has been paid 
to postsurgical pain in sham controls or to C-fiber nociceptor OA promoting ongoing pain. 
Operant assays that reveal negative motivational and cognitive aspects of voluntary 
pain-related behavior may be particularly sensitive to pain-related alterations. In the mechanical 
conflict (MC) test, rodents can freely choose to escape from a brightly lit chamber by crossing 
sharp probes. Most studies employing the MC test habituate rodents to the device and 
measure the latency to escape the bright light. We found reducing habituation caused rats to 
repeatedly return to the light chamber when probes were absent, presumably as part of their 
exploratory behavior. We asked whether combining motivations to avoid the bright light and to 
explore the device would reveal a conflicting, pain-related reluctance of rats to cross noxious 
probes. Rats with a thoracic spinal cord injury (SCI), lumbar spinal nerve transection, or chronic 
constriction injury of the sciatic nerve, as well as their sham controls, exhibited heightened 
pain-avoidance behavior compared to uninjured controls. These findings have important 
implications for investigations into behavioral and neuronal alterations contributing to 
postsurgical and neuropathic pain. 
vi 
 
Many C-fiber nociceptors generate OA in vivo in rats with SCI and ongoing pain. 
Probable nociceptors continue to generate OA in vitro after dissociation. We used whole-cell 
recordings from isolated dorsal root ganglion neurons and novel algorithms that analyze 
irregular changes in membrane potential (MP) to define neurophysiological alterations 
underlying SCI-induced nociceptor OA. In a distinct type of probable nociceptor, SCI caused 3 
chronic alterations that promote OA: 1) depolarization of resting MP, 2) reduction in the voltage 
threshold for action potential generation, and 3) enhancement of depolarizing spontaneous 
fluctuations (DSFs) in MP. In vitro modeling of acute inflammation by combining serotonin with 
artificial depolarization also potentiated DSFs and OA. These findings reveal nociceptor 
specializations for generating OA during ongoing pain.  
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Preface 
I joined the lab of Edgar T. Walters, Ph.D. because he and I have broad, mutual 
interests in animal behavior, nociception, and pain from an evolutionary perspective. My 
personal goal from the beginning has been to better characterize the negative affective and 
motivational components of pain in rats with spinal cord injury (SCI) to better understand their 
experiences and to develop a deeper appreciation of their sacrifice for human benefit. I began 
my research using operant behavioral tests that assess evoked and ongoing pain, and I gained 
an interest in using in vitro whole-cell patch electrophysiology to study the neurophysiological 
basis of nociceptor activity that may translate at the behavioral level to ongoing pain. 
Ultimately, everything we study in preclinical pain research must make sense at the behavioral 
level at some point. Some of my behavioral and electrophysiological experiments cover topics 
that currently lack well-defined outcome measures. Therefore, I have adopted a descriptive 
approach in combination with using some novel methodologies and analytical tools in hope of 
establishing a solid foundation upon which future mechanistic predictions can be made. 
Descriptive science matters [144], and any predictions about pain-related mechanisms are only 
as powerful as our descriptions of pain behavior and nociceptor function. 
For continuity, I have decided to first present my behavioral study using a recently 
developed operant mechanical conflict (MC) test to reveal postsurgical effects of sham 
procedures on evoked pain and avoidance behaviors. My behavioral experiments using the 
conditioned place preference (CPP) test to reveal SCI-induced ongoing pain will not be the 
primary focus, but some of the work will be referenced (see [389]) and shown when 
appropriate. This will be followed by my electrophysiology study using whole-cell recordings of 
nociceptors in vitro and novel algorithms to characterize the neurophysiological basis of 
ongoing activity associated with ongoing pain. This reflects my mentality that one ought to first 
be able to describe pain-related behavior before trying to attribute it to potential underlying 
mechanisms.  
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Chapter 1: The fundamental unit of pain is assessed behaviorally 
Contrary to the proclamation of Reichling et al. in their 2013 review in the journal Pain 
[300], the fundamental unit of pain is not the cell. I think this reductionist perspective has been 
integral to the overwhelming expansion in knowledge of mechanisms associated with pain, but 
it simultaneously diminishes the importance of the means by which those with pain show it and 
how researchers ultimately must assess it (i.e., behaviorally). Pain-related behavior is not the 
mere result of a few mechanisms of interest. Indeed, there is a wide disconnect (e.g., “valley of 
death”, see [118,370,390,392]) between preclinical mechanistic research using laboratory 
animals and the successful translation of clinical therapeutics for pain. The International 
Association for the Study of Pain defines pain as “an unpleasant sensory and emotional 
experience associated with actual or potential damage, or described in terms of such damage”. 
This most widely accepted definition of pain is predicated upon the notion that pain is 
emergent. I think the nested model for the universe of pain proposed by J.D. Loeser [228] 
makes this point in the simplest manner possible (Fig. 1). In his model the second principal 
component of pain is perception, which is largely dependent upon a great multitude of 
molecular and cellular processes that underlie the first principal component, nociception. This is 
important to distinguish, nociception is not pain and the two are not interchangeable. 
Nociception is the body’s detection system for damaging and/or potentially damaging stimuli. 
Pain can be perceived in the absence of nociception, and a noxious stimulus can activate 
nociceptive systems without being perceived as painful [129]. Typically, once a noxious 
stimulus is transduced in the peripheral nervous system (PNS) by nociceptors (neurons 
specialized for responding to noxious stimuli) and integrated in the dorsal horn of the spinal 
cord, the encoded sensory information is relayed to higher-order processing centers (i.e., pain 
matrix) in the central nervous system (CNS) for perception. The third principal component in 
Loeser’s model that follows pain perception is suffering. Loeser broadly defines suffering as the 
affective response to any psychosocial constructs (e.g., fear, depression) which can influence 
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the valence attributed to pain. For a review of psychosocial constructs that influence pain and 
expansions upon Loeser’s principal components see [112,245]. Any perceived threat to a 
person’s or animal’s integrity is likely to contribute to suffering [59]. Loeser emphasizes that 
these three principal components (nociception, pain perception, and suffering) are experienced 
internally and therefore cannot be explicitly quantified nor validated. This is especially true in 
laboratory animals, they cannot directly communicate with researchers and we ought to 
meticulously observe their behavior in an attempt to draw plausible inferences about their 
experiences. Loeser makes this point very clear when he states that the objectively real, 
quantifiable sum of nociception, pain perception, and suffering is pain behavior, the final all-
encompassing piece in his model. In light of Loeser’s perspective, it is my interpretation that the 
fundamental unit of pain is not the cell, it is the amalgamation that is a person, an animal. Any 
mechanisms that potentially underlie and describe the nature of nociception, the perception of 
pain, and the emotional consequences thereof must be able to reasonably explain for and/or 
predict observable changes in behavior. Thus, the tests that pain researchers have designed to 
study pain-related behavior in animals are the crucibles by which mechanisms can be 
discovered, refined, and… set aside for later consideration. To be clear, I do not think the 
behavioral tests that are currently available are the single points of failure that solely explain 
why there is this “valley of death”, but their application and whether or not the behaviors being 
measured are as informative as originally considered have been questioned [255,351]. 
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Figure 1. A nested model for the universe of pain, proposed by J.D. Loeser, M.D. Colors 
adapted from Figure 1 in [228] and reprinted with permission under license. Title: Pain and 
Suffering; Author: John Loeser; Publication: Clinical Journal of Pain, The; Publisher: Wolters 
Kluwer Health, Inc.; Date: June 1, 2001. Copyright © 2000, © 2000 Lippincott Williams. License 
number 4443780134967 granted to Max A. Odem on October 7, 2018. 
 
1.1. In the beginning there were only reflex tests… 
To be considered an appropriate, potentially translatable animal model for pain, a model 
should recapitulate the pathophysiology of a clinical condition of interest and it should present 
symptoms and signs that mirror clinical manifestations of pain. Behavioral outcome measures 
should be feasibly obtainable, objectively interpretable, replicable across research groups, and 
most importantly be assessed under strict ethical and humane guidelines. Researchers have a 
plethora of behavioral tests [21,140,141,344,352] at their disposal for studying the many facets 
of pain. Furthermore, there is a diverse collection of animal models that recapitulate a broad 
spectrum of clinically relevant pain-related conditions, injuries, and disease states 
[21,32,40,68,140,141,164,182,197,199,238,361]. Elucidating how mechanisms underlying pain 
behavior converge and diverge in many different animal models has been crucial for identifying 
some new and potentially successful treatment strategies [33,79,187]. Despite many options 
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and advancements, the preclinical side of pain research has been stymied due to multiple 
factors [253,351,390,392]. Mogil and Crager identified one factor early on; in only 4 years 
(2000 to 2004) 90% of the 259 studies published in Pain that utilized behavioral assessments 
of inflammatory or neuropathic pain relied solely upon reflex tests that measure rodents’ 
sensitivity to evoked stimuli, typically mechanical or thermal in nature [255]. Mogil and Crager 
also astutely point out the disparity between the dogmatic-like use of reflex tests for nociception 
and growing numbers of preclinical rodent models of neuropathic, inflammatory, postsurgical, 
and other painful conditions. Vierck et al. also state very clearly “pain is not a reflex” as they 
echo a growing call to expand our understanding of the motivational and emotional 
consequences of pain [351]. I think the value of behavioral tests currently available to pain 
researchers ought to be reassessed according to their descriptive power, and a greater 
emphasis should be placed on tests that might characterize animal models and conditions 
based upon multidimensional components of pain [256,286]. 
1.2. Overview of tests of pain-related behaviors in rodents 
Loeser broadly defined the complexities of pain behavior [228] while others [112,245] 
have expanded upon his definitions to identify more intricate interactions among a breadth of 
psychosocial constructs. Here I will suggest how Loeser’s principal components and three 
other characteristics can be applied to subdivide many of the behavioral tests used today. I 
think doing so provides insight into the theoretical validity, descriptive power, and dependability 
of each test. As will be evident, the use of multiple overlapping and non-overlapping tests 
based on different principal components ought to improve the predictive validity of experiments 
and help studies arrive to stronger conclusions about any pain-like states and treatment-related 
effects; studies that do so are potentially more informative [140]. 
I posit the following non-exhaustive list (see Table 1 and references in the legend) of 
common behavioral tests for rodents and key test characteristics by which I think they should 
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be delineated (for broader review see [21,140,344,387]). The first characteristic is Loeser’s 
principal component for pain behavior. To reiterate, the three principal components are 
nociception, pain perception, and suffering [228]. To be effective at revealing some aspect of 
pain behavior, a behavioral test should yield results that pertain to at least one or more of the 
following: 1) evidence of nociceptor activation, 2) evidence of motivational states and/or non-
reflexive pain-directed behaviors that necessitate higher-order processing and would suggest 
pain perception, and 3) evidence of altered emotional states (e.g., anxiety- and depression-like 
behaviors) that might imply suffering (note: a single test does not quantify suffering, but a 
collective profile of altered emotional states might reasonably imply the presence of suffering). 
The type of behavior that is elicited is also critical; for the second characteristic I note whether 
the rodent is permitted to behave independently under its own volition or is purposefully 
restrained for response evocation (i.e., voluntary or involuntary behavior). The third 
characteristic is whether or not an evoked stimulus is necessary to assess the behavior of 
interest, and if so the nature of the stimulus. To clarify, no external stimuli are applied to 
rodents in the gait analysis/weight bearing test, but the rodents’ own movement and substrate 
may be sufficiently painful (see [30]). Finally, in an effort to identify potential sources of 
unconscious bias, I have listed if a test requires any direct human interaction. This does not 
refer to general handling procedures before/after a test is completed, it is specifically in 
reference to circumstances in which an investigator must evoke a behavioral response to 
record the outcome (e.g., hand-held delivery of von Frey filaments). In sum, Table 1 reviews 
pain-related behavioral tests with regards to 4 major categories: 1) tests of involuntary reflexes 
in response to external stimuli, 2) tests of voluntary behaviors in response to external stimuli, 3) 
tests of ongoing/spontaneous pain in the absence of external stimulation, and 4) tests designed 
to identify affective disorders and phenotypes.  
7 
 
 
Table 1. Non-exhaustive list of pain-related behavioral tests for rodents. References 
(superscript corresponds to the table, number in brackets corresponds to bibliography): 
1Broekkamp et al., Eur J Pharmacol, 1986 [45]; 2Calvino et al., Neuroreport, 1996 [51]; 
3Chaplan et al., J Neurosci Methods, 1994 [63]; 4Choi et al., Pain, 1994 [393]; 5Clarke et al., 
Physiol Behav, 1997 [76]; 6Crawley and Goodwin, Pharmacol Biochem Behav, 1980 [80]; 
7D’Amour and Smith, J Pharmacol Exp Ther, 1941 [84]; 8Deacon, Nat Protoc, 2006 [87]; 
9Dubuisson and Dennis, Pain, 1977 [110]; 10Hall, J Comp Physiol, 1934 [150]; 11Hargreaves et 
al., Pain, 1988 [152]; 12Johansen et al., Proc Natl Acad Sci U S A, 2001 [178]; 13Katz, 
Pharmacol Biochem Behav, 1982 [185]; 14King et al., Nat Neurosci, 2009 [192]; 15LaBuda and 
Fuchs, Exp Neurol, 2000 [204]; 16Langford et al., Nat Methods, 2010 [208]; 17Lau et al., 
Neurorehabil Neural Repair, 2012 [210]; 18Mauderli et al., J Neurosci Methods, 2000 [241]; 
19Pellow et al., J Neurosci Methods, 1985 [280]; 20Porsolt et al., Nature, 1977 [287]; 21Randall 
and Selitto, Arch Int Pharmacodyn Ther, 1957 [295]; 22Seltzer et al., Pain, 1990 [319]; 23Woolfe 
and MacDonald, J Pharmacol Exp Ther, 1944 [373]. CPA, conditioned place avoidance; CPP, 
conditioned place preference; EPM, elevated plus-maze; EZM, elevated zero-maze; PEAP, 
place escape/avoidance paradigm.  
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1.2.1. Notable limitations associated with involuntary reflex tests 
A majority of the standard reflex tests are limited to measuring involuntary withdrawals 
of the paws or tail to an applied mechanical or thermal stimulus. They can potentially reveal 
alterations in sensory and nociceptor properties that manifest both peripherally and in the 
dorsal horn (for review [21]), but flexion does not necessitate cognition and stimuli may not be 
consciously perceived (see [240]). Additional limitations of reflex tests pertain to methodology, 
testing consistency, and reliability of the results. Rodents often require acclimation to testing 
facilities and researchers [334] as well as laborious baseline testing procedures, re-testing, and 
detection of potential outliers. Another important requirement of these tests is that stimuli are 
evoked in a consistent, repeatable manner and rodents are treated equally. In other words, 
rodents are often restrained either by hand or in small, usually clear acrylic, chambers and 
there is some form of human interaction with the rodent. This is an opportunity for unknown 
sources of bias to negatively impact data recording [38], so the exclusive use of reflex tests 
ought to be met with caution.  
As an example, the von Frey test is one of the simplest, most efficient tests for 
assessing mechanical nociception. Each von Frey filament is calibrated to bend at a specific 
gram force and are hand applied to the plantar surface of the paws; filaments range from <1 
gram to >100 grams. Unfortunately, there is no agreed upon standard method using von Frey 
filaments (e.g., see Table 1 in [90]). Not all groups use the same range of filaments, starting 
filament, number of stimuli, stimulus duration (e.g., some groups press filaments for ~1 second 
while others press 4-5 seconds; see [58,90]), or threshold calculation methods (e.g., original 
Chaplan/Dixon “up-down” method [63,98,99] versus reduced procedure [37]). Finally, many 
studies report absolute thresholds in grams using aforementioned calculation methods, but 
Mills et al. point out many studies do not use log transforms of the data to account for Weber’s 
law [251]. Proper representation is necessary to identify meaningful treatment-related effects 
(e.g., see [251]). Incomparable results between studies may be due methodological differences 
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[38] (see also [97] for Hargreaves radiant heat test) combined with differences in mechanisms 
associated with pain wind-up (for review [162]). The von Frey test is also a poor approximation 
of human pain test conditions [352]. It is possible the von Frey test preferentially recruits 
myelinated, fast conducting A-fibers without recruiting unmyelinated, slowly conducting C-fibers 
[36], suggesting it may not be effective at modeling some forms of pain. 
1.2.2. Tests of voluntary behavior offer greater insight into multidimensional 
components of pain 
Under typical conditions the needle/pin-prick and formalin tests require that rodents be 
restrained, but the noxious stimuli used promote “spontaneous” pain behaviors that may be 
voluntary and reflect cognitive processing. Reflex intensity and hyperalgesic behaviors are 
distinguished using qualitative descriptions (e.g., prolonged withdrawal, excessive grooming of 
stimulated paws). In the needle/pin-prick test a rodent’s paws are quickly probed using a sharp 
needle/pin. Under naïve conditions the test elicits typical rapid withdrawal reflexes, but under 
some potentially painful conditions rodents elicit exaggerated withdrawals and behaviors such 
as limb guarding, licking, and vocalizations [165]. In one test variant rodents learn to passively 
avoid noxious stimulation of an injured paw (see [375]), suggesting awareness. Similar 
hyperalgesic behaviors are observed when formalin is injected into a rodent’s paw; behavioral 
assessments are made during early and late phases of “spontaneous” pain. Other inflammatory 
substances can be used in place of formalin (e.g., complete Freund’s adjuvant, CFA; serotonin, 
5-hydroxytryptamine, 5-HT). 
Considerations for rodent autonomy during development of new behavioral read-outs 
may help improve the predictive value of preclinical models of pain for translational drug 
discovery [32]. Indeed, newer, more sophisticated behavioral tests have been specifically 
designed to take advantage of the innate preferences (e.g., exploration of novel environments 
[80,113]) and stock behaviors (i.e., naturally occurring in the wild) of freely behaving rodents 
10 
 
(for review [140,344,387]), and to remove human sources of bias. These voluntary tests are 
gaining tremendous traction as effective, automated tools for identifying the negative affective-
motivational components of pain that are particularly important clinically 
[256,286,344,351,352,392]. Operant behavioral tasks such as the CPP test 
[19,85,192,264,265,291,389] and the place escape/avoidance paradigm (PEAP) 
[15,41,124,204–206,375] can capture persistent, aversive pain-like states and demonstrate 
how spontaneous pain influences decision-making [256,286]. Noxious sensory information may 
be self-evoked in some rodents with painful conditions (see [30]), so gait analysis/weight 
bearing tests might also reveal how ongoing pain can influence natural ambulatory movement. 
Animal suffering may not be quantifiable and difficult to qualitatively describe without 
using anthropomorphic terms, but the reality is laboratory rodents exhibit primal emotional 
states, complex signs of empathy, and pain-related distress (for review [248]). Meyza et al. 
[248] state that acknowledging the presence of empathy permits generation of animal models 
relevant to human conditions. Behavioral tests of altered emotional states like anxiety (e.g., 
open field, elevated mazes) and depression (e.g., forced swim, sucrose preference) have 
begun to reveal the emotional consequences of neuropathic pain in rodents [387]. High-
frequency vocalizations and facial grimacing may confer to conspecifics distress due to 
ongoing/spontaneous pain, but this has not been adequately tested or ruled out (for review 
[254]). In their current forms, the marble burying and burrowing tests are used to assess 
anxiety, but I also interpret them to involve some degree of self-evoked mechanical stimulation. 
Burrowing is decreased in some painful conditions like nerve injury and SCI [11,41,232]. These 
studies do not directly determine whether burrowing is sensitive to above and at-level injury-
induced hypersensitivity in the forelimbs. Rats with SCI exhibit robust above and at-level 
mechanical hypersensitivity [28,57,171], so it is plausible their performance in the burrowing 
test may not reflect an anxiety-like phenotype as much as sensitization to mechanical 
stimulation. Likewise, there is insufficient evidence with the marble burying test to distinguish 
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affective and nociceptive components. It is self-evident, but the forced swim test is pseudo-
voluntary; rodents must swim to stay afloat inside an inescapable water-filled chamber. This 
test is predicted to model learned helplessness (i.e., coping) and depression-like behavior; 
under painful conditions rodents spend less time vigorously swimming while maintaining their 
head above water with minimal movement [387]. Despite the availability of many behavioral 
tests, the affective consequences of pathological forms of pain are still unclear [387]. 
1.3. Modeling clinically relevant neuropathic pain conditions in rats 
In this section I want to narrow focus to neuropathic pain and briefly describe relevant 
patient conditions. I will then provide a brief overview of several rat models of surgically-
induced neural injury used to study neuropathic pain. Finally, I will review some of the 
behavioral evidence for pain in these neuropathic models that has been extracted using many 
of the aforementioned behavioral tests. 
 Pain which originates from acute activation of nociceptors is referred to as nociceptive 
pain, but pain can also be inflammatory and/or pathological in origin. Neuropathic pain covers a 
range of disorders whose etiology stems from some primary damage and/or disease to regions 
of the PNS and/or CNS (for review [79,188]). Classifying neuropathic pain becomes extremely 
important when attempting to better understand the symptoms, underlying mechanisms, and 
pain associated with different etiologies. An important distinction in terminology must be 
established when describing pain as acute or ongoing/spontaneous. Ongoing pain can 
originate after extrinsic stimulation of nociceptors and/or activity generated in central circuits, or 
it can be truly spontaneous in origin. The terminology for the neuronal/nociceptor activity that 
underlies ongoing and spontaneous pain must also be distinguished. Ongoing activity (OA) is 
any continuous discharge of actions potentials (AP) due to extrinsic and/or intrinsically driven 
activation of the neuron/nociceptor. Spontaneous activity (SA) is a subclass of OA in which 
activity is solely generated due to intrinsic properties of the neuron/nociceptor, that can only be 
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reasonably demonstrated when the neuron/nociceptor is isolated. Things become increasingly 
more complex when one considers the type of pain sensation (i.e., modality); persons with 
neuropathic pain report many different sensations such as sharp pins and needles, radiant 
burning, a dull aching, etc. The predominant view is that many nociceptors are polymodal [23], 
meaning they can respond to multiple types of stimuli and encode for multiple sensations. Two 
common and troublesome symptoms associated with neuropathic pain are allodynia (i.e., an 
innocuous stimulus becomes painful) and hyperalgesia (i.e., a normally noxious stimulus elicits 
an exaggerated pain response). Clinical outcome measures for the intensity and degree of pain 
typically involve sensory assessments of allodynia and hyperalgesia [175]; which stimuli evoke 
which types of nociceptive responses. For the truly unfortunate, ongoing/spontaneous pain 
might not ever dissipate as it is potentially driven by peripherally and/or centrally generated OA 
and/or SA.  
A recent meta-analysis of epidemiological studies estimates roughly 7-10% of the 
general population has neuropathic pain [160], but the prevalence rates vary per condition. For 
example, roughly 15% of those with diabetic neuropathy are predicted to have neuropathic 
pain, while amputees and persons with SCI may have some of the highest prevalence rates 
exceeding ~50% [188]. Furthermore, different neuropathic etiologies will exhibit vastly different 
sensory and pain profiles. Baron et al. used cluster analysis with a hypothesis-free approach 
(i.e., no assumptions about underlying mechanisms) to identify distinct sensory profiles in 
patient consortia with peripheral forms of neuropathic pain: polyneuropathy, peripheral nerve 
injury (PNI), postherpetic neuralgia, and radiculopathy [20]. Their cluster analysis reveals three 
major sensory profiles that span all four peripheral forms of neuropathic pain included in the 
study: sensory loss (42-53% of patients), thermal hyperalgesia (33%), and mechanical 
hyperalgesia (14-24%). The Baron et al. study reinforces the fact that not all neuropathic pain 
conditions are the same in all patients. There is a substantial amount of heterogeneity within 
and across conditions, each involving potentially distinct, complex sets of underlying 
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mechanisms [79]. Persons with persistent forms of neuropathic pain can suffer tremendously 
due to development of what is generally referred to as chronic pain (difficult to define, see [184] 
for review). Treatment options are sorely inefficient [120,390]. Besides pain, persons must also 
contend with associated comorbidities (e.g., affective disorders like anxiety, depression) which 
can develop and plague livelihoods [54,119,387]. For example, persons with SCI can exhibit 
varying degrees of above-level, at-level, and below-level pain, with multiple distribution patterns 
(e.g., diffuse, localized), spanning multiple sensory experiences (e.g., aching, burning, 
throbbing) for the rest of their lives [46,119,367]. Compared to the general population, persons 
with SCI are 3 times more likely to commit suicide [54]. These diverse conditions can be 
difficult to effectively model, no single rodent model exhibits all conditions that might be 
relevant clinically. 
1.3.1. An overview of common rat models of surgically-induced neural injury 
A myriad of rat neural injury models have been developed to study neuropathic pain-
related behaviors and mechanisms. Some models are elegantly simple, requiring minimal 
surgical expertise, while others can be technically sophisticated and demanding. Each of the 
following models requires major surgery (i.e., extensive tissue dissection) and careful 
experimental considerations for postsurgical forms of acute and chronic pain ought to be taken 
(for review of postsurgical pain [64]).  
A common form of peripheral neuropathic pain is radiculopathy (i.e., pinched nerve). 
This condition has been modeled using a steel rod to chronically compress the dorsal root 
ganglia (DRG) in the CCD model [167,233,333,400,405] and by rhizotomy of proximal 
dorsal/ventral roots in the spinal column [22,116,220,327,340]. Notably, the CCD and 
rhizotomy models require substantial damage to muscle and bone surrounding the spinal cord. 
Multiple SCI models have been designed to recapitulate more severe central injuries. The level 
of injury (e.g., cervical, thoracic) and severity of injury (e.g., complete transection, hemisection, 
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contusion) can be modified to best fit the patient population characteristics (e.g., level of pain) 
that are of interest to researchers. Some models are designed to reflect conditions in which the 
cord has been sectioned [71] or compressed [73,74], but contusive SCI models are considered 
to be the most clinically relevant [391]. Contusive SCI is performed by weight drop or controlled 
piston impact; most mild to moderate contusions are performed in the mid to lower thoracic 
regions [24,25,28,57,90,171,196,377,389]. Due to difficulties associated with using paralyzed 
rats (e.g., long recovery for behavioral testing, loss of neurogenic bladder function), a unilateral 
cervical contusive model has also been developed that may be better suited for early post-SCI 
behavioral testing and exercise rehabilitation studies [91,309].  
Peripheral nerve injury models that reflect common forms of peripheral neuropathy are 
more widely used. The PNI models typically involve axotomy/ligation or constriction of the 
nerves and/or nerve branches innervating the hindlimbs; this typically provides critical within 
animal controls (e.g., uninjured limb contralateral to side of injury). There are several prominent 
PNI models, like the spinal nerve ligation/axotomy (SNL/SNA) injury in which the lumbar L5 
and/or L6 nerves are ligated and axotomized [108,163,214,225]. Some groups transect L5 
without ligation (spinal nerve transection, SNT) [338,339,345] while others tie additional loose 
ligatures around an uncut L4 nerve (modified SNA, mSNA) [105,215]. Moving distally, ligatures 
can be loosely tied around the sciatic nerve (chronic constriction injury, CCI) 
[13,31,77,108,181,193,214,242,350] or the nerve can be partially ligated/transected (partial 
sciatic injury, PSI) [108,214,319]. In the spared nerve injury (SNI) model 2 of the 3 sciatic nerve 
branches are axotomized [88,108,213]. Finally, miscellaneous complete nerve transections 
have also been used [108,249,354,395]. Among many benefits, the surgical procedures for 
these models are simpler and damage fewer peripheral tissues. 
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1.3.2. Behavioral evidence for pain-like states in rat models of neuropathic pain 
After several decades of research, what is the collective behavioral evidence for pain-
like states in rat models of surgically-induced neural injury? Two common symptoms (e.g., 
allodynia and hyperalgesia) reported by persons with neuropathic pain pertain to some 
underlying sensory dysfunction that causes modality-specific forms of hypersensitivity. 
Following review of the original descriptions of each rat model and multiple follow-up studies, it 
is evident a vast majority of evidence for pain-like states comes from reflex tests for nociception 
(see Table 2 and references in the legend). All eight of the neural injuries described cause 
some form of mechanical and thermal (heat and/or cold) hypersensitivity, although some 
models have received less attention due to extenuating circumstances (e.g., limb autotomy; 
see rhizotomy and miscellaneous nerve transections). Despite the efficiency and widespread 
use of reflex tests, they do not accurately reflect all of the complex, multidimensional 
components of pain [255,351,352,392]. There exist other models/tests [21,140,258] in which 
inflammatory mediators (e.g., serotonin, bradykinin, prostaglandins [166,307,341]), chemical 
irritants (e.g., formalin [110]), or biological irritants (e.g., carrageenan, CFA) are injected in the 
paws to assess nociception and ongoing inflammatory pain. A CFA-soaked cuff can also be 
directly applied to the sciatic nerve to produce neuritis, a localized inflammation, that can also 
induce mechanical/thermal hypersensitivity (see [39,93–95]). Electrical stimulation is also 
sometimes used, but this form of stimulation does not accurately reflect naturally occurring 
threats for rodents [21]. Inflammatory pain is an equally important component in clinical pain 
conditions worthy of addressing [392], but I felt it necessary to limit the scope of my review to 
examples of mechanical and/or thermal hypersensitivity induced by neural injury.  
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Table 2. Non-exhaustive review of the behavioral evidence for pain-like states in rat models of 
surgically-induced neural injury. References (superscript corresponds to the table, number in 
brackets corresponds to bibliography): 1Andrews et a., Eur J Pain, 2012 [11]; 2Attal et al., Pain, 
1990 [13]; 3Baastrup et al., Brain Res, 2011 [15]; 4Baastrup et al., Pain, 2010 [16]; 5Baastrup et 
al., Scand J Pain, 2018 [14]; 6Bannister et al., Pain, 2017 [19]; 7Basbaum, Exp Neurol, 1974 
[22]; 8Bedi et al., J Neurosci, 2010 [28]; 9Bennett and Xie, Pain, 1988 [31]; 10Bravo et al., 
Anesthesiology, 2012 [42]; 11Bravo et al., Pain, 2013 [41]; 12(Burke et al., Brain Behav Immun, 
2014 [48]; 13Burke et al., Genes Brain Behav, 2013 [47]; 14Carlton et al., Pain, 2009 [57]; 
15Chen et al., PLoS ONE, 2014 [65]; 16Clatworthy et al., Neurosci Lett, 1995 [77]; 17Dalm et al., 
Pain, 2015 [85]; 18Decosterd and Woolf, Pain, 2000 [88]; 19Detloff et al., Exp Neurol, 2010 [90]; 
20Ding et al., Behav Brain Res, 2010 [96]; 21Djouhri et al., J Neurosci, 2006 [105]; 22Djouhri et 
al., Pain, 2012 [103]; 23Dowdall et al., Pharmacol Biochem Behav, 2005 [108]; 24Eschenfelder 
et al., Pain, 2000 [116]; 25Fukuhara et al., Cell Mol Neurobiol, 2012 [125]; 26Galan-Arriero et al., 
Neurosci Lett, 2015 [126]; 27Goncalves et al., Exp Neurol, 2008 [134]; 28Grace et al., Brain 
Behav Immun, 2018 [137]; 29Grace et al., Proc Natl Acad Sci U S A, 2016 [138]; 30Hogan et al., 
Anesthesiology, 2004 [165]; 31Hu and Xing, Pain, 1998 [167]; 32Huang et al., Pain, 2012 [169]; 
33Hubbard et al., Neuroimage, 2015 [170]; 34Hulsebosch et al., J Neurotrauma, 2000 [171]; 
35Kim and Chung, Pain, 1992 [163]; 36Kim et al., Exp Brain Res, 1997 [190]; 37King et al., Nat 
Neurosci, 2009 [192]; 38Kingery et al., Pain, 1993 [193]; 39Kontinen et al., Pain, 1999 [198]; 
40Krupina et al., Bull Exp Biol Med, 2002 [201]; 41LaGraize and Fuchs, Exp Neurol, 2007 [206]; 
42LaGraize et al., Exp Neurol, 2006 [205]; 43Lee et al., Eur J Pain, 2003 [215]; 44Lee et al., Exp 
Brain Res, 1998 [214]; 45Lee et al., Neuroreport, 2000 [213]; 46Leite-Almedia et al., Pain, 2012 
[217]; 47Li et al., Mol Cell Neurosci, 2003 [220]; 48Liu et al., Sci Rep, 2015 [226]; 49Luedtke et 
al., J Neurotrauma, 2014 [232]; 50Ma et al., Mol Pain, 2010 [234]; 51Maldonado-Bouchard et al., 
Brain Behav Immun, 2016 [236]; 52Maves et al., Pain, 1993 [242]; 53McNabb et al., Neurosci 
Lett, 2012 [243]; 54Ning et al., Neurol Res, 2014 [261]; 55Qu et al., Biomed Res Int, 2016 [293]; 
56Qu et al., Pain, 2011 [291]; 57Roeska et al., Pain, 2009 [303]; 58Sang et al., Mol Pain, 2018 
[310]; 59Seltzer et al., Pain, 1990 [319]; 60Seminowicz et al., Neuroimage, 2009 [320]; 61Shao et 
al., Evid Based Complement Alternat Med, 2015 [325]; 62Sheth et al., Pain, 2002 [327]; 63Song 
et al., J Neurophysiol, 1999 [333]; 64Sweitzer et al., J Pharmacol Exp Ther, 2001 [339]; 
65Sweitzer et al., Neuroscience, 2001 [338]; 66Tabo et al., Pain, 1999 [340]; 67Tawfik et al., J 
Pharmacol Exp Ther, 2001 [345]; 68Vierck et al., J Pain, 2005 [350]; 69Wall et al., Pain, 1979 
[354]; 70Wang et al., Anesthesiology, 2011 [363]; 71Wang et al., BMC Neurosci, 2015 [364]; 
72Wei et al., Pharmacol Biochem Behav, 2013 [366]; 73Wu et al., J Pain, 2010 [375]; 74Wu et al., 
Pain, 2013 [377]; 75Xie et al., Neural Plast, 2016 [382]; 76Yang et al., J Neurosci, 2014 [389]; 
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77Zeltser et al., Pain, 2000 [395]; 78Zeng et al., Brain Res, 2008 [397]; 79Zhang et al., J 
Neurophysiol, 1999 [400]; 80Zhang et al., Neural Plast, 2015 [401]; 81Zhang et al., Neurosci Lett, 
2008 [402]. CCI, chronic constriction injury; CCD, chronic compression of DRG; CPP, 
conditioned place preference; DRG, dorsal root ganglia; EPM, elevated plus-maze; EZM, 
elevated zero-maze; FST, forced swim test; L4/L5/L6, lumbar segment 4, 5, or 6; PSI, partial 
sciatic injury; SCI, spinal cord injury; SNI, spared nerve injury; SNL, spinal nerve ligation.  
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During my review, I noted any behavioral evidence that would suggest the potential for 
pain perception and/or anxiodepressive phenotypes. This includes altered motivational states 
(e.g., altered preferences, avoidance of noxious stimuli, seeking relief) and/or nocifensive 
behaviors (e.g., tending to an injured paw, licking) whose elicitation potentially requires 
cognition. I also limited my review to anxiety- and depression-like behaviors as they are two of 
the most common comorbidities associated with neuropathic pain. There is simply insufficient 
evidence to draw strong conclusions about pain perception and alterations in emotional states 
in the rhizotomy, CCD, and miscellaneous nerve transection models. As I mentioned, limb 
autotomy prevents proper behavioral investigations in the rhizotomy and miscellaneous nerve 
transection models, but others have argued occurrence of limb autotomy itself is sufficient 
evidence for a pain-like state as autotomy reflects rats’ direct response to dysesthesias and 
pain [78]. Limb autotomy is also observed following SNL, but less frequently. Studies using the 
CCD model preferentially use reflex tests, possibly explaining the lack of stronger evidence. 
However, one study does demonstrate CCD rats exhibit a thermal preference for the 30°C side 
of a hot plate over 35°C side [382], which could be interpreted as a passive avoidance 
behavior. There is ample evidence of pain-like states in rats with SCI, SNL, CCI, PSI, or SNI. 
For example, evoked vocalizations have been described in rats with SCI, CCI, or PSI when a 
mechanical force is applied to a sensitive region of the body above or below the site of SCI or 
affected paws in the case of CCI and PSI. It should be noted SCI-induced spasticity can be 
difficult to assess and it is possible reflexive responses evoked below injury are not cerebrally 
mediated [16]. Other nocifensive behaviors like spontaneous licking and limb guarding occur in 
rats with SNL, CCI, or PSI. During my review I did not encounter SNI studies with similar 
descriptions.  
Much of the evidence for pain perception in Table 2 comes from behavioral tests with 
more descriptive power than standard reflex tests; many of the studies were conducted 
during/after commentary critical of the pain field [253,255,351]. Operant tests like the PEAP 
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and CPP offer more conclusive evidence of pain perception [256,286,352]. Rats with SCI, SNL, 
CCI, or SNI will avoid mechanical stimulation (sometimes noxious, see [375]). This 
demonstrates the mechanical stimuli are considered to be aversive. Rats with SCI, SNL, or SNI 
exhibit a preference for analgesic-paired chambers, suggesting the presence of spontaneous 
pain and drive to seek relief. The CCI model appears to be an exception, Dalm et al. [85] report 
CCI rats do not develop CPP when bupivacaine is used for chamber pairing. They also do not 
see significant increases in dorsal horn neuronal activity that would suggest peripherally-driven 
spontaneous pain [85]. No other studies have investigated CCI-induced spontaneous pain 
using the CPP test.  
The evidence for anxiety phenotypes in rats with SNL, CCI, PSI, or SNI are 
inconsistent, possibly due to multiple uncontrolled factors (e.g., missing controls, low power; 
see [29,253,290,334]). For example, Bravo et al. [41] do not report naïve controls for the 
marble burying test, which might have revealed both sham and CCI rats develop anxiety. 
Inconsistencies across studies might also reflect heterogeneity in rats and humans in regards 
to development of pain-associated comorbidities. One study shows PSI decreases 
spontaneous burrowing behavior [11], but it is unclear whether it is due to evoked pain in 
affected limbs or ongoing/spontaneous pain, or if burrowing is a general measure of an 
animal’s well-being [87,177]. There is even less evidence from which to draw strong 
conclusions about injury-induced depression. Unintended damage to the L4 nerve during the 
SNL surgical procedure can cause partial paralysis (see [163]), which might explain for rats’ 
inability to swim in the Kontinen et al. study [198]. Otherwise, the presence of anhedonia (i.e., 
inability to feel pleasure; injured rodents do not exhibit a preference for sucrose-flavored water) 
in some of the models does accurately reflect human conditions, especially in persons with SCI 
[371]. Greater emphasis needs to be placed on using behavioral tests that might reveal anxiety, 
depression, and other comorbidities associated with neuropathic pain. 
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1.4. Using an operant mechanical conflict test to reveal pain-avoidance behaviors in 
freely behaving rodents 
Some of the strongest evidence for pain caused by neural injury comes from operant 
behavioral tests. One of the tests for nociception/pain perception I included in Table 1, but did 
not discuss in context of Table 2, is the operant MC test and mechanical conflict system (MCS) 
device developed by Harte et al. [155] (see also [210]). The MC test is theoretically a marked 
improvement over mechanical reflex tests and operant tests like the PEAP which capture 
rodents’ decisions to avoid noxious stimulation. I think the MC test and device might be 
appealing to pain researchers due possible improvements in descriptive power of pain-
avoidance behaviors. Unfortunately, it is a relatively new test and has received little attention 
compared to many other tests I described. In this section I want to briefly cover the benefits 
associated with the MC test and review current literature. This will set the stage for my 
behavioral study in Chapter 2. 
The MC test is an operant behavioral paradigm that combines “dose”-dependent testing 
of evoked noxious stimuli with free-choice; rodents can decide whether or not they want to 
escape from a brightly lit chamber by crossing over a floor lined with sharp probes. Rodents 
assess the painful risk associated with crossing the probes and exhibit longer latencies to 
escape the brightly lit chamber as probe height increases [155]. The currently established 
outcome measure is the escape latency (i.e., time it takes a rodent to leave the light chamber 
and step onto the probes with all 4 paws). Under painful neuropathic conditions like CCI [155], 
diabetic neuropathy [143], and SNI [326], rats and mice exhibit longer escape latencies. Among 
other benefits, the test removes the potential for unconscious experimenter bias inherent in 
reflex tests and PEAP that utilize hand-held stimuli [38]. The fact that freely behaving rodents 
actively avoid the probes demonstrates they find them to be truly aversive, thus providing 
stronger evidence for pain-like states in the aforementioned conditions. Brain regions that 
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mediate the affective-motivational components of pain are recruited during performance in the 
MC test [271], similar to the PEAP [205,206,403]. 
1.4.1. Review of current literature using the operant mechanical conflict test 
There are currently only 6 studies that report use of the MC test and device. Careful 
review (see Table 3 and references in legend) shows there is an underrepresentation of critical 
sham controls in studies that report use of injury models, and the majority of studies rely upon a 
single behavioral metric to describe pain-avoidance behavior. Reflex tests are also omitted for 
validation of mechanical nociception in several studies. The earliest known study from 2012 
measures the time rats spend on the probes [210]. Rats with a blunt force SCI injected with a 
herpes simplex virus-based gene transfer vector for the anti-inflammatory cytokine interleukin-
10 (vIL10) spend more time on the probes than SCI rats injected with control vector. Lau et al. 
conclude SCI-induced pain and performance in the MC test are influenced by activation of the 
neuroimmune system. One would reasonably extrapolate that naïve and/or sham rats behave 
similarly to vIL10-treated SCI rats, but these controls were not introduced to the MC test even 
though the study mentions use of shams for other experiments. No other study has followed up 
on measuring time on the probes. In 2016, Harte et al. describe a more rigorous training 
regimen and reproducible outcome measure to be used for the MC test (i.e., escape latency) 
[155]. Rats with CCI exhibit longer escape latencies than naïve controls on probes ranging 0.5 
to 4 mm in height. They also demonstrate analgesics like pregabalin and morphine attenuate 
this behavior. Again, sham rats were not tested in any context. Later studies investigating 
painful diabetic neuropathy in rats [143], morphine dependency in naïve rats [271], and SNI in 
mice [326] all measure escape latency without other measures of performance in the MC test. 
Sham surgery controls were not relevant in the diabetic neuropathy or morphine dependency 
study. The SNI study is particularly interesting for several reasons: 1) it is the only study to use 
mice, 2) it includes use of sham surgery controls, and 3) it includes use of the opioid analgesic 
buprenorphine on both SNI and sham mice at 8 days post-surgery. Shepherd and Mohapatra 
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demonstrate that SNI in mice, like CCI in rats [155], increases escape latency and is attenuated 
by buprenorphine [326]. However, the experiment appears to be missing a critical vehicle-
treated sham group that is not mentioned in the study. At 8 days post-surgery buprenorphine 
may have masked acute postsurgical pain in sham mice, but this possibility cannot be 
addressed without a vehicle-treated sham group for comparison. It is not explained why this 
control was not performed. Furthermore, the SNI effect on escape latency is skewed by 3 of the 
8 mice tested. There appears to be a bimodal distribution in escape latencies, which suggests 
escape latency is not effectively capturing some aspect of pain-avoidance behavior. Perhaps 
the underlying pain-like state induced by SNI is not uniform in rodents – like other peripheral 
neuropathies in humans [20] – and can be qualitatively/quantitatively distinguished. Indeed, 
other studies will sometimes segregate rodents (e.g., no “pain”, yes “pain”) based on measures 
of other behavioral tests. The most recent study (2018) using the MC test explores the role of 
exercise therapy in mitigating neuropathic pain following contusive SCI in rats [67]. Chhaya et 
al. segregate SCI rats into “pain” and “no pain” groups based on their percent change from 
baseline in mechanical withdrawal thresholds following SCI. The authors conclude that 
exercise promotes a modest improvement in the MC test (i.e., reduced escape latency), but the 
effects are not statistically significant. Unfortunately, no sham control groups were included for 
comparison. Chhaya et al. also demonstrate that escape latencies in SCI rats with or without 
exercise, and with or without pain, do not correlate with von Frey reflex tests. This suggests the 
two tests may not reflect similar aspects of pain-related behavior.  
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Table 3. Summary of research articles that report use of the operant mechanical conflict test. 
References (superscript corresponds to the table, number in brackets corresponds to 
bibliography): 1Lau et al., Neurorehabil Neural Repair, 2012 [210]; 2Harte et al., PLoS ONE, 
2016 [155]; 3Griggs et al., J Pain, 2016 [143]; 4Pahng et al., Neuroscience, 2017 [271]; 
5Shepherd and Mohapatra, Neuropharmacology, 2018 [326]; 6Chhayah et al., J Neuroatrauma, 
2018, in press [67]. CCI, chronic constriction injury; CFA, complete Freund’s adjuvant; IL-10, 
cytokine interleukin-10; NSAID, nonsteroidal anti-inflammatory drug; PDN, peripheral diabetic 
neuropathy; SCI, spinal cord injury; SNI, spared nerve injury; ZDF, Zucker Diabetic Fatty rats; 
ZL, Zucker Lean rats.  
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1.4.2. Improving the validity of the operant mechanical conflict test  
Several studies have demonstrated the MC test to be useful for assessing mechanical 
nociception and pain-avoidance behavior. However, a thorough review of current literature has 
revealed missing information and several unanswered questions. I think there is an unmet need 
for additional validation of multiple neuropathic injury models with their appropriate sham 
control groups and more thorough quantitative analyses to better understand how neuropathic 
pain conditions influence avoidance behaviors in the MC test. Experiments that address the 
following questions will improve the validity of the MC test as an informative test for revealing 
aversive pain-like states. To outline:  
1) Do rodents in sham-operated control groups for surgically-induced neuropathic pain 
conditions also avoid the probes in the MC test? 
2) Are there additional behaviors elicited during the MC test that could more effectively 
reveal the presence of an aversive pain-like state? 
3) Does the standard reflex measure of mechanical sensitivity accurately predict pain-
avoidance behavior in the MC test?  
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Chapter 2: Persistent postsurgical pain caused by sham surgeries for neuropathic pain 
models is revealed by behavioral alterations in an operant conflict test 
Disclosure: The work described in this chapter was performed in collaboration with the Grace 
Lab at The University of Texas MD Anderson Cancer Center in Houston, TX, that includes the 
following: Peter M. Grace, PhD, Michael J. Lacagnina, PhD, and Jiahe Li, PhD. The Grace Lab 
has given their permission for portions of the text, results, and figures relating to the use rats 
with a chronic constriction injury, and related controls, to be included in this chapter. A 
manuscript has been submitted to the journal Pain with Max A. Odem, Michael J. Lacagnina, 
and Stephen L. Katzen as co-first authors. Additional authors include Jiahe Li, Peter M. Grace, 
and Edgar T. Walters as the corresponding, senior author. 
2.1. Rationale 
In principle, an operant test in which an animal's voluntary behavior discloses the 
aversiveness of a test stimulus might reveal evoked pain that has not been evident in reflex 
tests. We modified the MC test to take advantage of rats’ innate drive to explore novel 
environments [113], allowing efficient measurement of pain-related changes in a rat's 
motivation to repeatedly cross noxious probes. Prior studies using the MC test usually 
habituated exploratory behavior prior to testing and permitted only a single crossing of the 
probes, measuring the escape latency [67,143,155,210,271,326]. Pilot experiments using 
sham-operated and rats with SCI tested several months post-surgery revealed both groups 
avoided the noxious probes, suggesting the MC test may reveal persistent postsurgical 
alterations in behavior. Humans often experience painful hypersensitivity long after surgical 
procedures similar to those used to expose peripheral nerves or the spinal cord in rodent 
neuropathic pain models [64]. Sham controls are sorely underrepresented in prior studies that 
use the MC test [67,143,155,210,326]. Here we use our modified MC test to reveal previously 
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unrecognized postsurgical alterations in behavior after the sham surgeries for a thoracic T10 
SCI, L5 SNT, and CCI of the sciatic nerve. 
2.2. Materials and methods 
2.2.1. Animals 
 All procedures followed the guidelines of the International Association for the Study of 
Pain and were approved by the Animal Care and Use Committees for the University of Texas 
Health Science Center at Houston (UTHealth) and the University of Texas MD Anderson 
Cancer Center. Male, Sprague-Dawley rats (Envigo, USA) were used at both institutions. At 
McGovern Medical School, the rats (250-300 g, 2 per cage) were acclimated to a controlled 
environment (12-hour reverse light/dark cycle, 21 ± 1°C) for ≥4 days before beginning 
experiments. The corn cob bedding was replaced 2-3 times per week while food and water 
were provided ad libitum. At MD Anderson Cancer Center, the rats (10 weeks old, 2-3 per 
cage) were acclimated to the controlled laboratory environment (12-hour light/dark cycle, lights 
on at 07:00 h, 22 ± 1°C) for at least 7 days before beginning experiments. The corn cob 
bedding was replaced once per week while food and water were provided ad libitum. 
2.2.2. Injury models and surgical procedures 
Spinal cord injury 
Surgeries were performed at McGovern Medical School as previously described 
[25,28,377,389]. Anesthesia in most of the studies (see Figures 4-6) was by isoflurane 
(induction 4-5%; maintenance 1-2%). In the remainder (see Figure 3 and 7), intraperitoneal 
(i.p.) injection of ketamine (60 mg/kg), xylazine (10 mg/kg), and acepromazine (1 mg/kg) was 
used. Rats were determined to be deeply anesthetized and areflexic before proceeding. Local 
anesthetic (bupivacaine, 2 mg/kg) was delivered subcutaneously (s.c.) at the incision site near 
T10 before incising the skin from T8-T12. Laminectomy of the T10 vertebrae was followed by 
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contusion impact (150 kdyne, 1 s dwell time) using an Infinite Horizon Spinal Cord Impactor 
(Precision Systems and Instrumentation, LLC, Fairfax Station, VA, USA). Following impact, the 
paravertebral muscles were closed with vicryl-coated, absorbable suture and the skin incision 
was closed with 9 mm wound clips. Sham rats received the same laminectomy surgery minus 
spinal impact. Rats were returned to their home cage and placed on a heating pad maintained 
at 37°C. The analgesic buprenorphine hydrochloride (0.02 mg/kg; Buprenex, Reckitt Benckiser 
Healthcare Ltd., Hull, England, UK) was administered in 0.9% saline (2 mL/kg, i.p.) twice, daily 
up to 5 days post-surgery. The prophylactic antibiotic enrofloxacin (0.3 mL; Enroflox, Norbrook, 
Inc., Overland Park, KS, USA), was also administered in 0.9% saline daily up to 10 days post-
surgery. Manual bladder evacuations were performed twice, daily until rats recovered 
neurogenic bladder voiding. The day after surgery hindlimb locomotion was assessed using the 
Basso, Beattie, and Bresnahan (BBB) Locomotor Rating Scale [24]. Only sham rats with BBB 
scores of 21 for both hindlimbs were accepted. The majority of SCI rats were scored a 0 or 1 
for both hindlimbs 1 day after surgery. Naïve rats were transported to the surgical suite at the 
same time as surgeries were performed, but were otherwise left undisturbed in their home 
cages. 
Spinal nerve transection 
Surgeries were performed at McGovern Medical School. A modified version of the SNL 
model [163] was used in which the L5 spinal nerve was transected without ligation 
[338,339,345], herein referred to as the SNT procedure. Rats were anesthetized using 
isoflurane (induction 4-5%; maintenance 1-2%) and local anesthetic (bupivacaine, 2 mg/kg, 
s.c.) was used before incising the skin above the lumbar spine. The left transverse process at 
L6 was removed and the ventral rami of the L4 and L5 spinal nerves were exposed. The L5 
nerve was axotomized using microdissection scissors and a 1-2 mm segment of the distal L5 
stump was removed. Manipulation of the L4 nerve was minimal, it was not cut. The 
subcutaneous layers were sutured closed using vicryl-coated absorbable suture and the 
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cutaneous layer was closed using 9 mm wound clips. The sham surgery was the same minus 
transection of the L5 nerve. An analgesic (0.02 mg/kg; Buprenex) was administered twice, daily 
(2 mL/kg, i.p.) up to 2 days post-surgery and an antibiotic (0.3 mL; Enroflox) was also 
administered daily up to 10 days post-surgery. Naïve rats were transported to the surgical 
suite, but were otherwise left undisturbed in their home cages. 
Chronic constriction injury 
Surgeries were performed at MD Anderson Cancer Center. Neuropathic pain from 
peripheral injury was induced using the CCI model of unilateral sciatic nerve injury [31] as 
previously described [137,138]. Rats receiving CCI or sham surgeries were anesthetized with 
isoflurane (4% in oxygen for induction; 2-3% maintenance) and placed on an electric heating 
pad. Skin at the mid-thigh level of the left leg was shaved with an electric razor and cleansed 
with povidone-iodine and 70% ethanol. An incision of the skin was made with a scalpel blade 
and the sciatic nerve was exposed through blunt dissection of the biceps femoris muscle. Using 
glass nerve hooks, a segment of the sciatic nerve was gently liberated from the surrounding 
connective tissue. For CCI surgeries, 4 ligatures (4-0 chromic gut; Ethicon, USA) were loosely 
tied around the sciatic nerve approximately 1 mm apart. For sham surgeries, the sciatic nerve 
was manipulated with nerve hooks and isolated in an identical fashion, but no chromic gut 
ligations were sutured around the nerve. The muscle layer was closed with non-absorbable 
sutures (4-0 silk; Ethicon, USA), 9 mm wound clips were applied to close the skin, and rats 
were then returned to their home cage and monitored post-operatively until fully ambulatory. 
Naïve rats were transported to the surgical suite, but were otherwise left undisturbed in their 
home cages. 
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2.2.3. Behavioral testing procedures 
Habituation to ambient testing conditions 
At McGovern Medical School, rats were acclimated to the behavioral testing room each 
morning for 1 hour under red light and constant background white noise generated by a 
TaskMasking speaker (K.R. Moeller Associates Ltd., Burlington, Ontario, Canada). Several 
days prior to testing the rats were acclimated to the presence of an investigator and the acrylic 
chambers (IITC Life Science Inc., Woodland Hills, CA, USA) used to isolate rats for hindpaw 
reflex tests. During gentling (i.e., handling and acclimation to experimenters) the rats were 
placed in the chambers on raised wire-mesh platforms for 20 minutes and periodically fed 
sweetened cereal. Two experimenters were female (<30 years old) and one experimenter was 
male (>30 years of age). Male and female experimenters did not perform tests on the same 
days in order to limit male-induced stress and analgesia [334]. 
At MD Anderson Cancer Center, rats were acclimated to the behavioral testing room for 
at least 1 hour under red light illumination prior to each behavioral test. Rats were handled by 
the experimenter in 5 min sessions over 3 days. Habituation to hindpaw reflex testing occurred 
by placing rats in acrylic chambers on raised wire-mesh platforms for 60 min sessions over 3 
days. One female and one male experimenter (>30 years of age) performed all experiments, 
and each rat was always manipulated by the same experimenter. 
Hindpaw mechanical sensitivity 
At McGovern Medical School, hindpaw sensitivity to mechanical stimuli was measured 
at 1-2 months post-surgery for naïve, sham, and SCI rats. For SNT experiments, naïve, sham, 
and SNT rats were tested up to 1.5 weeks post-surgery. Following habituation and gentling 
procedures, the rats were placed in acrylic chambers and the 50% mechanical withdrawal 
threshold was assessed using the “up-down” method [63,90,98,99] of presenting calibrated von 
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Frey filaments (Stoelting Co., Wood Dale, IL, USA). The range of logarithmically incremental 
filaments used included (in grams): 0.4, 0.6, 1.0, 1.4, 2.0, 4.0, 6.0, 8.0, 10.0, 15.0, 26.0, 60.0. 
Filaments (starting with 6.0 g) were presented perpendicularly to the plantar surface of the 
hindpaw between the footpads at a constant speed until the filament bent. Filaments were held 
for ~1 s before removal. Each hindpaw was presented with a series of 10 stimuli, spaced 30 s 
apart to provide consistent testing durations and treatment. A rapid, robust withdrawal of the 
hindpaw from the filament was considered to be a positive response and care was taken to not 
present stimuli during ambulatory movements in the chamber. In experiments using SCI rats 
the withdrawal thresholds for the left and right hindpaws were calculated separately and then 
averaged together for a single score per rat. Thresholds for the ipsilateral (side of injury) and 
contralateral hindpaws were calculated separately for experiments with SNT and sham rats. 
For CCI experiments at MD Anderson Cancer Center, the naïve, sham, and CCI rats were 
tested 2 weeks post-surgery using the “up-down” method. The range of filaments included (in 
grams): 0.4, 0.6, 1.2, 1.4, 2.0, 4.0, 6.0, 8.0, 10.0, 15.0. Filaments were administered to the 
distal portion of the heel [137,138]. The mechanical thresholds for the two hindpaws were 
scored separately. 
All mechanical withdrawal thresholds were log transformed to account for Weber’s Law 
[251]. Mills et al. demonstrate that the original equation used to calculate the 50% paw 
withdrawal threshold (PWT; in grams) described by Chaplan et al. [63] can be reduced to the 
following: 
Log(PWT) = Xf + Ƙδ – 4 
where Xf = the final filament used (i.e., the filament handle #), Ƙ = the tabular value for the 
delivered sequence of test stimuli (refer to table in [63]), and δ = the mean difference between 
the delivered sequence of test stimuli (calculated using the filament handle #’s). The filament 
handle # = Log10 of (10 x filament force in milligrams) (Stoelting Co. Touch TestTM Sensory 
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Evaluators Operation Manual), indicating the handle #’s can be used in the Chaplan or Mills 
equations without converting gram forces into log units. Also, δ is not a fixed value. Note that 
gram forces between 1 g and 0 yield negative numbers when log transformed. 
Hindpaw heat sensitivity 
Hindpaw sensitivity to radiant heat [152] was measured at 1-2 months post-surgery for 
naïve, sham, and SCI rats. Experiments with SNT and CCI rats did not test heat sensitivity in 
order to limit the exposure to hyperalgesic test stimuli that might influence the results of the 
subsequent MC tests. Once habituated and gentled, the rats were placed in acrylic chambers 
on a glass platform (Plantar Analgesia Meter; IITC Life Science Inc., Woodland Hills, CA, USA) 
and acclimated to the 30°C temperature-controlled surface [97] for 20 minutes. Settings for the 
radiant heat stimulus: idle beam intensity = 10%, active beam intensity = 45%, active beam 
cutoff = 20 seconds. While idle, the light beam was positioned between the footpads of either 
the left or right hindpaw, and once positioned the active beam was turned on. A rapid, robust 
withdrawal of the hindpaw was considered a positive response to the radiant heat stimulus. 
Rats that did not exhibit a withdrawal by the time of the automatic active beam cutoff were 
given a score of 20 seconds. Tests continued until the withdrawal latency was recorded 5 times 
for each hindpaw, switching back and forth between the hindpaws every 30 seconds. If 
ambulatory movements occurred during presentation of the stimulus the active light beam was 
turned off, the experimenter waited 30 seconds, and the other hindpaw was tested. The 
average withdrawal latency for each hindpaw was calculated using the 3 middle latencies, the 
highest and lowest latencies were omitted. The two hindpaw latencies were then averaged 
together for a single score per rat. 
Operant mechanical conflict tests 
Voluntary pain-related aversion to a noxious stimulus was assessed using the 
mechanical conflict system (MCS; Coy Laboratory Products, Inc., Grass Lake, MI, USA). The 
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MC test presents rats with a choice in responding to two aversive stimuli – remain exposed to 
an aversive bright light or escape the light by crossing a floor covered with sharp probes. 
Longer latencies to leave the light chamber indicate increased motivation to avoid the probes,  
and escape latency is currently the most common measure of pain-related behavior in the MC 
test [67,143,155,271,326]. We found (pilot studies and see Figure 3) that when the MCS is still 
relatively novel, uninjured rats cross the noxious probes multiple times. The repeated return to 
the brightly lit chamber across the sharp probes indicates the presence of a second motivation 
to cross the probes, which is probably the rats’ exploratory drive in a novel environment [113]. 
We modified the MC paradigm of Harte et al. [155] so that both motivations to cross – 1) to 
escape the light and 2) to explore the MCS – were in conflict with the aversiveness of the 
noxious probes. 
Harte et al. describe a lengthy familiarization procedure to the MCS that lasts 1-2 days 
followed by an escape training procedure that lasts 3-5 days, with a total of 10 to 19 
opportunities (each 5 minutes duration) for the rat to explore the MCS before experiencing the 
sharp probes [155]. During this training the rats learn that when the exit door opens they can 
escape from the light room and reach the dark room. We abbreviated the MC test by combining 
the familiarization and training procedures into three 5 minute familiarization trials without the 
probes, repeated 3 times on day 1, spaced 30-60 minutes apart. In each trial: 1) a rat was 
placed inside the light chamber with the lid closed, the light off, and the exit door closed, 2) 
after 20 seconds the light was turned on, 3) after 15 seconds the exit door was opened when 
(or if) the rat faced the exit, 4) the rat freely explored all 3 chambers in the MCS for 5 minutes, 
5) the was rat was returned to its home cage, and 6) the MCS was thoroughly cleaned with 
70% ethanol (in distilled water) in preparation for the next trial. The rats rapidly learned to 
escape the light room as soon as the exit door was opened. Indeed, rats sometimes attempted 
to lift the door on their own by the second or third trials. For SNT experiments, rats received a 
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second day of 3 trials without probes the 1 day after surgery to assess any acute postsurgical 
effects on movement in the absence of probes before later testing with the probes. 
After the familiarization trials, rats underwent a 1-day testing sequence in which they 
were challenged with the probes. The first trial (baseline) was without probes to reacquaint the 
rats with the MCS. In the first study (Fig. 2, first SCI timeline), probe height was successively 
increased to 1, 2, 3, and 4 mm in 3-minutes trials spaced ~30 minutes apart. Probe heights 
were presented in ascending order to minimize possible sensitizing effects from higher probes 
and to permit testing multiple probe heights per rat on a single day. A shorter, 3-trial protocol in 
which rats were challenged with the probes twice was used in subsequent experiments (Fig. 2, 
second SCI, SNT, and CCI timelines). The testing sequence started with a single trial at 0 mm, 
followed by 2 trials at 4 mm, 5 minutes per trial, spaced ~30 minutes apart. All SCI rats were 
capable of weight-supported plantar stepping with BBB scores ≥10 by the time of testing, 
meaning they could readily traverse the probes without bodily harm. 
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Figure 2. Timelines of the operant mechanical conflict test used to measure changes in 
avoidance of noxious probes in three neuropathic pain models and their sham-surgery controls. 
Numbers (in mm) indicate elevation of the sharp probes above the floor of the middle chamber. 
Familiarization refers to the 5-minute periods in which the rat is free to explore the 3-chamber 
test device in the absence of elevated probes (0 mm). On the probe exposure day (test day), a 
baseline exposure to the 0-mm probe condition is given for comparison to responses during the 
two subsequent noxious probe exposures. CCI, chronic constriction injury; mm, millimeter; SCI, 
spinal cord injury, SNT, spinal nerve transection. Figure prepared by Max A. Odem. 
 
All trials during training and probe testing were video recorded in 1080i resolution at 30 
frames per second using a Panasonic HC-V750 camcorder (Panasonic Corporation, Osaka, 
Japan) or 1080p resolution at 30 frames per second using an Apple iPhone (Apple Inc., 
Cupertino, CA, USA) and scored by a blinded experimenter. The following measures were 
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collected for post-hoc analysis: 1) the escape latency during the first crossing, 2) the number of 
crossings of the probe chamber, and 3) the total time elapsed to the completion of the second 
crossing. A subset of videos were scored for behavioral measures that might reveal above-
level mechanical hypersensitivity in the forepaws [28]. The number of times each rat withdrew 
one of their forepaws after contacting the probes was scored. No formal definitions of a 
crossing currently exist for the MC test, and measures other than escape latency depend upon 
this definition. We defined the first crossing as the rat placing all 4 paws inside the dark 
chamber after leaving the light chamber. Every subsequent crossing was defined as the rat 
placing its head and two forepaws inside the light or dark chamber. 
2.2.4. Data analysis and experimental design 
Statistical analyses were performed using Prism v7.03 (Graphpad Software, Inc., La 
Jolla, CA, USA). Data are presented as the mean ± standard error (SEM), median with 
interquartile range, or as incidence (% of rats tested). The Shapiro-Wilk test was used to 
assess normality for continuous measures. Planned comparisons between naïve, sham, and 
injury groups were made using 1-way ANOVA or Kruskal-Wallis tests followed by Tukey’s or 
Dunn’s post-hoc tests. Comparisons between incidence measures were made using Fisher’s 
exact tests with Bonferroni corrections for multiple comparisons. Significance for all statistical 
tests was set at P < 0.05 and all reported P values are two-tailed. 
Hindpaw withdrawal measures 
Mechanical withdrawal thresholds collected from naïve, sham, and SCI rats at 1-2 
months post-surgery by a single female experimenter were compared using a 1-way ANOVA 
followed by Tukey’s post-hoc test. Potential relationships between mechanical withdrawal 
thresholds and measures of SCI severity (contusion displacements and day 1 post-SCI BBB 
scores) were assessed by a Spearman correlation. Heat withdrawal latencies collected from 
naïve, sham, and SCI rats at 1-2 months post-surgery by a single female experimenter were 
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compared using 1-way ANOVA followed by the Tukey’s post-hoc test. For SNT and CCI 
experiments, mechanical withdrawal thresholds for the ipsilateral (injured) and contralateral 
(uninjured) paws were compared, separately, across naïve, sham, and injured groups using a 
1-way ANOVA or Kruskal-Wallis test followed by Tukey’s or Dunn’s post-hoc test. 
Operant mechanical conflict measures 
To determine the effects of probe height on the number of crossings, 1, 2, 3, and 4 mm 
probes trials were compared to the baseline 0 mm probe trial on the same day using repeated 
measures 1-way ANOVA or Friedman tests followed by Dunnett’s or Dunn’s post-hoc test. 
Sphericity was not assumed when using the repeated measures 1-way ANOVA and the 
Geisser-Greenhouse correction was applied. Planned comparisons between groups were 
performed for trials with probe heights found to significantly reduce crossings. Subsequent SCI, 
SNT, and CCI experiments were performed with just two probe exposures using the 4 mm 
probes. Planned comparisons between groups were performed for both exposures. For SNT 
experiments, to determine whether acute postsurgical pain impacted crossings, additional 
baseline trials (3 total) without probes were performed 1 day following surgery and averaged 
together. Postsurgical trials (days 1 and 3) were compared to the averaged pre-surgery 
familiarization trials using the Friedman test followed by Dunn’s post-hoc test. The CCI 
experiments were performed 2 weeks after surgery. 
2.3. Results 
2.3.1. Reduction of repeated voluntary crossing of noxious probes indicates that both 
SCI and sham surgery cause pain-related suppression of exploratory behavior 
 During the 3 familiarization trials without probes in the MCS, all rats in the naïve, sham, 
and SCI groups learned to exit the light chamber quickly (Fig. 3A). No significant differences 
between groups on the 3rd trial were found (1-way ANOVA P = 0.10). Escape latencies 
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measured 24 hours later during the single baseline trial without probes were almost unchanged 
(naïve: 13.0 ± 6.8 s, n = 8 rats; sham: 4.3 ± 1.9 s, n = 8 rats; SCI: 7.1 ± 2.7 s, n = 11 rats; 1-
way Kruskal-Wallis P = 0.50). These are similar to but slightly longer than the escape latencies 
reported for rats that underwent more extensive familiarization and escape training [155]. 
Unexpectedly, many rats voluntarily crossed back into the light chamber as they explored the 
MCS during each familiarization trial (Fig. 3B). The mean number of crossings between groups 
during familiarization trial 3 were not significantly different (1-way ANOVA P = 0.78). Multiple 
returns to the light chamber occurred during familiarization trials in all experiments (SCI, SNT, 
and CCI; see below), suggesting that the motivation to continue exploring the MCS remained 
high enough to offset the aversiveness of the bright light, even after 3 exposures to the MCS. 
This raised two questions: 1) how would exploratory behavior (as indicated by multiple 
crossings) be affected by noxious probes in the middle chamber, and 2) would the response to 
the probes be altered by prior neural injury or surgical injury?  
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Figure 3. Rats make multiple crossings in the brightly lit mechanical conflict system when 
noxious probes are not present. The abbreviated familiarization and training procedure 
consisted of three 5-minute trials spaced ~30 minutes apart. Rats were tested at ~3 months 
post-surgery. Escape latencies (A) and crossings (B) decreased as the groups habituated to 
the MCS. No significant differences between groups were found during trial 3, comparisons 
between groups were assessed using a 1-way ANOVA (escape latencies P = 0.10; crosses P = 
0.78). Note that on average rats crossed back into the light chamber multiple times after 
escaping from the light chamber. Data shown as mean ± SEM. MCS, mechanical conflict 
system; SCI, spinal cord injury. Contributions: Max A. Odem designed experiments, analyzed 
data, and prepared figures; experiments were performed by Tamara McGhee, Kendra C. 
Wicks, and Emily A. Spence. 
 
 These questions were addressed by exposing a new cohort of naïve, sham-operated, 
and SCI rats to a series of trials (3 minutes each) with progressively ascending probe heights 
(0 to 4 mm), spaced 30 minutes apart (see Figure 2, first SCI timeline). The SCI and sham 
rats, but not the naïve rats, crossed the 3 and/or 4 mm probes significantly fewer times than 
they had crossed the middle chamber during the 0 mm baseline trial 90 to 120 minutes earlier 
(Fig. 4A1 and 4A2). There was a trend for SCI and sham rats to cross the 1 and 2 mm probes 
less than the naïve rats, but post-hoc comparisons did not reveal significant differences (1-way 
ANOVA P = 0.14 and 0.19 for 1 and 2 mm probes, respectively). The effects of the 3 and 4 mm 
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probes on escape latency during the first crossing were less clear (Figs. 4B). Some SCI and 
sham rats showed much longer latencies, and a few refused to cross the probes even once. At 
the same time, ~50% of the sham and SCI rats had latencies that were comparable to naïve 
rats. No rats were excluded based on deviant latencies to cross the probes. SCI rats were less 
likely to cross the probes multiple times than naïve rats, and sham rats showed a very similar 
trend (Fig. 4C), with ~50% of the SCI and sham rats refusing to cross the 3 and 4 mm probes a 
second time. These results indicate that 1) exploratory behavior (multiple crossings) in naïve 
rats shows little or no reduction by the presence of noxious probes in the middle chamber, 2) 
prior SCI increases avoidance of the probes (reduces crossing), and 3) the surgical injury used 
as a sham control for the SCI procedure increases avoidance of the noxious probes (1 months 
or longer after injury) similar to the reduction caused by SCI.  
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Figure 4. Spinal cord injury and its corresponding sham surgery enhance pain-avoidance 
behavior in a mechanical conflict test. Rats were exposed to successively ascending probe 
heights (0 to 4 mm). (A1) Crossings on 3- and 4-mm probes were decreased in sham and SCI 
groups. Crossings at each probe height were compared to the 0 mm baseline using a repeated 
measures 1-way ANOVA or Friedman test. Significance levels for sham (stars) and SCI group 
(pound sign) shown for Dunn’s post-hoc tests. (A2) Planned comparisons on 3- and 4-mm 
probe trials revealed reductions in crossings in sham and SCI groups. (B) Escape latencies 
were not different among groups. (C) Some sham and SCI rats refused to cross back into the 
light chamber, indicated by 180-second crossing latencies. Planned comparisons in (A2-C) 
were performed using 1-way ANOVA or Kruskal-Wallis followed by Tukey’s or Dunn’s post-hoc 
test. Data shown as mean ± SEM (A1) and median with interquartile range (A2-C). *P < 0.05, 
**P < 0.01, ***P < 0.001, ****P < 0.0001. ANOVA, analysis of variance; SCI, spinal cord injury. 
Contributions: Max A. Odem and Stephen L. Katzen designed experiments and analyzed 
data; Max A. Odem prepared figures; experiments were performed by Stephen L. Katzen, 
Kendra C. Wicks, and Emily A. Spence. 
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2.3.2. Standard tests for reflex sensitivity show that SCI and perhaps sham surgery can 
increase hindpaw heat sensitivity without increasing mechanical sensitivity 
 The sham surgery effect in the MC test 1-2 months post-injury raised the question of 
whether commonly used assays of reflex sensitivity, the von Frey mechanical sensitivity test 
and the Hargreaves radiant heat test, were sensitive enough to detect differences between 
naïve and sham rats. Hindpaw sensitivity to von Frey filaments was tested using the 
Chaplan/Dixon up-down method to determine 50% threshold [63,98,99], using an extended 
range of filaments compared to many other studies (0.4-60.0 grams, starting filament = 6 
grams, modified from [90]) and log transformed for analysis and display (see [251]). No 
significant differences were found between the naïve, sham, and SCI groups (Fig. 5A). Mean 
non-transformed thresholds for SCI were 51 ± 5 grams, well within the range of gram forces 
observed in non-allodynic Sprague-Dawley rats tested using the Chaplan/Dixon up-down 
method (see [90]). A trend for the SCI rats’ thresholds to be higher than in the naïve and sham 
groups (35 ± 6 grams and 35 ± 7 grams, respectively), suggests that SCI might reduce 
sensitivity to mechanical stimuli under these conditions, in contrast to the mechanical 
hypersensitivity found in previous studies (see Table 2). Within a randomly selected subset of 
rats from the samples shown in Figure 4A, the SCI group exhibited significantly shorter 
latencies for paw withdrawal to a radiant heat stimulus than the naïve group (Fig. 5B), while the 
sham group exhibited latencies intermediate between the naïve and SCI groups, but were not 
statistically different from either group (P = 0.06 and 0.46, respectively). These results are 
similar to those in previous studies, but they also suggest that sham surgery may induce a 
modest increase in sensitivity to noxious heat. 
 The absence of an SCI-induced increase in hindpaw reflex sensitivity to mechanical 
stimuli was unexpected because multiple groups have described SCI-induced below-level 
hypersensitivity in similar mid-to lower thoracic contusive injuries (see Table 2) (e.g., 
[15,16,58,66,90,130,148,151,157,196,259,396]). In principle, insufficient injury to the spinal 
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cord might explain the lack of mechanical hypersensitivity. Two measures were used to assess 
injury severity (see [58,90,196]): tissue displacement during spinal impact recorded by the 
impactor device (in µm) and the BBB score 1 day after injury. As expected (see [58,90,196]), 
our results indicated that the 50% paw withdrawal threshold decreased as contusion 
displacement increased, and that the rate of change (slope of the linear regression) for the 
threshold was in agreement with the post-SCI BBB scores (Fig. 5C). Contusion displacements 
were typical for a 150 kdyne impact [58] and internally consistent with impact data collected by 
the prior surgeon in the lab (data not shown). The mean displacement of 920 ± 28.8 µm and 
the mean BBB score of 1.0 ± 0.4 one day after SCI were also consistent with a moderate SCI 
[58,196], and the significant correlation between the BBB scores and contusions displacements 
(Spearman r = -0.503, P = 0.014) suggested these two measures were in agreement. A 
trending correlation between the 50% PWT and contusions displacements (Spearman r = -
0.409, P = 0.052) was also observed. Moreover, all sham rats exhibited BBB scores of 21 for 
each hindpaw the day after surgery, indicating that unintended damage to the spinal cord 
during the T10 laminectomy had not occurred. Together, these data indicate that neither 
insufficient spinal injury in SCI rats nor inadvertent spinal injury in sham rats can explain the 
apparent lack of mechanical hypersensitivity in SCI rats (Fig. 5A). They also show that 
traditional reflex tests of pain may fail to reveal pain-like alterations in animals in which an 
operant test reveals a persistent increase in evoked pain-like behavior after either SCI or sham 
surgery. 
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Figure 5. Standard measures of reflex sensitivity show postsurgical enhancements to heat but 
not weak mechanical stimuli following spinal cord injury. (A) The 50% PWT 1-2 months post-
SCI was similar in naïve, sham, and SCI groups. Groups were compared using a 1-way 
ANOVA (P = 0.08). Corresponding gram forces indicated on right axis. (B) Withdrawal latency 
to a heat stimulus was lowered in SCI rats. Groups were compared using a 1-way ANOVA 
followed by Tukey’s post-hoc test. A trend was found for lower latencies in the sham compared 
to naïve group (Tukey’s P = 0.06). (C) The 50% PWT (triangles) decreased with increasing 
severity of the SCI, as indicated by two independent measures. Spinal cord displacement (x-
axis) was measured by the controlled impactor device and the post-SCI BBB score (squares) 
was measured 1 day after surgery. Linear regressions: BBB scores y = -0.004706*x + 5.245, 
R2 = 0.193; 50% PWT y = -0.0007266*x + 2.356, R2 = 0.196. Data shown as median with 
interquartile range (A-B). *P < 0.05, **P < 0.01. ANOVA, analysis of variance; BBB, Basso 
Beatie Bresnahan Locomotor Rating Scale; PWT, paw withdrawal threshold; SCI, spinal cord 
injury. Contributions: Max A. Odem and Stephen L. Katzen designed experiments and 
analyzed data; Max A. Odem prepared figures; experiments were performed by Stephen L. 
Katzen, Kendra C. Wicks, and Emily A. Spence. 
 
2.3.3. Voluntary behavior during the mechanical conflict test reveals forepaw 
hypersensitivity in SCI rats 
 Rats with SCI exhibit at- and above-level mechanical hypersensitivity [28] as shown by 
increased forepaw sensitivity to von Frey filaments. Although one study found no correlation 
between SCI-induced paw hypersensitivity measured with von Frey filaments and escape 
latency measured in the MC test [67], our observations suggested that forepaw hypersensitivity 
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after injury might be expressed during voluntary behavior. Video analysis showed that the rats 
often pause before crossing and use their forepaws to investigate the probes. Attempts to 
establish weight support on the probes with their forepaws often produced a rapid withdrawal 
response (Fig. 6A). To test whether prior injury produced forepaw hypersensitivity expressed 
during voluntary behavior, the numbers of rapid forepaw withdrawals from the 1, 2, 3, and 4 
mm probes made during initial investigation of the probes and immediately after the first 
crossing were counted and averaged together to increase statistical power. The SCI group 
showed a significant increase in the number of forepaw withdrawals compared to the naïve 
group (Fig. 6B), and the sham group was statistically indistinguishable from the other groups. 
In principle, each additional trial with the probes reduced their novelty and presumably the rats’ 
drive to investigate. Thus, we also examined the number of forepaw withdrawals made during 
the first probe exposure (1 mm probes). The SCI group exhibited more forepaw withdraws than 
the naïve group, and the sham group was again statistically indistinguishable from the other 
groups (withdrawal number: naïve = 0.1 ± 0.1, sham = 1.8 ± 1.0, SCI = 3.5 ± 0.9; Kruskal-
Wallis P = 0.02; naïve vs SCI comparison with Dunn’s test P = 0.02). Trends for increased 
forepaw withdraws in the SCI and sham groups were found for the trials with the 2, 3, and 4 
mm probes, but the trends were not statistically significant (data not shown). This indicates that 
operant investigations of forepaw hypersensitivity should take into consideration probe novelty. 
These results suggest that, when challenged with a novel, moderately noxious substrate, 
injured rats investigate the substrate more carefully than uninjured rats do before deciding to 
cross, and this investigative behavior reveals heightened sensitivity of the forepaws to noxious 
stimuli long after the injury. 
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Figure 6. Rats with spinal cord injury exhibit forepaw hypersensitivity when investigating novel 
noxious probes before crossing the probes in the operant mechanical conflict test. (A) Example 
sequence of paw movements and probe investigation by a SCI rat prior to crossing. Rapid 
forepaw withdrawal – middle image, red arrow. (B) Rats with SCI withdrew their forepaws from 
the noxious probes more than naïve rats. Comparisons between groups performed using a 
Kruskal-Wallis test followed by Dunn’s post-hoc test. Data shown as median with interquartile 
range. *P < 0.05. SCI, spinal cord injury. Contributions: Max A. Odem and Stephen L. Katzen 
designed experiments and analyzed data; Max A. Odem prepared figures; experiments were 
performed by Stephen L. Katzen, Kendra C. Wicks, and Emily A. Spence. 
 
2.3.4. Pain-like probe-avoidance behavior is enhanced chronically after SCI or sham 
surgery 
Does postsurgical enhancement of probe-avoidance behavior in SCI and sham rats 
persist long enough to be considered chronic? Can an increase in the novelty of noxious 
probes differentiate probe-avoidance behavior in SCI and sham-operated rats? To address 
these questions, naïve, sham, and SCI rats were examined 3 to 6 months after injury using a 
shortened testing protocol in which rats only encountered the probes (4 mm) twice (see Figure 
2, second SCI timeline). The day before exposure to the probes all rats showed similar 
exploratory behavior and crossings of the middle chamber during 3 familiarization trials, and 
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there was no significant difference among the groups on the 0 mm baseline trial on the day of 
probe exposure (Figs. 7A1). All groups showed decreases in the number of crossings on the 
probes compared to their baseline crossings without the probes, and this effect was significant 
for each group during the second 4 mm probe exposure. Planned comparisons showed that 
both the SCI and sham rats crossed the 4 mm probes fewer times than the naïve rats during 
the first exposure to the probes, and during the second exposure the SCI rats showed 
significantly less crossing than the naïve rats (Figs. 7A2). Scatter plots of the number of 
crossings (Figs. 7A2) and escape latencies (Fig. 7B) show that half the rats in the sham group 
and all the rats in the SCI group refused to cross the probes even once during the second 
probe exposure, whereas all the naïve rats crossed and 5 of 8 of the naïve rats crossed 
multiple times. Forepaw withdrawals elicited by 4 mm probes were compared in rats during 
their first exposure to probes. Both the sham and SCI groups exhibited significantly more 
forepaw withdrawals than the naïve group (Fig. 7C). Comparisons of forepaw withdrawals 
during the second exposure to the 4 mm probes were not performed because many of the rats 
in the SCI group completely avoided the probes, staying on the opposite side of the light 
chamber and facing away from the probes. These observations indicate both the SCI and sham 
surgery increase the aversiveness of the probes and enhance pain-avoidance behavior 
chronically (≥3 months post-surgery).  
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Figure 7. Spinal cord injury and its corresponding sham surgery chronically enhance pain-
avoidance behavior in the mechanical conflict test. (A1) Significantly reduced crossings in 
naïve, sham, and SCI groups during the second 4-mm probe trial. (A2) Planned comparisons 
between groups showed sham and SCI groups made fewer crossings than naïve rats on the 
first probe trial, and SCI rats crossed crossings fewer times than naïve rats on the second 
probe trial. All SCI rats (6 out of 6) and 50% of shams (3 out of 6) refused to cross at the 
second probe trial, while only 13% of naïve rats (1 out of 8) refused. (B) Escape latencies on 
the second probe trial reflected crossing results in (A2). (C) Forepaw withdrawals were 
increased in sham and SCI groups during the first 4-mm probe trial. Crossings for groups 
during both probe trials in (A1) were compared to the 0 mm baseline using the Friedman test. 
Significance levels for naïve (stars), sham (pound sign), and SCI group (plus sign) shown for 
Dunn’s post-hoc tests. Planned comparisons between groups (A2-C) were performed using a 
1-way ANOVA or Kruskal-Wallis test followed by Tukey’s or Dunn’s post-hoc tests. Data shown 
as mean ± SEM (A1) and median with interquartile range (A2-C). *P < 0.05, **P < 0.01. 
ANOVA, analysis of variance; SCI, spinal cord injury. Contributions: Max A. Odem and 
Stephen L. Katzen designed experiments and analyzed data; Max A. Odem prepared figures; 
experiments were performed by Stephen L. Katzen, Tamara McGhee, and Emily A. Spence.  
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2.3.5. Probe-avoidance behavior is enhanced by sham surgeries for peripheral nerve 
injury models 
 The studies above show that surgical damage to tissues, including muscle and bone, 
required to expose the spinal cord for controlled contusive injury was sufficient to persistently 
enhance avoidance of noxious probes. This hyperalgesic effect was shown more clearly by the 
MC test than by the von Frey reflex test, suggesting that the MC test may be a more sensitive 
test for pain evoked by mechanical stimuli. We asked whether the MC test might also reveal 
hyperalgesia produced by the sham surgeries used for common PNI models that also require 
damage to tissues (e.g., muscle retraction, nerve manipulation) that can contribute to 
inflammation and pain [40,122,131,197]. While the MC test has shown that rats with a CCI of 
the sciatic nerve exhibit prolonged escape latencies [155], this study did not compare MC tests 
and von Frey tests, or include sham controls. Mice with SNI-induced allodynia (assessed with 
von Frey tests) also exhibit longer escape latencies [326], but this study did not compare the 
SNI mice to appropriate sham controls in the MC test. Thus, whether peripheral sham surgery 
is sufficient to enhance pain-avoidance behavior in the MC test and whether the von Frey reflex 
test is a good predictor of pain-avoidance behavior after hindlimb surgery are unknown. 
 We used two PNI models to address these questions for either acute (days) or 
subacute (weeks) pain. One is the L5 SNT [338,339,345] along with its sham surgery 
procedure, which is identical to the sham surgery used as a control for SNL models [163]. The 
second is the sciatic nerve CCI model along with its sham surgery procedure [31,137,138]. 
 In the SNT experiments, rats were tested for exploratory behavior (crossings) <1 week 
before and 1 day post-surgery, and then exposed to the 4 mm probes after the final 0 mm trial 
3 days post-surgery (see Figure 2, SNT timeline). Interestingly, the SNT group exhibited a 
significant reduction in crossings compared to its pre-injury number when tested without probes 
3 days after injury (Fig. 8A1, A2). In contrast, the naïve and sham rats showed little or no 
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change in crossings in the absence of probes. The effect at 0 mm in the SNT rats might 
represent modest motor impairment or extreme allodynia that discourages locomotion on the 
allodynic limb. All groups showed a reduction in crossings on the 4 mm probes, with the largest 
difference from the pretests in the SNT group, while the sham group was not significantly 
different from the SNT or naïve groups. As in the SCI experiments, the escape latencies (Fig. 
8B) did not distinguish the three groups. In addition, the SNT group developed a robust 
mechanical hypersensitivity in the hindpaw ipsilateral to the injury (Fig. 8C left panel, ~4 g 
threshold in the SNT group versus ~12 g in the naïve and sham groups, before log 
transforming), but not in the contralateral hindpaw (Fig. 8C right panel). 
 In the CCI experiments, we tested rats 14 days post-surgery, a time when reported 
mechanical allodynia is well established [137,138]. All groups showed significantly reduced 
crossings during both 4 mm probe trials compared to their baseline crossings (Fig. 9A1). While 
no significant differences among the groups were observed for the first 4 mm trial, the sham 
and CCI groups crossed significantly fewer times than the naïve during the second 4 mm trial 
(Fig. 9A2). There were trends for longer escape latencies in the sham and CCI groups (Fig. 
9B), with some rats crossing back and forth over the probes freely while others refused to cross 
even once. In contrast to the robust effects found in the sham group in the MC test, no 
evidence of mechanical hypersensitivity in the sham group was found with the von Frey test 
(Fig. 9C). As expected, CCI produced strong mechanical hypersensitivity in the hindpaw 
ipsilateral to the injury (Fig. 9C, left panel).  
 In sum, sham-operated rats for both types of PNI models failed to exhibit mechanical 
hypersensitivity in von Frey tests that provided evidence for allodynia in SNT and CCI rats, yet 
both sham groups showed clear evidence of enhanced pain-avoidance behavior in the MC test.  
52 
 
 
Figure 8. Spinal nerve transection and sham surgery enhance pain-avoidance behavior in the 
mechanical conflict test 3 days after injury. (A1) All groups exhibited a reduction in crossings on 
the 4-mm probes. Crossings at each post-surgery trial were compared to the pre-surgery 0-mm 
baseline using the Friedman test. Significance levels for naïve (stars), sham (pound sign), and 
SNT group (plus sign) shown for Dunn’s post-hoc tests. (A2) Rats with SNT showed reduced 
crossings in the absence of the probes during the 0-mm baseline trial on day 3. The SNT rats 
had fewer crossings during both probe trials compared to naïve rats. The sham group was 
statistically indistinguishable from SNT and naïve groups. (B) Escape latencies did not reveal 
differences between groups. (C, left panel) The 50% PWT of the hindpaw ipsilateral to the side 
of injury was reduced in rats with SNT, but not on the contralateral (uninjured) hindpaw, while 
PWT measures for either hindpaw did not differ between sham and naïve groups (C, right 
panel). Corresponding gram forces shown on right axis. Planned comparisons between groups 
in (A2-C) were performed using a 1-way ANOVA or Kruskal-Wallis test followed by Tukey’s or 
Dunn’s post-hoc tests. Data shown as mean ± SEM (A1) and median with interquartile range 
(A2-C). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. ANOVA, analysis of variance; 
PWT, paw withdrawal threshold; SCI, spinal cord injury; SNT, spinal nerve transection. 
Contributions: Max A. Odem and Stephen L. Katzen designed experiments and analyzed 
data; Max A. Odem prepared figures; experiments were performed by Stephen L. Katzen, 
Kendra C. Wicks, and Emily A. Spence.  
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Figure 9. Chronic constriction injury of the sciatic nerve and its corresponding sham surgery 
enhance pain-avoidance behavior in the mechanical conflict test. (A1) All groups exhibited a 
reduction in crossings during both 4-mm probe trials compared to the 0-mm baseline (Friedman 
test). Significance levels for naïve (stars), sham (pound sign), and CCI group (plus sign) shown 
for Dunn’s post-hoc tests. (A2) No significant differences in crossings were observed on the 
first probe trial, but sham and CCI groups crossed fewer times than naïve rats during the 
second probe trial. (B) Escape latencies did not reveal differences between groups. (C, left 
panel) The 50% PWT of the hindpaw ipsilateral to the side of injury was reduced in rats with 
CCI, but not on the contralateral (uninjured) hindpaw (C, right panel). Note that 50% PWT 
measures <1 gram are negative after log transformation. Corresponding gram forces shown on 
right axis. Planned comparisons between groups in (A2-C) were performed using a 1-way 
ANOVA or Kruskal-Wallis test followed by Tukey’s or Dunn’s post-hoc tests. Data shown as 
mean ± SEM (A1) and median with interquartile range (A2-C). *P < 0.05, **P < 0.01. ANOVA, 
analysis of variance; CCI, chronic constriction injury; PWT, paw withdrawal threshold; SCI, 
spinal cord injury; SNT, spinal nerve transection. Contributions: Michael J. Lacagnina, Jiahe 
Li, Peter M. Grace, and Max A. Odem designed experiments; Michael J. Lacagnina and Max A. 
Odem analyzed data and prepared figures; experiments were performed by Michael J. 
Lacagnina and Jiahe Li.  
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2.3.6. Increased reluctance to repeatedly cross noxious probes provides a more 
sensitive indicator of enhanced evoked pain than latency to escape the light chamber  
In contrast to the present study, previous studies utilizing the MCS greatly reduced the 
rodents’ exploratory drive by giving many familiarization and training trials before introducing 
the probes during test trials. Moreover, these studies removed the rodent after a single 
crossing of the probes (not permitting multiple crossings), and usually used the latency to 
escape from the light chamber as their measure of pain avoidance [67,143,155,210,271,326]. 
Our results with each of the three neuropathic pain models and their corresponding sham 
surgeries suggested that, in rodents that have not been extensively familiarized with the MCS, 
the number of crossings of the noxious probes (presumably motivated by a drive to explore the 
MCS, see [113]) is a more sensitive measure of the aversiveness of the probes than is the 
initial escape latency. To test this possibility with greater statistical power, we took advantage 
of the fact that each of our studies had the same basic design, including limited familiarization 
trials, identical measures of escape latency and multiple crossings, and the inclusion of naïve, 
sham-operated, and neural injury groups. Thus, we combined corresponding groups from each 
study, with the escape latencies and crossings from SCI, SNT, and CCI rats and their sham 
controls pooled into separate neural injury and sham groups, which were compared to the 
pooled naïve group. 
Normalized escape latencies (Fig. 10A) only revealed significant increases in the neural 
injury and sham groups during the second exposure to noxious probes (4 mm in all studies, 
plus 3 mm from the study in Figure 4). Escape latencies (normalized to test duration) in the 
neural injury and sham groups showed a clear bimodal distribution, especially during the 
second noxious probe trial, which cannot be captured by the measure of central tendency 
(mean or median) that is usually reported. In contrast to the escape latencies, the number of 
crossings (normalized to test duration) on both the first and second noxious probe trials were 
significantly decreased in the neural injury and sham groups (Fig. 10B). Additional information 
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about the effects of neural and postsurgical injury on the aversiveness of the probes was 
shown by the relative reluctance of rats in each group to cross the probes more than once. The 
neural injury group and (on the second noxious probe trial) the sham group were significantly 
more reluctant to cross the probes two or more times than naïve rats (Fig. 10C). These results 
confirm that commonly used sham surgeries in rats induce persistent hypersensitivity to 
noxious probes that appears to enhance pain-avoidance behavior, and they show that 
previously unrecognized pain-related effects can be revealed by a reduction of exploratory 
behavior on a noxious substrate.  
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Figure 10. Reluctance to make multiple crossings over noxious probes in the mechanical 
conflict test is a sensitive measure of pain-avoidance behavior. Escape latencies and crossings 
measured during noxious probe trials (first 3- or 4-mm trial and second 4- mm trial) from all 
naïve, sham-operated, and rats with neural injury (SCI, SNT, and CCI) were pooled into 3 
separate groups. Escape latencies and crossings were normalized to test duration. (A) 
Normalized escape latencies were not different on the first probe trial, but latencies were 
greater in sham and neural injury groups on the second trial. Bimodal distributions reflect the 
refusal of many rats to cross during the second trial. (B) Normalized data reveal reduced 
crossings during both trials by sham and neural injury groups compared to naïve. (C) Indexing 
rats by their reluctance to make multiple crossings reveals a significant increase in the 
percentage of rats with neural injury that refused to cross on the first trial, and on the second 
trial the percentage of rats in both sham and neural injury groups that refused to cross was 
greater than in the naïve group. Planned comparisons between groups in (A-B) were 
performed for using a 1-way ANOVA or Kruskal-Wallis test followed by Dunnett’s or Dunn’s 
post-hoc tests, and planned comparisons between proportions in (C) were performed using 
Fisher exact tests with Bonferroni corrections for multiple comparisons. Data shown as median 
with interquartile range (A-B) and fractions above bars represent number of rats/total number in 
group (C). *P < 0.05, **P < 0.01, ***P < 0.001. ANOVA, analysis of variance; CCI, chronic 
constriction injury; SCI, spinal cord injury; SNT, spinal nerve transection. Contributions: Max 
A. Odem, Michael J. Lacagnina, Stephen L. Katzen, Jiahe Li, and Peter M. Grace designed 
experiments; Max A. Odem, Michael J. Lacagnina, and Stephen L. Katzen analyzed data; Max 
A. Odem prepared figures; experiments were performed by Michael J. Lacagnina, Stephen L. 
Katzen, Jiahe Li, Kendra C. Wicks, and Emily A. Spence. 
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2.4. Conclusions and significance 
Surprisingly, the most significant, novel finding in this study was that sham surgical 
procedures for three neuropathic pain models (SCI, SNT, and CCI) were sufficient to enhance 
evoked pain-avoidance behavior for periods lasting days, weeks, and months after surgery. 
This is the first known study to compare crossings across noxious probes in the MC test as a 
sensitive measure for postsurgical and neuropathic pain-related alterations in rats’ innate drive 
to explore novel environments. Furthermore, reflex sensitivity to innocuous mechanical 
stimulation was not a strong predictor of sham-induced hyperalgesia in the MC test; von Frey 
tests revealed mechanical hypersensitivity in SNT and CCI rats, but all sham and neural injury 
groups exhibited pain-avoidance behavior. While von Frey tests failed to reveal below-level 
mechanical hypersensitivity following SCI, rats exhibited below-level heat hypersensitivity as 
well as forepaw hypersensitivity that was revealed using a novel measure of voluntary 
investigation of noxious probes in the MC test.  
These findings have major implications for future studies that address mechanisms 
associated with neuropathic pain as one particular clinically relevant dimension (i.e., 
postsurgical pain) is underappreciated and not always explicitly investigated [75,186]. Many 
pain-related studies use similar rodent injury models and reflex tests to recapitulate neuropathic 
conditions. Both clinical and animal data show that postsurgical pain is greater for deeper, 
more extensive incisions [64,137,237]. Sham surgeries for most nerve injury models, including 
the SNT, SNL, and CCI models, produce deep tissue damage (see also [122]). Postsurgical 
pain is a pervasive problem that covers a breadth of different surgeries and conditions 
[75,172,297,347,363], and it is not uncommon for human patients to develop severe pain 
following surgery [114,127]. The underlying mechanisms [64,186] and time course for 
postsurgical pain can mirror that of chronic pain that persists ≥3 months [347,368].  
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Chapter 3: Ongoing pain is important after neural injury 
The novel observation of sham-induced hyperalgesia in the MC test suggests 
behavioral tests for evoked pain may not be appropriate for distinguishing pain-related 
alterations due to neural injury from postsurgical effects. Persons with chronic neuropathic and 
inflammatory conditions often describe ongoing pain as being debilitating compared to evoked 
pain [30]. Behavioral tests that capture the negative qualities of ongoing pain might be better 
suited for reflecting this clinical reality. Ongoing pain can be difficult to assess in rodents in 
contrast to evoked pain (for review see [344]), but progress using operant methods like the 
CPP test [256,286] has revealed ongoing pain in rodents with SCI [389], PNI 
[19,142,159,192,291,380], paw incision [85,257,380], inflammation and arthritis 
[159,227,265,277], cancer-induced bone pain [158], diabetic neuropathy [353], and 
chemotherapy-induced peripheral neuropathy [179,278]. These studies show naïve, sham, and 
other pertinent controls do not exhibit a strong preference for analgesic-paired chambers, 
suggesting the absence of ongoing pain. These studies demonstrate neuropathic and 
inflammatory conditions selectively produce ongoing pain. 
First-line treatments for patients with neuropathic pain often include gabapentinoids, like 
gabapentin or pregabalin (brand names Neurontin™ and Lyrica™, respectively). Gabapentin is 
commonly used in preclinical pain studies to promote CPP [19,142,179,278]. It is not innately 
rewarding [12] and appears to be exceptionally powerful, it produces CPP in rats with SNL after 
single-trial conditioning (i.e., one exposure to the unconditioned stimulus) [19]. I have wanted to 
optimize CPP procedures to facilitate drug testing on SCI-induced ongoing pain ever since my 
contribution to the CPP experiments described in [389] (CPP with the anticonvulsant retigabine 
was produced by 3 conditioning trials). The Bannister et al. study [19] suggests gabapentin 
might have robust effects on ongoing neuropathic pain which would assist in optimizing CPP 
for future studies using SCI. However, no studies have described gabapentin-produced CPP in 
SCI models despite the effectiveness of gabapentinoids to reduce SCI-induced above-level 
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hypersensitivity [171], spasticity [194], anxiety [14], and to lessen escape/avoidance behavior in 
the PEAP test [15]. In light of this, I predicted gabapentin might also be effective at producing 
CPP in SCI rats, but not naïve or sham controls. Surprisingly, single-trial conditioning with 
gabapentin (GBP, 100 mg/kg, i.p., saline vehicle; see Appendix for methods) was sufficient for 
rats with SCI to develop a significant preference for the GBP-paired chamber (see Fig. 11). 
Note that naïve and sham rats do not prefer the GBP-paired chamber. This is quite promising 
as a shortened CPP protocol can be used as a backdrop for relatively efficient screening of 
other experimental drugs that might reduce SCI-induced ongoing pain (see [25,389]). 
 
 
Figure 11. Single-trial conditioning with gabapentin selectively promotes conditioned place 
preference in rats with spinal cord injury, not in naïve and sham-operated rats. **P < 0.01. CPP, 
conditioned place preference; GBP, gabapentin; SCI, spinal cord injury. Contributions: Max A. 
Odem designed experiments, analyzed data and prepared the figure; Stephen L. Katzen and 
Emily A. Spence performed experiments.  
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The precise mechanism of action for gabapentin is not fully understood, but it is thought 
to reduce neuronal transmission at presynaptic terminals in the dorsal horn and potentially 
attenuate contribution of nociceptor OA to spinal sensitization and maintenance of ongoing pain 
in neuropathic conditions (for review [203]). Indeed, ongoing pain-related behaviors and central 
sensitization are dynamically driven by ectopic/OA generated in primary afferents 
[4,92,139,153,209,225,244,260,285]. Multiple signals for injury and inflammation integrate at 
the level of the DRG to promote a hyperfunctional state in nociceptors [356,358]. The Walters 
Lab group has demonstrated a majority of small-diameter dissociated DRG sensory neurons 
(putative nociceptors) enter into a hyperfunctional state and generate SA in vitro following 
contusive SCI [25,28,377,389]. Importantly, SCI-induced gross and single-unit C-fiber SA is 
generated in/near DRGs in vivo [28], further suggesting nociceptor somata are critical sources 
of SA that might drive central sensitization and ongoing pain. The tetrodotoxin-resistant (TTX) 
Na+ voltage-gated channel Nav1.8 is preferentially expressed in unmyelinated DRG sensory 
neurons [349] – many of which are nociceptors – and is important for AP generation 
[207,302,378]. Knockout or pharmacological blockade of Nav1.8 reduces SA generated in 
excised neuromas [306] and small-diameter dissociated DRG sensory neurons [174], 
respectively. Expression of Nav1.8 protein increases in DRGs following SCI, and selective 
knockdown of Nav1.8  (presumably in DRGs) in vivo using antisense oligodeoxynucleotides 
blocks CPP in SCI rats as well as nociceptor SA in vitro [389]. These studies strongly suggest 
nociceptor activity is critical for maintenance of ongoing neuropathic pain. Human/rodent 
microneurography studies [195,262,263,269,270,322–324] also link ongoing pain to OA 
generation in C-fiber nociceptors rather than OA generated in A-fibers. While the processes 
underlying OA in A-type neurons are well established (e.g., sinusoidal oscillations in membrane 
potential, see [7–9,223,224,384]), the neurophysiological basis for OA in C-type nociceptors 
remains largely unknown. Furthermore, in vitro investigations of firing properties in nociceptors 
using whole-cell current clamp recordings often utilize large, rapid, relatively brief current 
injections to depolarize neurons that do not permit reliable assessments of any sustained OA. 
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Wu et al. demonstrated that extremely low concentrations of capsaicin (~10 nM) are sufficient 
to promote sustained OA and speculate on possible mechanisms (e.g., oscillations in 
membrane potential) [377], but there has not been a thorough, quantitative analysis of any 
regular and/or irregular activity in membrane potential in nociceptors (see [239,337]). The rat 
thoracic contusive SCI model offers a unique opportunity to investigate the neurophysiological 
basis of nociceptor OA under conditions when ongoing pain is known to be present and a 
majority of nociceptors generate true SA [25,28,377,389]. In the next chapter I will address the 
following questions to describe the neurophysiological basis of nociceptor OA: 
Study 1: Are all putative nociceptors specialized to generate OA in vitro? 
Study 2: What are the electrophysiological signatures that define nociceptor OA? 
Study 3: Can nociceptor OA be potentiated under conditions other than SCI? 
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Chapter 4: Isolated nociceptors reveal multiple specializations for generating irregular 
ongoing activity associated with ongoing pain 
Disclosure: This chapter is based upon: Max A. Odem, Alexis G. Bavencoffe, Ryan M. 
Cassidy, Elia R. Lopez, Jinbin Tian, Carmen W. Dessauer, Edgar T. Walters, Isolated 
nociceptors reveal multiple specializations for generating irregular ongoing activity associated 
with ongoing pain, Pain 159 (11):2347-2362. Portions of the text, results, and figures are 
granted gratis to the first author with no formal licensing from Wolters Kluwer Health, Inc., July 
26, 2018. Copyright © 2018, © 2018 International Association for the Study of Pain. 
Study 1: One class of dorsal root ganglion sensory neurons is specialized for generating 
ongoing activity 
4.1. Rationale 
Whole-cell recordings from isolated DRG neurons offer powerful insight into the 
neurophysiology and function of individual neurons. For example, application of algogenic 
substances (e.g., capsaicin, serotonin) activates nociceptors and evoke bursts of sustained 
firing of APs and/or can sensitize nociceptors to other types of inflammatory agents 
[132,133,161,296]. The electrophysiological properties observed in vitro are likely to represent 
similar functions maintained in vivo in the soma and/or in the peripheral terminals [17,154,307]; 
indeed, injection of inflammatory mediators in the paw of rodents evokes hyperalgesic 
responses and spontaneous pain-like behaviors [166,301,341]. Notable electrophysiological 
properties that have been used to distinguish various subpopulations of DRG neurons include 
membrane properties such as the capacitance or transmembrane potential, chemical-evoked 
currents, voltage-dependent currents, and AP kinetics 
[70,102,104,106,132,156,282,283,302,315,398], all of which are often described within 
subpopulations of neurons delineated by soma diameter. But classification of DRG sensory 
neurons in vitro depends upon a myriad of additional anatomical, molecular, and 
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electrophysiological properties [23,117,211,268,282,283,336] across multiple species and 
phyla [331]. Genetic-editing tools reveal distinct subpopulations of nociceptors based upon 
anatomical projections, sensory modalities, and behavioral function in vivo (for example see 
[61] and for review see [284]). There are multiple subpopulations of sensory neurons with 
unique and overlapping gene expression profiles that may provide clues about sensory function 
[349] in different pain conditions [276,299]. These studies, and certainly many others, have 
greatly expanded our appreciation for sensory neuron heterogeneity and provide useful 
roadmaps for mechanistic analyses. It is generally accepted that the small diameter ≤30 µm 
DRG sensory neurons primarily represent overlapping subpopulations of unmyelinated C-type 
nociceptors while medium and large diameter >30 µm DRG sensory neurons are comprised of 
myelinated A-type neurons that are important for touch and proprioception, but also include 
some nociceptors.  
The major goal of these experiments was to characterize subpopulations of dissociated 
DRG sensory neurons in vitro based on functional capacity for sustained OA. In vitro whole-cell 
recordings of small-diameter (15-30 µm) DRG neurons dissociated from naïve rats were used 
to provide direct access to the neuron soma, which retains properties observed in vivo 
[17,132,154]. Series of prolonged depolarizing pulses (2 s sweeps, Δ5 pA increments) under 
current clamp were used to trigger possibly sustained OA during steady-state inactivation of 
most voltage-gated Na+ channels [70,156] and to assess any potential electrophysiological 
properties that would suggest neurons are specialized for generating sustained OA. Preliminary 
experiments indicated that one subpopulation of small dissociated DRG neurons was capable 
of sustained OA while another was not. The following experiments define the 
electrophysiological properties of those two subpopulations of probable nociceptors. 
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4.2. Materials and methods 
4.2.1. Animals 
 All procedures followed the guidelines of the International Association for the Study of 
Pain and were approved by the Animal Care and Use Committee for the University of Texas 
Health Science Center at Houston (UTHealth). Male, Sprague-Dawley rats (Envigo, USA) were 
housed at McGovern Medical School, the rats (250-300 g, 2 per cage) were acclimated to a 
controlled environment (12-hour reverse light/dark cycle, 21 ± 1°C) for ≥4 days before 
beginning experiments. The corn cob bedding was replaced 2-3 times per week while food and 
water were provided ad libitum. 
4.2.2. Dissociation and culture of dorsal root ganglion neurons 
Rats were euthanized using pentobarbital/phenytoin (0.9 ml; Euthasol, Virbac AH, Inc., 
Fort Worth, TX) followed by transcardial perfusion of ice-cold phosphate buffered saline 
(Sigma-Aldrich, St. Louis, MO). DRGs were excised from spinal segments T11 to L6 and 
incubated at 34°C for 40 minutes with trypsin (0.3 mg/ml) and collagenase D (1.5 mg/ml) 
enzymes in Dulbecco’s Modified Eagle Medium (DMEM; Sigma-Aldrich). Following digestion 
and washing the DRG fragments were mechanically triturated in DMEM with a fire-polished 
Pasteur pipette and plated on 8 mm glass coverslips coated with poly-L-ornithine (Sigma-
Aldrich). Dissociated neurons were incubated overnight (<5% CO2, 95% humidity, 37°C) in 
DMEM without serum, growth factors, or other supplements. 
4.2.3. Whole-cell recordings from dissociated dorsal root ganglion neurons 
Small DRG neurons (soma diameter ≤ 30 m) were recorded on glass coverslips at 
room temperature, 18-30 hours after dissociation, on either a Zeiss Axiovert 200M or Olympus 
IX71 inverted microscope with 40X or 20X magnification, respectively. The bath was filled with 
extracellular solution containing (in mM): 140 NaCl, 3 KCl, 1.8 CaCl2, 2 MgCl2, 10 HEPES, and 
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10 glucose, which was adjusted to pH 7.4 with NaOH and 320 mOsM with sucrose. HEKA 
EPC10 amplifiers (HEKA Elektronik, Lambrecht/Pfalz, Germany) were used for whole cell 
patch clamp recordings. Data were sampled at 20 kHz with PatchMaster v2x90.1 (HEKA 
Elektronik) and filtered with a 10 kHz Bessel filter. Borosilicate glass capillaries with outer 
diameter of 1.5 mm and inner diameter of 0.86 mm (Sutter Instrument Co., Novato, CA) were 
pulled using a Sutter P-97 Flaming/Brown Micropipette Puller. Fire-polished patch pipettes had 
electrode resistances of 3-8 MΩ after filling with intracellular-like solution containing (in mM): 
134 KCl, 1.6 MgCl2, 13.2 NaCl, 3 EGTA, 9 HEPES, 1 Mg-ATP, and 0.3 Na-GTP, which was 
adjusted to pH 7.2 with KOH and 300 mOsM with sucrose. Only neurons that were not in 
visible contact (at 20-60x magnification without any staining) with the somata or neurites of 
other neurons, or debris, were selected for whole-cell recording. Membrane resistance and 
capacitance were measured under voltage clamp using 5 ms, 5 mV depolarizing pulses from a 
holding potential of -60 mV. To permit direct comparison with previous papers, the liquid 
junction potential (calculated to be ~4.3 mV) was not corrected. This means that actual 
membrane potentials were probably ~4 mV more negative than all values reported. To 
measure SA, neurons were recorded under current clamp at resting membrane potential (RMP; 
0 current injected) for at least 1 minute beginning at least 1 minute after switching from voltage 
clamp. Next, membrane potential was set at -60 mV with a constant holding current under 
current clamp while a series of depolarizing current injections (2 second steps every 4 seconds, 
+5 pA increments) were used to measure rheobase, latency to the first AP at rheobase, the 
membrane time constant (), the AP voltage threshold, and any repetitive firing at rheobase or 
2x rheobase. In some experiments neurons were held at -45 mV under current clamp for ≥30 
second to facilitate OA. A subset of neurons was held at -60 mV and single APs were evoked 
by 2 ms depolarizing pulses (+20 pA increments) to measure AP and afterhyperpolarization 
(AHP) properties (modified from [398]). 
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4.2.4. Markers for nociceptive function 
A majority of nociceptors express the transient receptor potential vanilloid-1 (TRPV1) 
non-selective cation channel and/or bind the non-peptidergic marker isolectin B4 (IB4) 
[60,132,268,282–284,336,377]. At the end of some experiments neurons were superfused with 
1 µM capsaicin (dissolved in extracellular solution; Sigma-Aldrich, St. Louis, MO, USA) using a 
gravity-fed delivery system made with polyimide tubing (0.36 mm outer diameter, 0.31 mm 
inner diameter; Cole-Parmer, Vernon Hills, IL, USA) positioned ~600 um away from each 
neuron. Sensitivity to capsaicin was assessed under voltage or current clamp and a positive 
response was confirmed by the presence of capsaicin-evoked inward currents or depolarization 
and excitation, respectively. Non-peptidergic DRG neurons were identified by binding of IB4 
extracted from Griffonia simplicifolia (BSI-B4, FITC conjugate; Sigma-Aldrich, St. Louis, MO, 
USA). Coverslips were pretreated with 3 µg/mL IB4 for 5 minutes and washed for 3 minutes 
before beginning patching [28]. Neurons with a continuous green ring around the perimeter of 
the soma were considered IB4-positive. 
4.2.5. Data analysis 
Statistical analyses were performed using Prism v7.03 (Graphpad Software, Inc., La 
Jolla, CA, USA). Data are presented as the mean ± SEM or the incidence (% of neurons 
tested). The Shapiro-Wilk test was used to assess normality for continuous measures. 
Comparisons between incidence measures were made using Fisher’s exact tests with 
Bonferroni corrections for multiple comparisons. Significance for all statistical tests was set at P 
< 0.05 and all reported P values are two-tailed. 
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4.3. Results 
4.3.1. Probable nociceptors exhibit 2 predominant electrophysiological types in vitro: 
rapidly accommodating and nonaccommodating 
 Two distinct types of neurons were observed, “Nonaccommodating” (NA, Fig. 12A) and 
“Rapidly Accommodating” (RA, Fig. 12B), that exhibited opposite electrophysiological response 
patterns to ascending series of 2 second depolarizing steps delivered when a neuron was held 
under current clamp at an initial membrane potential of -60 mV. The NA type represented 69% 
of sampled neurons. Characteristic features of NA neurons were a relatively low rheobase and 
repetitive firing in response to injecting current equal to 2X rheobase (Fig. 12A and Table 4). 
An unusual feature was the random latency to the first AP at rheobase, which could occur at 
any time during the 2 second step depolarization. This is evident in the ranked distribution of 
first AP latencies, which appear evenly distributed and form a nearly straight line from shortest 
to longest latency (Fig. 12C). Some NA neurons at rheobase (Fig. 12C) and most neurons at 
2X rheobase (Fig. 12D) fired multiple irregularly spaced APs during the depolarizing steps 
(Table 4). All tested NA neurons fired multiple APs to one or more of the steps between 1X and 
2X rheobase, although not to all suprathreshold steps. In each NA neuron, these irregularly 
occurring APs were equally likely to occur at any time after the first AP during repetitive firing, 
as shown in the raster plots (Figs. 12C, D). The lack of any tendency for the interspike interval 
to increase during repetitive firing confirmed the lack of AP accommodation (Fig. 12E). This 
irregular NA activity continued for as long as the neurons were depolarized (>60 seconds, data 
not shown).  
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Figure 12. Two electrophysiologically distinct types of nociceptors exhibit opposite response 
patterns to prolonged depolarization. DRG neurons from naive rats (n = 18) were sampled 
using whole-cell recordings 18 to 30 hours after dissociation. (A) Representative AP discharge 
at rheobase and 2X rheobase in an NA neuron. An ascending series of 2 second depolarizing 
current steps was injected in 5 pA increments at 4 second intervals. A constant holding current 
that initially set membrane potential to -60 mV was continuously injected throughout the 
sequence. (B) Typical discharge in an RA neuron during the same test protocol. (C) 
Distribution of first AP latencies (ranked from shortest to longest) and time of occurrence of 
additional APs at rheobase across the 2 second depolarizing step in 95 NA neurons (initial APs 
are leftmost red dots) and 43 RA neurons (APs are blue dots). Additional activity is indicated 
along the same row at the time of each AP (red dots) for each repetitively firing neuron. (D) 
Timing of APs in the same tests at 2X rheobase from the subsets of neurons in which the 
depolarizing steps reached this level (30 NA neurons and 14 RA neurons). Each row 
represents a single neuron. (E) Interspike intervals at 2X rheobase in NA neurons fired ≥2 APs. 
Bars show the mean ± SEM, numbers in bars show neuronal sample size. AP, action potential; 
DRG, dorsal root ganglion; MP, membrane potential; NA, nonaccommodating; RA, rapidly 
accommodating. Contributions: Max A. Odem designed/performed experiments, analyzed 
data, and prepared figures; Edgar T. Walters designed experiments; additional experiments 
were performed by Alexis G. Bavencoffe, Jinbin Tian, and Elia R. Lopez.  
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In stark contrast, the RA type (31% of sampled neurons) never fired more than a single 
AP in these tests, which always occurred at the onset of the step depolarization (Figs. 12B-D). 
Interestingly, within the stimulation range of 1 to 3X rheobase, no RA neurons responded with 
multiple APs. Only at very high stimulus currents, did some RA neurons fire a brief burst of 2 or 
3 APs (not shown), and these were always confined to the onset of the stimulus. Compared to 
NA neurons, RA neurons showed a significantly more hyperpolarized RMP, higher rheobase, 
much shorter latency to the first AP, and lower membrane time constant (Table 4). Individual 
APs and AHPs evoked by 2 ms depolarizing pulses were similar between NA and RA neurons. 
The only statistically significant difference found in these samples was for AP duration at half-
amplitude to be ~20% briefer in the NA neurons than in RA neurons (Table 4). No significant 
differences were found between NA and RA neurons in soma diameter or membrane 
capacitance (Table 4). Interestingly, far greater excitability was found in NA neurons than in RA 
neurons, despite the NA neurons being more hyperpolarized after each of the larger 
depolarizing steps in the rheobase/repetitive firing test sequence. This is illustrated in Figures 
12A and 12B. Although both neurons had the same -60 mV holding potential at the beginning 
of the series of depolarizing steps (not shown), membrane potential at the beginning of later 
steps in the series was more negative in NA neurons than in RA neurons; in the illustrated NA 
neuron, this potential was ~-70 vs ~-65 mV in the RA neuron when rheobase and 2X rheobase 
were reached. This residual post-depolarization hyperpolarization resulted from there being 
insufficient time (2 seconds) between the larger 2 second depolarizing steps for recovery of 
membrane potential to -60 mV (a trade-off to allow for numerous tests on each neuron). 
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Table 4. Properties of NA and RA neurons. Data were collected from DRG neurons taken from 
naive rats (n = 18) 18 to 30 hours after dissociation. Sensitivity to 1 µM capsaicin was tested in 
neurons from 7 rats, and binding of IB4 was tested in neurons from 4 rats. Each value is the 
mean ± SEM followed in parentheses by number of neurons tested. Tests: UPT, unpaired t 
test; MW, Mann-Whitney U; F, Fisher exact test. AP, action potential; DRG, dorsal root 
ganglion; NA, nonaccommodating; RA, rapidly accommodating; RMP, resting membrane 
potential. Contributions: Max A. Odem designed/performed experiments, analyzed data, and 
prepared the table; Edgar T. Walters designed experiments; additional experiments were 
performed by Alexis G. Bavencoffe, Jinbin Tian, and Elia R. Lopez. 
 
4.3.2. Only nonaccommodating neurons exhibit ongoing activity when perfused with 
capsaicin or depolarized with injected current 
 Evidence that many of the NA and RA neurons are nociceptors was obtained by testing 
capsaicin sensitivity and binding of IB4. A majority of NA neurons and RA neurons tested with 1 
µM capsaicin responded strongly under current clamp (Fig. 13) or voltage clamp (not shown; 
see [377]), indicating that large fractions of both types are TRPV1-expressing nociceptors 
(Table 4). In addition, about half of the sampled NA neurons and 3 quarters of the RA neurons 
bound IB4, suggesting that both types contain large fractions of non-peptidergic nociceptors 
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(Table 4). Although most small dissociated neurons and nearly all capsaicin-sensitive and IB4-
binding neurons in rats are likely to be nociceptors [117,132,211,282,283,329], a minority of 
small DRG neurons are not nociceptive [100,117] and most small DRG neurons were not 
tested for capsaicin sensitivity or IB4 binding in this study. Thus, individual neurons selected for 
study were considered probable nociceptors, with the caveat that a minority of tested neurons 
would not have been nociceptive. Given the high incidence of capsaicin sensitivity and/or IB4 
binding in NA and RA neurons, general properties established across sufficiently large samples 
of small DRG neurons under the culture conditions described primarily represent the properties 
of small nociceptors, and that these include 2 physiologically defined classes, NA and RA. 
The responses of each electrophysiological type to capsaicin under current clamp 
provided additional evidence that NA neurons but not RA neurons are capable of OA. Perfusion 
of capsaicin (1 µM) evoked multiple APs in NA neurons under current clamp (Fig. 13A) (see 
also [377]), whereas none of the tested RA neurons (n = 5 from 3 rats) discharged any APs 
despite similar depolarization by capsaicin treatment (Fig. 13B). A low concentration of 
capsaicin (10 nM) can sometimes activate isolated small DRG neurons while depolarizing the 
neurons to between -50 and -45 mV [377]. To see whether similar depolarization can produce 
OA such as that produced by capsaicin, a 30 second step depolarization to -45 mV was 
produced by injecting current through the patch pipette. This evoked OA in 30% of the NA 
neurons but in none of the RA neurons (Fig. 13C).  
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Figure 13. Nonaccommodating and RA neurons are depolarized to a similar degree by 
superfusion of capsaicin, but only NA neurons exhibit repetitive discharge when depolarized by 
a high dose of capsaicin or by injected current that mimics depolarization produced by a low 
dose of capsaicin. (A) Representative example of depolarization and discharge evoked by a 
high dose of capsaicin (1 µM) in an NA neuron. (B) Example of depolarization evoked by the 
same dose of capsaicin in an RA neuron. Notice the lack of APs. (C) Examples showing part of 
the responses to prolonged depolarization (30 seconds) to -45 mV in RA and NA neurons 
similar to that produced by 10-nM capsaicin (see text). (D) OA was promoted in NA neurons 
but not RA neurons by artificial depolarization to -45 mV. *P < 0.05, the Fisher exact test. 
Neurons are from a subset (n = 12) of the naive rats used for Figure 12. AP, action potential; 
MP, membrane potential; NA, nonaccommodating; OA, ongoing activity; RA, rapidly 
accommodating. Contributions: Max A. Odem designed/performed experiments, analyzed 
data, and prepared figures; Edgar T. Walters designed experiments; additional experiments 
were performed by Alexis G. Bavencoffe and Jinbin Tian. 
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Study 2: Three functional aspects of membrane potential synergistically promote 
ongoing activity in nonaccommodating neurons following spinal cord injury 
4.4. Rationale 
In principle, there are 3 functional aspects of membrane potential that could facilitate 
OA: 1) depolarization of RMP, 2) hyperpolarization of the voltage threshold for AP generation, 
and 3) enhancement of transient depolarizing spontaneous fluctuations (DSFs) that trigger 
APs. Contusive SCI in rats induces persistent OA generated peripherally in primary nociceptors 
in a peripheral skin-nerve preparation [57] and within the DRG in probable C-fiber and Aδ 
nociceptors in vivo [28]. It also dramatically enhances SA in small DRG neurons (primarily 
nociceptors) in vitro [25,28,377,389]. While the signaling mechanisms important for the 
maintenance of SCI-induced SA are beginning to be elucidated [25], it is not fully known how 
the 3 functional aspects of membrane potential facilitate sustained OA in putative nociceptors. 
Given that the NA neurons are specialized for generating OA, it is likely that SCI-induced SA is 
unique to the NA neurons and does not occur in RA neurons. In addition, enhanced evoked 
pain and avoidance of noxious probes in the MC test (Chapter 2) may be due to increased 
excitability in response to extrinsic depolarizing stimuli and/or increased SA in NA neurons that 
might maintain central sensitization. Indeed, C-fiber SA and robust increases in AP firing rates 
are both observed in vivo following deep tissue incisions [386]. To address these predictions, 
small DRG neurons dissociated from naïve, sham, and SCI rats at 1-6 months post-injury were 
tested for SA and other measures of increased excitability, and electrophysiologically profiled 
as NA and RA neurons. 
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4.5. Additional materials and methods 
4.5.1. Spinal cord injury surgical procedure 
Surgeries were performed at McGovern Medical School as previously described 
[25,28,377,389]. One of two methods of anesthesia were used: intraperitoneal (i.p.) injection of 
ketamine (60 mg/kg), xylazine (10 mg/kg), and acepromazine (1 mg/kg) or isoflurane (induction 
4-5%; maintenance 1-2%). Rats were determined to be deeply anesthetized and areflexic 
before proceeding. Local anesthetic (bupivacaine, 2 mg/kg) was delivered subcutaneously 
(s.c.) at the incision site near T10 before incising the skin from T8-T12. Laminectomy of the 
T10 vertebrae was followed by contusion impact (150 kdyne, 1 s dwell time) using an Infinite 
Horizon Spinal Cord Impactor (Precision Systems and Instrumentation, LLC, Fairfax Station, 
VA, USA). Following impact, the paravertebral muscles were closed with vicryl-coated, 
absorbable suture and the skin incision was closed with 9 mm wound clips. Sham rats received 
the same laminectomy surgery minus spinal impact. Rats were returned to their home cage 
and placed on a heating pad maintained at 37°C. The analgesic buprenorphine hydrochloride 
(0.02 mg/kg; Buprenex, Reckitt Benckiser Healthcare Ltd., Hull, England, UK) was 
administered in 0.9% saline (2 mL/kg, i.p.) twice, daily up to 5 days post-surgery. The 
prophylactic antibiotic enrofloxacin (0.3 mL; Enroflox, Norbrook, Inc., Overland Park, KS, USA), 
was also administered in 0.9% saline daily up to 10 days post-surgery. Manual bladder 
evacuations were performed twice, daily until rats recovered neurogenic bladder voiding. The 
day after surgery hindlimb locomotion was assessed using the BBB score [24]. Only sham rats 
with BBB scores of 21 for both hindlimbs were accepted. The majority of SCI rats were scored 
a 0 or 1 for both hindlimbs 1 day after surgery. Naïve rats were transported to the surgical suite 
at the same time as surgeries were performed, but were otherwise left undisturbed in their 
home cages. 
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4.5.2. Quantifying spontaneous fluctuations of membrane potential and action potential 
threshold 
Published methods for quantifying spontaneous fluctuations (SFs; first known 
descriptions in C-type DRG neurons [239,337]) of membrane potential in DRG neurons rely on 
power spectral density analyses, which require that the SFs be oscillations or appear at regular 
intervals if not oscillatory [8–10,224,381,383]. We developed a novel series of algorithms that 
identifies waveforms independent of frequency or regularity, inspired by the Ramer-Douglas-
Peucker algorithm [107,294] to identify curves, in order to quantify the irregular DSFs observed 
in whole-cell recordings. Our program, termed SFA.py, was written and tested using Python 
v3.5.2 (Python Software Foundation, Beaverton, OR) and Anaconda v4.1.1 (Continuum 
Analytics, Austin, TX) with dependency on matplotlib and NumPy libraries. Time and voltage 
coordinate data for 30-50 second periods exported from PatchMaster were imported into the 
script. SFA.py then performed the following functions: 1) generate a linear regression model as 
an initial estimate of membrane potential; 2) group the runs of unidirectional residuals into 
discrete membrane fluctuations, and employ user-defined criteria to classify some of these as 
AP/AHP complexes; 3) exclude AP/AHPs from analysis, then calculate the RMP at each point 
as a sliding median of the raw data within a 1 second window centered on that point – this 
accounts for slow, non-linear changes in RMP which would otherwise increase or decrease the 
estimated amplitude of a given fluctuation; 4) run the groups of unidirectional residuals as 
discrete fluctuations, then apply user-defined criteria for minimum amplitude and duration (1.5 
mV and 10 ms for this study) to identify DSFs or hyperpolarizing spontaneous fluctuations 
(HSFs); 5) quantify and report the following values: coordinates, amplitudes, and durations of 
identified APs, AHPs, DSFs, and HSFs. DSFs and HSFs ≥1.5 mV were measured as 
differences from the sliding median of membrane potential. DSFs were subdivided into small 
(>1.5 to ≤3 mV), medium-sized (3-5 mV, almost always subthreshold) and large (>5 mV, often 
suprathreshold) DSFs as described. All HSFs were ≥1.5 mV, and were not subdivided for 
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further analysis. Descriptive data for the recordings also include standard deviation of the 
membrane potential, number of APs, AP frequency, number of DSFs and HSFs, and their 
frequencies. Color-coded line graphs with labeled APs, AHPs, DSFs, and HSFs were 
generated using the matplotlib library. Inspection of SA indicated that most APs in NA neurons 
were triggered by suprathreshold DSFs. As a conservative estimate of the amplitude of 
suprathreshold DSFs, these were assigned an amplitude equal to the AP voltage threshold. 
This threshold was estimated for each neuron by three independent measures that together 
provided a more accurate estimate of AP threshold than commonly utilized analytic methods 
[318] that were tested. To estimate threshold, 1) the inflection point for apparent acceleration of 
the change in membrane potential was measured at the base of the ascending limb of the AP, 
2) the peak membrane potential was measured for the maximum subthreshold DSF found 
anywhere in the 1-2 second step depolarizations used to determine rheobase in the same 
neuron, and 3) the peak membrane potential was measured for the largest subthreshold DSF 
during recorded SA at RMP. The most depolarized of these three independent measurements 
was defined as the AP threshold for that neuron, and in all cases at least two of these three 
values were in good agreement with each other (within ~2 mV). 
4.5.3. Data analysis 
Planned comparisons between naïve, sham, and injury groups were made using 1-way 
ANOVA or Kruskal-Wallis tests followed by Tukey’s or Dunn’s post-hoc tests. To assess main 
injury-related effects, electrophysiological measures collected from neurons recorded across 
multiple experiments (e.g., days, surgeons) were pooled according to rat surgical history: 
naïve, sham, or SCI. To assess SA-dependent effects, neurons were pooled based on the 
presence or absence of SA and the aforementioned analyses were performed. 
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4.6. Results 
4.6.1. Spinal cord injury increases spontaneous activity in nonaccommodating but not 
rapidly accommodating neurons 
 SA was found in at least some of the NA neurons taken from naive, sham, or SCI rats, 
but was not found in any RA neurons (Figs. 14A and 14B). As predicted by earlier findings 
[25,28,376,377,389], the incidence of SA was significantly greater in neurons from SCI rats 
than in neurons from naive or sham rats (Fig. 14B). In contrast to an earlier finding [28], the 
incidence of SA in the sham group was modestly but significantly higher than in the naïve 
group (Fig. 14B). This finding and other evidence for persistent hyperexcitability in the sham 
group (see below and Table 5) differ from an earlier study [28]. Unmasking of sham effects 
may reflect improvements in DRG extraction and dissociation procedures that reduced cellular 
stress, lowering the incidence of SA in the naive group in this study. These results indicate that 
SCI strongly enhances SA in NA neurons but not in RA neurons. In addition, tissue injury 
caused by the sham surgery can produce a small increase in incidence of SA in NA neurons. 
One possibility that cannot be ruled out is that extrinsic factors in the neuronal cultures (either 
soluble factors or contact signals from small adjacent or underlying cells invisible to the 
microscopy methods used) might contribute to the neuronal activity observed after SCI, but it is 
highly likely that SA is produced by mechanisms intrinsic to NA neurons. No differences are 
observed in the incidence of SCI-induced SA in cultures across a wide range of cell densities, 
whether the nearest neighboring cell is several hundreds of microns away or in clear contact 
with the sampled neuron, and because the incidence of SA is unchanged by rapid perfusion or 
no perfusion of the culture dish [25,28,376,377] (and unpublished observations). 
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Figure 14. Injury-induced SA occurs in NA neurons but not RA neurons. Small DRG neurons 
from naive (n = 18), sham (n = 5), and SCI rats (n = 13) were recorded 18 to 30 hours after 
dissociation under current clamp without injected current for ≥1 minutes to measure SA. (A) 
Representative recordings of NA neurons from the indicated groups. (B) SA incidence in RA 
and NA neurons in each group. Fractions represent number of neurons with SA/total sample. 
Comparisons made using the Fisher exact test (Bonferroni corrected), *P < 0.05, **P < 0.01, 
****P < 0.0001. DRG, dorsal root ganglion; MP, membrane potential; NA, nonaccommodating; 
RA, rapidly accommodating; SA, spontaneous activity; SCI, spinal cord injury. Contributions: 
Max A. Odem designed/performed experiments, analyzed data, and prepared figures; Edgar T. 
Walters designed experiments; additional experiments were performed by Alexis G. 
Bavencoffe.  
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Table 5. Effects of SCI on NA and RA neuron excitability. Data were collected 18 to 30 hours 
after dissociation of DRG neurons taken from naive (n = 18), sham (n = 5), or SCI rats (n = 13). 
Comparisons were not made between groups for RA neurons in the cases of number of APs at 
rheobase or at 2X rheobase because repetitive firing did not occur in any RA neuron. Each 
value is the mean ± SEM followed in parentheses by number of neurons tested. Tests: KW, 
Kruskal-Wallis followed by Dunn tests; ANOVA, 1-way ANOVA followed by Tukey tests. 
ANOVA, analysis of variance; AP, action potential; DRG, dorsal root ganglion; NA, 
nonaccommodating; RA, rapidly accommodating; RMP, resting membrane potential; SCI, 
spinal cord injury. Contributions: Max A. Odem designed/performed experiments, analyzed 
data, and prepared the table; Edgar T. Walters designed experiments; additional experiments 
were performed by Alexis G. Bavencoffe.  
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SCI-induced SA in dissociated small DRG neurons has been found up to 8 months after 
SCI [28] but previous studies did not distinguish NA from RA neurons. The incidence of SCI-
induced SA in neurons from rats tested 1 to 3 months and 3 to 6 months after SCI was 
compared to see whether the occurrence of SA in NA neurons changed over the period of this 
study. The mean incidence of NA neurons with SA at 1 to 3 months (63 ± 7%, n = 6 rats) was 
not significantly different from the incidence at 3 to 6 months (70 ± 3%, n = 5 rats) (P = 0.36, 
unpaired t test). The ratio of NA to RA neurons between groups was compared to determine 
whether SCI might shift one type of probable nociceptor (RA or NA) into the other type. Very 
little difference was found in the ratio of NA to RA neurons in the naïve or sham groups, so 
these were combined into a single control group. In this control group, 71% of 143 tested 
neurons were NA and 29% were RA. In the SCI group, 77% of 198 tested neurons were NA 
and 23% were RA. The small shift from RA to NA was not statistically significant (P = 0.098), 
but the possible trend suggests that further investigation is warranted into the question of 
whether in vivo injury or inflammation might promote a transition of one nociceptor type into the 
other. The NA/RA ratio was not affected by time after SCI (82 ± 7% NA neurons at 1-3 months, 
n = 6 rats; 84 ± 5% NA neurons at 3-6 months, n = 5 rats; P = 0.86, unpaired t test). 
4.6.2. Spinal cord injury persistently depolarizes resting membrane potential and lowers 
action potential threshold in nonaccommodating neurons 
 What are the neurophysiological mechanisms by which SCI promotes SA and OA in NA 
neurons? Two of the 3 intrinsic functional aspects of membrane potential that in principle can 
generate SA (and promote extrinsically driven OA) are prolonged depolarization of RMP and a 
hyperpolarizing shift in the voltage threshold for AP generation. Persistent SCI-induced 
depolarization of RMP was found previously in dissociated small DRG neurons [28], but AP 
voltage threshold was not measured, and whether either of these SA-promoting effects occurs 
in NA neurons after SCI has not been documented. Compared to NA neurons in the naive and 
sham groups, NA neurons in the SCI group showed significant depolarization of RMP and 
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significant reduction in voltage threshold for AP generation (Table 5). No significant differences 
in these properties were found between the naive and sham groups. Three other measures 
also revealed significantly greater excitability in NA neurons in the SCI group vs the naive 
group: rheobase dropped by 50%, repetitive firing in response to currents twice the rheobase 
value nearly doubled, and membrane resistance increased by 30% (Table 5). Interestingly, 
rheobase and membrane resistance in the sham group were significantly different from values 
in the naive group, providing additional evidence for persistent hyperexcitability after sham 
surgery. No significant effects of SCI were found in RA neurons (Table 5). Fewer RA than NA 
neurons were examined, so it is possible that weak effects of SCI or sham treatment could be 
revealed by larger samples of RA neurons. These results show that 2 physiological alterations 
important for driving SA, persistent depolarization and reduction of AP voltage threshold, are 
induced in NA neurons by SCI. All the measures of hyperexcitability were especially prominent 
in spontaneously active NA neurons taken from SCI rats (Table 6), consistent with a 
hyperexcitable state being induced by SCI that functions to promote SA [28]. In addition, sham 
surgery can also persistently increase excitability of NA neurons, expressed as lowered 
rheobase, but without substantial alteration of RMP or AP voltage threshold.  
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Table 6. Properties of silent and spontaneously active NA neurons taken from SCI rats. Data 
were collected from a randomly selected subset of the SCI group in Table 2 (n = 8 rats). Each 
value is the mean ± SEM followed in parentheses by number of neurons tested. Tests: UPT, 
unpaired t test; MW, Mann-Whitney U. AP, action potential; NA, nonaccommodating; RMP, 
resting membrane potential; SA, spontaneous activity; SCI, spinal cord injury. Contributions: 
Max A. Odem designed/performed experiments, analyzed data, and prepared the table; Edgar 
T. Walters designed experiments; additional experiments were performed by Alexis G. 
Bavencoffe.  
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4.6.3. Spinal cord injury persistently enhances depolarizing spontaneous fluctuations in 
nonaccommodating neurons 
 The third functional aspect of membrane potential that in principle can generate SA and 
promote extrinsically driven OA is an increase in the frequency of large DSFs that can reach 
AP threshold. Irregular SFs of membrane potential have long been evident in published whole-
cell patch recordings from dissociated small- and medium-sized DRG neurons, but they have 
received remarkably little experimental attention. The most detailed study [337] found no 
obvious association between fluctuation amplitude and SA in a rat CCI model of neuropathic 
pain, but systematic quantitative measurements were not performed. Two quantitative 
approaches were used to test whether SCI increases DSF amplitude and frequency in NA 
neurons. The first approach was to measure total fluctuation amplitude (peak to peak) after 
SCI. Preliminary results (not shown) indicated that, unlike the regular sinusoidal oscillations in 
large and medium-sized DRG neurons that are enhanced by axotomy [7,9,223], the irregular 
fluctuations in small DRG neurons lack large sinusoidal components that contribute significantly 
to OA generated at RMP negative to -40mV (see also [9]), which is the RMP range at which SA 
and OA have been investigated [25,28,377,389]. Thus, as an alternative to fast Fourier 
transform analysis, the SD of all points (excluding APs and AHPs) in randomly selected 50 
second samples in NA cells was compared across groups. SD provides a symmetrical measure 
of dispersion of the fluctuations from the mean RMP. The SDs of fluctuation amplitudes were 
significantly larger in the SCI group (mean of the fluctuation SDs for each neuron, 3.0 ± 0.3 mV, 
27 neurons) than in the naive group (1.2 ± 0.3 mV, 9 neurons) or sham group (1.1 ± 0.2 mV, 12 
neurons) (Tukey multiple comparison P < 0.01 in each case). This result shows that SCI 
increases fluctuation amplitudes but does not distinguish between any differential effects of SCI 
on DSFs and HSFs. 
Plotting all points in each trace relative to the median instead of the mean revealed a 
skew in the depolarizing direction, raising the possibility that SCI might selectively promote the 
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generation of large DSFs in addition to (or instead of) enhancing oscillatory or hyperpolarizing 
fluctuations. This is important because HSFs as well as sinusoidal oscillations have been 
described in isolated DRG neurons [9,239]. To rigorously test this prediction, a novel SF 
analysis program was used to measure DSFs and HSFs, which were defined by reference to a 
sliding median of all points measured during 50 second samples. An example of part of an 
analyzed trace is shown in Figure 15A. Note that DSFs are defined operationally and are 
unlikely to represent unitary events; indeed, there seems to be complex summation of smaller 
depolarizing (and possibly hyperpolarizing) events in many of the DSFs shown. Analysis of 
DSFs in NA neurons exhibiting SA (from naive, sham, and SCI groups) revealed that mean 
DSF amplitude was largest (>5 mV) when RMP was between -45 and -40 mV (Fig. 15B). 
Given that the voltage threshold for AP generation after SCI ranged from -28 to -50 mV, and 
RMP ranged between -70 and -40 mV (see also Table 5), relatively large DSFs (>5 mV) could 
reach AP threshold often enough to contribute significantly to observed SA. Analysis of NA 
neurons exhibiting SA showed that the frequency within each trace of DSFs with amplitudes >5 
mV (most of which initiated APs; see below) and medium-sized DSFs with amplitudes of 3 to 5 
mV (which almost never evoked APs) showed striking parallels to the frequency of APs in the 
same neurons plotted as a function of RMP (Fig. 15C). This close parallel provides strong 
evidence that large DSFs play an important role in triggering APs in NA neurons. Importantly, 
significantly more NA neurons in the SCI group had large DSFs (>5 mV) than did neurons in 
the naive or sham groups (Fig. 15D). Moreover, frequencies both of large DSFs and of APs 
within each recording were significantly greater in the SCI group (Fig. 15E).  
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Figure 15. Spinal cord injury enhances the amplitudes and frequencies of DSFs in NA 
neurons. DSFs were quantified with an algorithm that estimates RMP through a sliding median 
function, and then identified SFs exceeding 1.5 mV above and below this continuously 
changing reference line. (A) Sample recording of SA after SCI. Color labels: purple undulating 
line – sliding median, red arrowheads and red trace segments – subthreshold and 
suprathreshold DSFs ≥3 mV, blue arrowheads and blue trace segments – all HSFs ≥1.5 mV, 
and green dashed line – AP threshold. (B) Neurons with SA (n = 27) showed enhanced DSF 
amplitudes compared with silent neurons at RMPs between -60 and -40 mV. DSFs were 
binned according to the RMP at the DSF onset. DSF sample sizes left to right: 286, 68, 186, 
386, 49, 568, 91, and 425. Data are shown as mean ± SEM. Comparisons between silent and 
SA groups at each bin made using Mann-Whitney U tests. (C) The frequency of medium 
amplitude DSFs (3-5 mV, squares) and large DSFs (>5 mV, circles) increased at more 
depolarized RMPs in neurons with SA (solid symbols) but not in silent neurons (open symbols), 
paralleling the increase in AP frequency (blue circles). Almost no APs were triggered by 
medium-sized DSFs (blue squares) in neurons with or without SA. DSFs and APs from neurons 
in naive, sham, and SCI conditions were pooled together into silent and SA groups for analysis. 
Each point represents frequency (Hz) calculated by dividing the total number of DSFs or APs 
by the number of neurons per group (silent n = 21, SA n = 27) and the recording duration (50 
seconds for each neuron). (D) Large DSF incidence was significantly greater after SCI. 
Fractions represent number of neurons exhibiting large DSFs/total sample. Comparisons made 
using Bonferroni-corrected Fisher exact tests. (E) SCI increased the frequency of large DSFs 
and APs in each neuron. Green lines – medians. Overall significance assessed with the 
Kruskal-Wallis test, multiple comparisons with Dunn tests. *P < 0.05, **P < 0.01, ***P < 0.001, 
****P < 0.0001. Neurons are a randomly selected subset taken from the naive (n = 2), sham (n 
= 3), and SCI rats (n = 8) used in Figure 14. AP, action potential; DSF, depolarizing 
spontaneous fluctuation; HSF, hyperpolarizing spontaneous fluctuation; MP, membrane 
potential; NA, nonaccommodating; RMP, resting membrane potential; SA, spontaneous 
activity; SCI, spinal cord injury. Contributions: Max A. Odem designed/performed 
experiments, analyzed data, and prepared figures; Edgar T. Walters designed experiments; 
Ryan M. Cassidy, Max A. Odem, and Edgar T. Walters designed the SF analysis program; 
additional experiments were performed by Alexis G. Bavencoffe. 
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The effects of SCI on SFs are shown in greater detail in Figure 16. A frequency 
distribution for DSFs and for HSFs was obtained for each trace and averaged across all traces 
in each group. No apparent differences were found in the incidence or amplitude of either DSFs 
or HSFs in naive compared with sham groups, so these 2 groups were pooled into a single 
control group for further analysis. Compared to the combined control group, SCI increased the 
frequency of occurrence of larger DSFs and HSFs, but most of the SCI effect on DSFs was on 
amplitudes from 3 to >10 mV (Fig. 16A1), whereas most of the effect on HSFs was on 
amplitudes between 2 and 4 mV (Fig. 16A2). Raster plots showed higher frequencies of 
medium amplitude (3-5 mV) (Figs. 16B1 and 16B2) and large DSFs (>5 mV) (Figs. 16C1 and 
16C2) in neurons from the SCI group compared with the control group. Almost none of the 3 to 
5 mV DSFs triggered APs in neurons from the SCI or control groups (Fig. 16B2), whereas 
more than 50% of DSFs >5 mV triggered APs in neurons from SCI and control groups (Fig. 
16C2).  
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Figure 16. Spinal cord injury enhances the incidence of large and medium amplitude DSFs and 
medium amplitude HSFs in NA neurons. SCI induced a rightward shift in the frequency 
distribution (% of total) of DSFs (A1) and HSFs (A2) of different amplitudes. Distributions 
obtained from each neuron for a 50 second period were averaged across neurons; bars 
represent the mean ± SEM for each amplitude bin. Naive and sham groups were pooled 
together into a combined control group. (B1, C1) Medium amplitude and large DSFs showed 
stochastic occurrence in control and SCI neurons. Each row represents one neuron and each 
dot a single DSF. (B2, C2) SCI increased the mean frequency of medium amplitude and large 
DSFs in the 50 second samples, but not the fraction of large DSFs that evoked APs. Bars 
represent the mean ± SEM or fraction of the total sample. Significance tested with Mann-
Whitney U or Fisher exact tests. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Neurons 
are the same as in Figure 15. AP, action potential; DSF, depolarizing spontaneous fluctuation; 
HSF, hyperpolarizing spontaneous fluctuation; NA, nonaccommodating; SCI, spinal cord injury. 
Contributions: Max A. Odem designed/performed experiments, analyzed data, and prepared 
figures; Edgar T. Walters designed experiments; additional experiments were performed by 
Alexis G. Bavencoffe. 
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Large DSFs, similar to OA observed in vitro and in vivo in presumptive C-fiber 
nociceptors after SCI [28], occur randomly (Fig. 16C1) (see also [337]). Stochastic DSF 
occurrence was also seen during the 2 second depolarizations used to measure rheobase and 
repetitive firing (Fig. 12). A striking finding was the much longer latency to the first AP 
generated in the rheobase tests in NA compared with RA neurons (Table 4). This is consistent 
with the AP at rheobase in NA neurons being triggered by infrequent, randomly occurring, large 
DSFs. If so, the increase in frequency of large DSFs after SCI should increase the likelihood 
that large DSFs occur early during depolarizing test pulses, and this should decrease the 
latency to the first AP. Confirming this prediction, the mean latency to the first AP generated in 
NA neurons during rheobase measurement in the SCI group was much shorter than the latency 
in the naive or sham groups (Table 5). Together, these findings show 1) that DSFs play a 
major role in generating the irregular SA found in NA neurons, and 2) that enhancement of DSF 
amplitude and large DSF frequency contributes to SCI-induced SA. 
Study 3: An inflammatory mediator, serotonin, acutely potentiates ongoing activity in 
nonaccommodating neurons from naïve rats 
4.7. Rationale 
 Is enhancement of DSFs and the consequent promotion of nociceptor activity solely a 
long-term phenomenon, perhaps unique to SCI, or can NA nociceptor DSFs also be enhanced 
acutely by extrinsic signals? In particular, could acute exposure to an inflammatory signal 
enhance DSFs and promote OA? The inflammatory mediator, serotonin, can induce pain and 
hyperalgesia in the periphery [2,166,222,275,313,341] (for review [230,332]). It is interesting 
because it has complex effects on nociceptors [189,222,308,317,343,394], one of which is to 
reduce AP voltage threshold [56]. In contrast to nearly all other studies of 5-HT’s actions on 
nociceptors, which used very high 5-HT concentrations (typically 10 mM), an early study 
showed that 10-nM 5-HT caused alterations in TTX-resistant Na+ current that should lower AP 
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threshold [133]. An implication of this observation is that a 5-HT concentration that sensitizes 
but does not activate NA neurons could potentiate depolarization-dependent OA in NA 
neurons. Potentiation of such OA would be much more likely if the same concentration of 5-HT 
also enhances DSFs. Dissociated DRG neurons from naïve rats were treated with 5-HT, 
electrophysiologically profiled as NA or RA neurons, and tested for OA in order to determine 
whether 5-HT had a potentiating effect on NA neurons. 
4.8. Additional materials and methods: Serotonin treatment and data analysis 
The day following dissociation, DRG neurons isolated from naïve rats were pretreated 
with 100 nM serotonin (5-hydroxytryptamine; 5-HT; Sigma-Aldrich, St. Louis, MO) dissolved in 
extracellular solution for 10-30 min. 5-HT remained in the recording chamber for the duration of 
each experiment. To assess 5-HT effects parametric t-tests and non-parametric Mann-Whitney 
U tests were used. 
4.9. Results 
4.9.1. Serotonin selectively potentiates OA in nonaccommodating neurons by lowering 
action potential threshold, but does not depolarize resting membrane potential 
 Treatment of each dish with 100 nM 5-HT for 10 to 30 minutes before and during 
recording produced no hint of sustained depolarization (Table 7). Furthermore, 5-HT did not 
induce OA at RMP (Fig. 17A, left panel). When a prolonged extrinsic depolarizing input 
(modeled by constant current injection through the patch pipette to hold the membrane 
potential at ~-45 mV for 30-60 seconds) was added to promote OA after vehicle treatment, no 
significant increase in the incidence of OA was found vs the incidence of SA at RMP (compare 
vehicle groups in left and right panels of Fig. 17A). By contrast, when 5-HT-treated neurons 
were depolarized to -45 mV, ~80% showed OA (Fig. 17A, right panel). At -45 mV, AP firing 
rates during OA and the corresponding large DSF frequencies were significantly greater in 5-
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HT-treated neurons than in vehicle-treated neurons (Fig. 17B). Amplitudes of DSFs ≥1.5 mV 
were also enhanced in 5-HT-treated neurons that were depolarized to -45 mV (Fig. 17C, left 
panel), and like the effects of SCI (see Figure 14B), the DSFs were largest in neurons with OA 
(Fig. 17C, right panel). Examples of DSFs and APs (OA) in NA neurons held at -45 mV with 
and without 5-HT treatment are shown in Figure 17D. 
 
 
Table 7. Effects of 5-HT on NA and RA neuron excitability. Tests were conducted in the 
presence of 5-HT or vehicle applied 10 to 30 minutes earlier onto small DRG neurons taken 
from naive rats (n = 4). Comparisons were not made between groups for RA neurons in the 
cases of number of APs at rheobase or at 2X rheobase because repetitive firing did not occur 
in any RA neuron. Tests: UPT, unpaired t test; MW, Mann-Whitney U. AP, action potential; 
DRG, dorsal root ganglion; NA, nonaccommodating; RA, rapidly accommodating; RMP, resting 
membrane potential. Contributions: Elia R. Lopez designed/performed experiments; Max A. 
Odem designed experiments, analyzed data, and prepared the table; Edgar T. Walters 
designed experiments.  
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Figure 17. Potentiation by 5-HT of OA in NA neurons. DRG neurons from naive rats (n = 4) 
were treated with vehicle or 100 nM 5-HT for 10 to 30 minutes before and during each 
recording. After measurement of any SA, extrinsically driven OA was modeled by 
depolarization to -45 mV under current clamp for 30 to 60 seconds. (A) Pretreatment with 5-HT 
did not induce OA at RMP but significantly increased OA at -45mV (the Fisher exact test). (B) 
In neurons tested at -45 mV, 5-HT significantly increased AP frequency during OA and large 
DSF frequency. Black lines – medians. Comparisons made using Mann-Whitney U tests. (C) 5-
HT increased the amplitude of DSFs measured at -45 mV, and the neurons with OA showed 
larger DSFs than silent neurons. DSF sample sizes left to right: 1360, 2113, 1256, and 2217. 
Data are shown as mean ± SEM. Comparisons between vehicle- and 5-HT-treatments or silent 
and OA groups made using Mann-Whitney U tests. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 
0.0001. (D) Representative recordings SFs and OA at -45 mV after treatment with vehicle or 5-
HT. Insets: enlarged sections from each trace. AP, action potential; DRG, dorsal root ganglion; 
DSF, depolarizing spontaneous fluctuation; MP, membrane potential; NA, nonaccommodating; 
OA, ongoing activity; RMP, resting membrane potential; SA, spontaneous activity. 
Contributions: Elia R. Lopez designed/performed experiments; Max A. Odem designed 
experiments, analyzed data, and prepared figures; Edgar T. Walters designed experiments. 
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4.9.2. Serotonin enhances depolarizing spontaneous fluctuations in nonaccommodating 
neurons 
 Depolarizing SFs occurred randomly after either vehicle treatment or 5-HT treatment 
(Figs. 17D, 18A1 and 18B1). 5-HT increased the number of medium amplitude (3-5 mV) and 
large (>5 mV) DSFs during each recording (Figs. 18A2 and 18B2). The number of large DSFs 
paralleled the number of APs evoked during the same 30 second samples (Fig. 18B2). As 
predicted [56], 5-HT treatment also significantly (and substantially) lowered the voltage 
threshold for AP generation (Table 7). This likely contributed to the increased percentage of 
DSFs 3 to 5 mV and especially >5 mV that triggered APs (Figs. 18A2 and 18B2). In addition, 
5-HT treatment significantly decreased the rheobase (consistent with an increase in the 
frequency of large DSFs) (Table 7). In contrast to the effect of SCI on AP latency at rheobase, 
5-HT did not decrease AP latency. However, because of the low frequency and stochastic 
occurrence of APs (and underlying DSFs), demonstrating possible effects on AP latency is 
likely to require a much larger sample size. 
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Figure 18. Serotonin increases the number of medium amplitude and large DSFs at -45 mV in 
NA neurons from naive rats. (A1, B1) Raster plots of medium amplitude and large DSFs during 
depolarization to -45 mV. Each row represents one neuron and each point a single DSF. (A2, 
B2) At -45 mV, 5-HT increased the number of medium amplitude and large DSFs, and the 
percentage of DSFs evoking APs. Bars represent the mean ± SEM or fraction in total sample, 
and significance was tested using Mann-Whitney U or Fisher exact tests. *P < 0.05, **P < 0.01, 
****P < 0.0001. Neurons are from the naive rats (n = 4) used in Figure 17. AP, action potential; 
DSF, depolarizing spontaneous fluctuation; NA, nonaccommodating. Contributions: Elia R. 
Lopez designed/performed experiments; Max A. Odem designed experiments, analyzed data, 
and prepared figures; Edgar T. Walters designed experiments.  
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4.10. Conclusions and significance 
The goal of these experiments was to define the electrophysiological specializations for 
low frequency, irregular OA in putative nociceptors associated with ongoing pain. A significant 
discovery in this study was the contribution of large DSFs (>5 mV, majority being 
suprathreshold) to persistent OA in NA neurons under SCI and inflammation-like conditions. 
The large DSFs are 1 of 3 functional aspects of membrane potential (others include 
depolarized RMP and hyperpolarized AP voltage threshold) that can promote an OA state in 
NA neurons. While this is not the first study to describe mechanisms driving OA in DRG 
sensory neurons (see oscillations in A-type neurons [7–9,223,224,384]), this is the first study to 
implement novel algorithms to quantitatively measure irregular SFs in membrane potential that 
drive OA in putative nociceptors. Furthermore, this is the first study to functionally segregate 
nociceptors based on specializations for generating OA and demonstrates that the OA state 
may be restricted to the NA type, not the RA type. The NA neurons dissociated from rats with a 
sham surgery exhibit modest signs of increased excitability. Given these alterations and the 
fact that artificial depolarization reveals a serotonin-induced potentiation of OA in NA neurons, 
one possible explanation for the observed sham-induced hyperalgesia in the MC test (Chapter 
2) is that noxious probes elicit OA in probable C-fiber nociceptors; in short, severe peripheral 
damage to deep tissues may act as a priming event [183,300,301]. The noxious probes may 
cause sufficient depolarization in peripheral terminals of C-fibers to rapidly, and robustly, 
activate the nociceptors and generate a prolonged burst of APs (brief OA) that enhances 
evoked pain responses. Potentiation of OA in C-fiber peripheral terminals is one such 
mechanism by which serotonin and other inflammatory mediators may promote hyperalgesia. 
This raises an interesting possibility that serotonin and other inflammatory mediators may have 
stronger effects – and at lower concentrations – in NA neurons dissociated from rats with sham 
surgery or neural injury. Characterization of the neurophysiological basis of the stochastic AP 
discharge in the OA state under other pain-related conditions will potentially elucidate the 
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biophysical and signaling mechanisms governing the DSFs, thereby leading to the identification 
of new therapeutic targets for the treatment of many different forms of postsurgical and 
neuropathic pain.  
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Chapter 5: Discussion 
5.1. Rethinking how to assess postsurgical pain in rodent injury models 
Much of our understanding of the behavioral and physiological consequences of neural 
injury come from use of rodent models that involve substantial tissue damage in corresponding 
sham surgical procedures, yet little attention has been paid to postsurgical pain in these 
controls. Rather, separate rodent models have been developed for the explicit purpose of 
recapitulating surgical consequences of extensive tissue damage, and corresponding 
postsurgical pain studies exist tangential to many neuropathic studies. For example, behavioral 
hypersensitivity can be observed lasting a few days following incision of the skin and deep 
muscles in the plantar surface of the paw [43,386], about 2 weeks after laparotomy [136], up to 
1 month after prolonged retraction of the skin and muscles in the thigh [122], >1-2 months 
following thoracotomy [49,173], and potentially longer following laminectomy [199,238] (see 
also Chapter 2). While some postsurgical models exhibit signs of acute [85,257,380] and 
subacute [173] ongoing pain, many postsurgical pain studies rely upon von Frey testing for 
assessing evoked mechanical hypersensitivity (for review [40]), and other types of behavioral 
tests are marginally used. 
The MC test revealed the presence of postsurgical pain in sham-operated rats at 1-2 
months and ≥3 months post-surgery for SCI, at <1 week post-surgery for SNT, and at 2 weeks 
post-surgery for CCI. The SCI experiments demonstrate that laminectomy can promote chronic 
postsurgical pain, long after the initial wound has healed. It is usual for rodent SCI studies to 
continue >1 month in order to adequately assess motor recovery using the BBB test and to 
perform von Frey reflex tests (for example see [24,57,58,90,171,196]). On the other hand, the 
SNT and CCI experiments demonstrate their respective sham surgeries acutely promote 
postsurgical pain at times (e.g., <1 month) when a majority of studies using PNI models 
typically perform von Frey reflex tests (for example [105,108,163,190,214,225]). Review of any 
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of the referenced studies will show little to no observed effects in sham control groups tested 
with von Frey filaments. It remains to be seen if any postsurgical pain due to sham surgeries for 
the SNT and CCI persist ≥1 month. Regardless, data suggest the MC test is sensitive for 
detecting postsurgical alterations in nociception and pain-avoidance behavior in 3 different rat 
models of surgically-induced neural injury, and may prove useful for studying transitional 
stages from acute to chronic pain. Besides the direct effects of the noxious probes, another 
possible explanation for the observed sham effects is that non-nociceptive stressors associated 
with conducting the MC test (e.g., handling, bright light) may have unmasked a postsurgical 
latent pain-like state that was potentially masked by µ-opioid-related mechanisms (see 
[52,221,281,305] and [346] for review). Additional studies are needed to adequately address 
this possibility. Indeed, current studies that report use of the MC test do not address its 
potential usefulness in assessing postsurgical pain or latent pain sensitization. 
5.1.1. Factors that can occlude observation of postsurgical pain in rodents 
Relatively mild rodent incision models and severe postsurgical injury models can show 
transient to chronic signs of increased behavioral hypersensitivity, ongoing pain, and nociceptor 
hyperexcitability [18,43,49,52,53,122,173,182,199,238,385,386]. Therefore, it is not 
unreasonable to expect that noxious mechanical stimuli, like the probes in the MCS, may 
reveal persistent postsurgical alterations in nociceptor sensitivity and evoked pain in sham-
operated rodents. But why has a sham effect not been widely reported when noxious stimuli 
are used alongside or in place of innocuous stimuli? For one, the studies that use rodent injury 
models in the MC test do not include the proper sham controls [67,155,210,326]. Hogan has 
stated “…there are only modest effects evident in sham surgery control groups…”, but at the 
time (2002) that statement was made it was primarily based upon knowledge gained from 
reflex tests of nociception [164]. There may be other confounding factors related to the use of 
these kinds of tests that have occluded observation of a sham effect. In studies using the von 
Frey filaments, rats that receive the sham surgery for a T13 hemisection SCI do not exhibit 
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mechanical hyperalgesia that is otherwise present in rats with SCI [147,149], but these studies 
make the highly unlikely assumption that ≤20 gram von Frey filaments constitute noxious 
stimuli. Naïve Sprague-Dawley rats have mechanical sensory thresholds upwards of 15-100 
grams (see Figures 5A and 8C in Chapter 2 and [90]), but many studies apply an arbitrary 
cutoff of 15 grams to replicate the “up-down” method described by Chaplan et al. [63]. It is not 
uncommon to encounter studies in which a ceiling effect is observed in the withdrawal 
threshold results (i.e., the naïve and sham groups are reported to have similar thresholds at 
~15 grams; see also CCI experiments in Chapter 2). Other studies that use automated force 
delivery methods (e.g., Randall-Selitto analgesiometer) capable of administering noxious forces 
also suggest sham surgeries for clip-compression, transection, and contusive SCI do not 
induce mechanical hyperalgesia [89,272]. But again, like in the other studies using ≤20 gram 
von Frey filaments, Densmore et al. [89] assumed a maximum force of 20 grams is noxious 
and they did not use a naïve control group for comparison. Singh et al. [272] delivered 
maximum forces ≤1000 grams and describe their behavioral endpoint as when rats “vocalized 
or struggled vigorously”. Thresholds for the sham group were lower compared to the naïve 
control group (~199 grams compared to ~210 grams) at 2 weeks post-surgery, but this effect 
was not statistically significant. It is unclear if sham-operated rats might have exhibited lower 
thresholds before the 2 week timepoint. 
A seminal SNL study from Hogan et al. goes a step further and uses truly noxious 
stimuli (i.e., needle/pin-prick test) ([165] and see also [108,319]). Surprisingly, the Hogan et al. 
study reveals mild sham-induced hypersensitivity to innocuous touch and acetone, but the 
sham control group did not elicit hyperalgesic behavioral responses (e.g., sustained lifting, 
grooming) when probed with noxious stimuli. It is necessary to reiterate that in the needle/pin-
prick test noxious stimuli are hand-delivered and the behavioral responses are not voluntary. In 
an effort to include a voluntary component in a follow-up study, Wu et al. designed a behavioral 
paradigm where rats could choose to avoid noxious stimulation by staying on a raised platform, 
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or jump down from the platform and receive a noxious stimulus to an injured hindpaw [375]. 
The rats with SNL learned to passively avoid the noxious stimuli, but sham-operated rats did 
not, presumably because they did not consider stimulation to be aversive. Again, noxious 
stimuli were hand-delivered and susceptible to unconscious bias [38]. More importantly, the 
authors only performed a skin incision for the sham surgery [375] (see also [238] for an 
incorrect sham control group in an unrelated study describing a postsurgical laminectomy 
model); the Wu et al. study is flawed because the sham surgery does not match the SNL 
surgery (i.e., the same deep tissues were not manipulated/damaged equally), and therefore the 
sham and SNL groups are not directly comparable nor is the “absence of effect” in the sham 
group truly conclusive. This oversight is not an isolated occurrence (see also [273]), and in 
some instances naïve or sham controls are outright omitted in studies using noxious stimuli 
(e.g., see [121,311,350]). It is possible that these confounding factors and those described in 
the prior paragraph have occluded observation of sham effects and postsurgical pain in studies 
using sham control groups for neural injury models.  
Sham-induced postsurgical pain may also be a context-dependent phenomenon that is 
not revealed under conditions when noxious stimuli are hand-delivered. Stressful, investigator-
induced analgesia and its effects on rodent withdrawal reflexes [334] is a recently described 
factor that may complicate interpretation of prior studies that use noxious stimuli as well as 
future studies if it is not properly controlled and reported. Unconscious bias [38] is another real 
possibility that can also influence hand-delivery of noxious stimuli similarly to von Frey 
filaments. Attempts to blind investigators can be complicated when rodents exhibit noticeable 
motor and/or postural deficits due to injury. Finally, standard reflex tests are not ethologically 
relevant as evoked withdrawals are not voluntary; the need for more tests that permit 
observations of voluntary behaviors has been expressed [344,392]. The MC test performed as 
a suitable workaround to these various issues: 1) both female and male experimenters 
conducted tests following appropriate handling and acclimation to the rats, 2) experimenters did 
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not need to hand-apply any noxious stimuli during tests, 3) scoring the videos – while blinded to 
the rats’ surgery histories – for simple, objective behavioral metrics like number of crossings 
and latencies limited experimenter bias, and 4) the rats maintained a degree of autonomy 
within the confines of the MCS without any direct human interactions and/or influence. 
5.1.2. Using the operant mechanical conflict test to assess postsurgical pain: 
Advantages, limitations, and future directions 
The MC test may serve as an exceptionally sensitive test for evaluating signs of acute 
and chronic postsurgical pain in freely behaving rodents. Completion of this study has identified 
several areas of future research and applications as well as several limitations that will need to 
be addressed. Besides this study, rigorous testing with proper sham control groups is lacking 
but may prove useful for studying the underlying mechanisms associated with transitions from 
acute to chronic postsurgical pain (see [64]) in various neuropathic models. Analgesic efficacy 
of common treatments (e.g., gabapentinoids, opioids) for neuropathic pain may also need to be 
re-assessed in sham control groups of different types of injuries. Modifications to the MCS that 
outfit the probe chamber instead with dynamic hot or cold plates (see [21] for review) will allow 
for assessments of other modalities under more tightly controlled testing paradigms and 
contexts. The MCS is essentially a light/dark box that can also be used to assess comorbidities 
associated with pain (see [218,387] for review) like SCI-induced anxiety [14,232,236]. 
Preliminary experiments (unpublished observations) with SCI rats suggested pharmacological 
blockade of Nav1.8, and presumably nociceptor SA [174,389], had an anxiolytic effect when 
probes were absent; SCI rats spent more time outside of the dark chamber. One other 
surprising observation involved SCI rats with low to mid BBB scores (~10; occasional weight-
supported stepping, no coordination) suddenly exhibiting carefully coordinated stepping 
behavior when introduced to the probes, suggesting that noxious stimulation can promote 
improved motor control after SCI.  
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Limitations of using the MCS most notably involve probe novelty, physical spacing, and 
learned aversion to the probes. Rats can quickly habituate to lower probe heights; some rats 
will exhibit notably high exploratory drives in the MCS (i.e., they cross frequently) while 
simultaneously developing novel crossing strategies to avoid placing their paws on the probes. 
Furthermore, the probes are simply not spaced close enough together to prohibit rats from 
learning to place their paws between them. I have observed many instances of rats (naïve, 
sham, and injured) placing their forepaws and/or hindpaws between the probes after enough 
exposure. Some of the sham and a majority of injured rats exhibited clear signs of a learned 
aversion to the probes. After the first exposure to 4 mm probes rats would refuse to cross the 
probes during a second trial, instead opting to face away from the probes against the far wall of 
the light chamber. Rats that exhibited this behavior would then explore the MCS without 
hesitation the following day when no probes were present, but reintroducing rats to the probes 
would prompt similar refusals to cross. These general observations suggest multiple tests with 
the same rats may not always be feasible if one were to test the effects of any experimental 
analgesics after pre-treatment trials with probes present. The order of probe exposure does not 
seem to affect escape latency in CCI rats well-habituated to the MCS [155], but the results 
described in Chapter 2 demonstrate that investigators may need to make predictions at very 
specific time points post-injury and carefully limit probe exposures. The robust aversion 
observed in all three neuropathic injury models likely involves complex supraspinal 
mechanisms (see [271]) that are still open to investigation at acute and chronic time points 
post-injury. 
5.2. Sham surgical procedures, like severe peripheral injuries, are possibly priming-like 
events 
The behavioral and electrophysiological results collectively feed into a larger narrative 
pertaining to nociceptor sensitization and priming. These topics have been extensively 
reviewed [183,301,358]. Nociceptive sensitization is an adaptive response to injury with 
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proposed survival benefits (for review [50,355,358]). This was not experimentally confirmed 
until recently; injury-induced nociceptive sensitization and SA in advanced cephalopods 
[6,82,83] promotes survival during predator attacks [81]. Many lower invertebrate phyla exhibit 
signs of nociceptive sensitization [357,359,372] as it was likely selected for early on during 
evolutionary development. Price and Dussor discuss the implications and potential difficulty in 
battling against the evolutionarily ancient machinery that underlies nociceptive sensitization in 
our efforts to curtail chronic pain [289]. Despite these difficulties, more recent work into 
mechanisms of priming has proved fruitful in identifying specific molecular signals that underlie 
nociceptive sensitization and transitional stages from acute to chronic pain. In the hyperalgesic-
priming model posited by Reichling and Levine [301], injection of an inflammatory cytokine 
(e.g., prostaglandin E2; PGE2) in the paw of a naïve rodent normally leads to a rapidly-
resolving hyperalgesic behavioral response in the von Frey test. However, if a naïve rodent is 
exposed to an initial priming stimulus (e.g., carrageenan injection in the paw) ~1 week ahead of 
injection of PGE2, then the behavioral response to PGE2 will be more robust and long-lasting. 
This primed state depends upon protein kinase C epsilon (PKCε) activity; inflammatory and 
other stressful neuropathic insults trigger a switch from protein kinase A-mediated to PKCε-
mediated signaling. Notably, Bavencoffe and Li et al. demonstrate that PKA-mediated signaling 
is still important for maintenance of persistent nociceptor hyperexcitability and SA following SCI 
[25]. These molecular switch-like mechanisms may be important in many pain conditions and 
disorders that involve some component of cellular stress. In light of this, the sham surgical 
procedures used as controls for many neural injuries can be considered a priming event. The 
damage to deep tissues and localized inflammation near peripheral nerve terminals may be 
tapping into some of the same molecular machinery, thereby adding an additional layer of 
complexity not previously – or at least fully – considered when using neural injury models. 
Indeed, the Levine and Price groups have speculated on the possibility that postsurgical pain is 
the result of a surgery-related priming event (i.e., tissue damage and/or localized inflammation) 
[183,300,301]. 
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5.2.1. Sham procedures for surgically-induced neural injury models: Similarities, 
differences, and pain-related outcomes 
The three neuropathic pain models used (SCI, SNT, and CCI) represent severe, 
clinically relevant injuries at distinctly different anatomical levels, each of which yield partial or 
complete axotomy of populations of nerve fibers. Yet, results in Chapter 2 suggest that the 
varying levels of injury severity did not necessarily add much in regard to effect size of 
behavioral measures in the MC test. The sham surgeries were sufficient to suppress 
exploratory behavior, but did not exhibit strong effects in the von Frey reflex tests with 
innocuous mechanical stimuli. What other insults (i.e., tissue damage) are commonly shared 
between the three sham surgeries that might account for the behavioral similarities between 
sham-operated and injured rats? If so, are they pertinent to clinical conditions of postsurgical 
pain conditions? The SCI and SNT require bluntly dissecting and retracting the paravertebral 
muscles to reach the thoracic and lumbar vertebra, respectively. The SCI and SNT also require 
significant damage of and removal of bone; the T10 dorsal process and lamina are removed 
during laminectomy and the L6 transverse process is removed to expose the L4/L5 ventral 
rami. Damage to the paravertebral musculature can promote degenerative lumbar kyphosis 
[68]; kyphotic deformities are relatively common adverse surgical outcomes [145,250] that can 
contribute to postsurgical pain in patients [363]. Spinal instability due to laminectomy can also 
contribute to signs of postsurgical pain in rodents [199,238], but the T10 lamina was not fully 
removed during laminectomy in my experiments and the degree of instability was likely 
miniscule. Meanwhile, the SNT and CCI require manipulation of the L4/L5 spinal nerves and 
sciatic nerve, respectively. Nerve manipulation (e.g., exposure, dissection) can cause moderate 
to severe discomfort as well as development of persistent postsurgical pain (see orofacial 
nerve manipulation [5,202]). The BBB score [24] effectively removes sham (T10 laminectomy) 
rats that unknowingly receive minor contusions during the laminectomy procedure, therefore 
the SCI sham surgery does not typically involve direct manipulation of the spinal cord itself if 
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performed correctly. The CCI surgery is notably less damaging than the SCI and SNT as it 
does not require any removal of bone, but it does involve blunt dissection and retraction of 
deep muscles in the thigh to expose the sciatic nerve. Besides the initial skin incision – that 
produces only transient effects on nociceptors [386] that cannot reasonably account for the SCI 
and CCI results observed at 1-3 months and 14 days, respectively – the only insults that are 
commonly shared between the three surgeries are the blunt dissections/retractions of deep 
muscles and inflammation due to surgery. Local tissue damage and inflammation certainly 
have powerful effects on nociceptors (see below and for review [23]). An underappreciated 
postsurgical pain model demonstrates that incision and retraction of the skin/muscles in the 
medial thigh is sufficient to cause persistent mechanical hypersensitivity without causing a 
dramatic increase in a neuronal injury marker in the DRGs [122]. The mechanical 
hypersensitivity is also reversible by administration of morphine and gabapentin [123]. These 
studies suggest that PNI models whose sham surgeries require unavoidable damage to 
musculature in the thigh ought to regularly present positive signs for a pain-like state (i.e., 
mechanical hypersensitivity) at 3 days to 3+ weeks post-surgery. Why this basic effect of 
skin/muscle incision and retraction on reflex sensitivity to innocuous mechanical stimuli is not 
always apparent – or at least described – in sham control groups reported in other pain-related 
studies may be partially due to inconsistencies in behavioral testing methodologies and 
reporting. 
Unfortunately, reported experiments were not necessarily focused on the 
differences/similarities in the sham surgical procedures and consequences thereof. Molecular 
assays that quantify the degree of muscle deterioration (e.g., muscle weight, myofibrillar protein 
count; see [69]) and inflammation (e.g., B1 and B2 bradykinin receptors in muscle tissue; see 
[247]) were not performed, but it would be interesting to explore the relation between 
postsurgical musculoskeletal pain (for review see [40,246]) and inflammation with pain-
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avoidance behavior in the MC test in future experiments. It is plausible that some of the 
postsurgical pain unveiled by the MC test is due to muscle strain and damage. 
5.2.2. Neurophysiology of primed nociceptors 
Whether or not the NA and RA neurons described in vitro can be reasonably called 
nociceptors must be addressed first before considering their functional relevance in vivo in the 
MC test and coming sections of the discussion. Capsaicin and IB4 identify TRPV1-expressing 
and non-peptidergic nociceptors [60,132,268,282–284,336,377], respectively, and were used to 
identify a subset of the NA and RA neurons. A majority of NA and RA neurons (70% and 67%, 
respectively) responded to capsaicin under voltage or current clamp with a capsaicin-evoked 
inward current or depolarization of membrane potential. Between 50 to 70% of the NA and RA 
neurons bound IB4, respectively. See also [377] and [28] for probable NA neurons responding 
to low concentrations of capsaicin and binding IB4, respectively, under similar conditions. The 
small soma diameters for the NA and RA neurons correspond to similar demarcations for 
nociceptors in vitro [132,282,283]. While the NA and RA monikers likely include some 
subpopulations of non-nociceptive DRG sensory neurons with similar discharge patterns, large 
majorities that show capsaicin sensitivity and bind IB4 strongly suggest both neuron types are 
comprised of putative nociceptors, and will be referred to as such through the remainder of the 
discussion. 
Assuming the electrophysiological results collected from naïve, sham (T10 
laminectomy), and SCI rats roughly parallel – the experimental manipulations (i.e., surgical 
procedures) were the same between studies – the behavioral results for the same groups in 
Chapter 2, then it is plausible to infer that postsurgical pain and related changes in avoidance 
behaviors in the MC test may have been mediated by changes in vivo in NA nociceptors. 
Several pieces of evidence collected in vitro coalesce to indirectly support this hypothesis: 1) 
sham surgery increased excitability in NA nociceptors, 2) SCI increased excitability in NA 
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nociceptors to an even greater degree in a graded fashion, and in additional metrics, 3) RA 
nociceptors isolated from sham and SCI rats exhibited little to no increases in excitability, and 
4) “naïve” NA nociceptors pretreated with 5-HT exhibited increased excitability and generated 
more OA following extrinsic stimulation.  
The amount of SA generated by NA nociceptors in the sham group was notably less 
prevalent than the SCI group (~19% vs ~59%, respectively), but the uptick in SA over the naïve 
group (~3%) and significant reduction in rheobase (see also [28]) indicated the sham surgery 
was sufficient to increase excitability in NA nociceptors. There were additional SCI-induced 
effects on NA nociceptors not caused by sham surgery (see Table 5). The fact that SCI 
selectively increased excitability in NA nociceptors supports the plausibility that the behavioral 
effects may be mediated by NA nociceptors; like in the behavioral tests, there was a graded 
response in electrophysiological measures and the sham group was often “between” the naïve 
and SCI groups. As an additional and novel measure of nociceptor excitability, the DSF 
analysis demonstrated that SCI-induced SA and depolarization-induced OA in NA nociceptors 
are both driven by large DSFs. Three functional aspects of membrane potential synergistically 
promote SA and OA in NA nociceptors (Fig. 19): 1) a prolonged depolarization of RMP, 2) a 
lowered AP voltage threshold, and 3) enhancements in the amplitude and/or frequency of 
DSFs. Looking at the sham group as a whole (see Table 5) suggests sham surgery did not 
robustly depolarize RMP or lower the AP voltage threshold. However, a sizable proportion ~15-
20% of NA nociceptors isolated from sham-operated rats exhibit similar excitability profiles like 
that shown in Table 6 (unpublished observations). These sham NA nociceptors that generate 
SA invariably exhibit alterations in one or more of the following: RMP, AP voltage threshold, 
and/or rheobase. Because the majority of NA nociceptors taken from sham rats do not exhibit 
these alterations, they drown out other NA nociceptors that do become more excitable. While 
the DSF analysis did not specifically focus on NA nociceptors isolated from sham-operated rats 
– rather, naïve and sham groups were combined to increase statistical power in comparison to 
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the SCI group – it is likely that DSFs are enhanced in amplitude and/or frequency in the select 
proportion of NA nociceptors that become more excitable due to sham surgery.  
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Figure 19. Summary of neurophysiological specializations that promote OA in NA nociceptors. 
The OA can be entirely intrinsic and thus completely spontaneous (denoted as SA) or 
extrinsically driven. Nociceptor OA in vivo may be driven by acute or ongoing exposure to 
extrinsic drivers of activity, sometimes combined with long-lasting intrinsic alterations. 
Representative recordings from two NA nociceptors illustrate the normal inactive state (sample 
from a naïve rat) and the OA state (sample of SA from a rat with SCI). Compared to the normal 
state, the OA state is marked by 3 alterations: 1) depolarized RMP (blue arrow), 2) decreased 
AP voltage threshold for (green arrow), and 3) increased amplitude and frequency of DSFs (red 
arrowheads indicate DSFs >5 mV, which are highly likely to elicit APs). Serotonin (5-HT, 
orange) potentiates OA by decreasing the AP voltage threshold and enhancing the DSFs. Both 
the inter-DSF intervals and interspike intervals between APs are irregular in the OA state and 
the discharge does not accommodate. 5-HT, serotonin; AP, action potential; DSF, depolarizing 
spontaneous fluctuation; MP, membrane potential; NA, nonaccommodating; OA, ongoing 
activity; RMP, resting membrane potential; SA, spontaneous activity; SCI, spinal cord injury. 
Figure prepared by Max A. Odem.  
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There was a modest trend for a SCI-induced decrease in rheobase in RA nociceptors, 
but the degree of change (~26% decrease in RA nociceptors, ~49% decrease in NA 
nociceptors) and post-SCI values (~125 pA vs 45 pA, respectively) were noticeably in favor of 
NA nociceptors being more excitable and susceptible to alterations by bodily injury. A thorough 
DSF analysis was not performed on the RA nociceptors as they were encountered far less 
often than NA nociceptors during experiments. However, the fluctuations appeared to be more 
regular in waveform during artificial depolarization (i.e., having oscillatory components, general 
observations), suggesting the fluctuations may be mechanistically distinct from those generated 
by NA nociceptors. An analysis of the DSFs in RA nociceptors will be informative for future 
mechanistic studies when the functional relevance of the RA type becomes more apparent. 
The RA nociceptors may overlap with and include the Aδ class of sensory neurons, as 
indicated by their slightly larger diameter and membrane capacitance. A-type sensory neurons 
generate rapid, oscillatory bursts in membrane potential that trigger bursts of APs [7–
9,223,224,383]. However, none of the RA nociceptors generated SA or OA under any 
conditions tested (e.g., no fluctuations or oscillations generated bursts of APs at -45 mV) and 
their functional relevance is uncertain. No other trending SCI or 5-HT-induced effects on RA 
nociceptors were observed.  
Due to the limited evidence of altered excitability and uncertain functional relevance of 
the RA nociceptors, it is currently more plausible to attribute behavioral changes in vivo to 
changes in NA nociceptors. This is further supported by experiments demonstrating NA 
nociceptors were sensitive to low concentrations of an inflammatory mediator, serotonin. 
Pretreating “naïve” DRG sensory neurons with 5-HT selectively increased excitability in NA 
nociceptors. The AP voltage threshold and rheobase were both significantly lowered, and the 
amount of OA generated in response to depolarization to -45 mV dramatically increased from 
19% in the control condition to 85% in the presence of 5-HT. First of all, these results parallel 
other in vitro observations of 5-HT-induced excitability in peripheral fibers and DRG sensory 
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neurons [55,56,133,222,231,307,316,317]. Secondly, these results demonstrate the functional 
capabilities of the NA nociceptors in vitro, which parallel other in vivo and ex vivo observations 
of 5-HT-induced sensitization and activation of C-fibers, pain-related behavioral responses, and 
synergism with other inflammatory mediators (e.g., bradykinin, PGE2) 
[2,62,161,166,222,252,275,307,313,341] (see also [230,332] for review). In light of these 
parallels, I predict the damage to deep tissues and inflammation associated with sham surgery 
and neural injury may act upon NA nociceptors in a similar manner and sensitize them to 
extrinsic stimuli, like the noxious probes in the MC test. 
5.3. Functional significance of the NA nociceptors: Evoked pain, ongoing pain, or both? 
 I have addressed how postsurgical pain in rodents has been somewhat overlooked and 
how the avoidance behaviors elicited in the MC test relate to postsurgical pain. I have also 
touched on the plausibility that changes in NA nociceptors mediate behavioral changes in vivo, 
possibly in the MC test. Still, I have not established a clear functional role for NA nociceptors in 
vivo under postsurgical or neuropathic pain conditions, the types of sensory modalities and 
pain they may mediate, and pathways in which they may operate. Since nociceptor OA is a 
likely driver of central sensitization, then circuits in the dorsal horn are critical for appropriately 
modulating input from nociceptor OA in a functionally relevant manner for somatosensory 
processing. Indeed, where different types of nociceptors project in the dorsal horn tells a great 
deal about their sensory modalities and functional significance. I will attempt to establish a 
functional role and propose a theoretical model of NA nociceptor activity by addressing the 
following questions: 
1. Is NA nociceptor activity generated in vitro relevant in vivo? 
2. Is the MC test assessing an evoked or ongoing pain-related behavior? 
3. Is that behavior mediated by different subpopulations of NA nociceptors and driven 
by OA? 
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5.3.1. Activity generated by NA nociceptors in vitro is relevant in vivo 
Patients often describe ongoing/spontaneous pain as being the most discomforting and 
debilitating, yet some of that pain may be unknowingly evoked by the patient during their daily 
routines. The mechanisms underlying evoked and spontaneous pain in many different 
neuropathic and inflammatory pain conditions are unclear, and definitions of what constitutes 
truly spontaneous pain is still open to debate [30]. The strongest links between conscious 
reports of pain by patients – some of which have peripheral neuropathies – and activity in C-
fibers are from microneurography studies [195,262,263,269,270,323,324]. Activation of C-fibers 
is reported to evoke burning and/or aching pain sensations, and spontaneous activity in C-
fibers is considered an optimal readout for neuropathic pain [312,314]. For technical review see 
[128,321]. Microneurography recordings also demonstrate that multiple rat neuropathic models 
(three PNI models, two polyneuropathy models in this particular study) have incidences of 
spontaneously active C-fibers that are similar to those of patients with peripheral neuropathies 
[322]. Many rodent neuropathic and inflammatory models have spontaneously active C-fibers 
[3,28,105,249,330,374,379,386], and the SA correlates with pain-related behaviors like 
spontaneous foot lifting [105,386]. Direct activation of C-fibers, ablation of C-fiber populations, 
or knockdown of Nav1.8 aptly demonstrate the role C-fibers play in pain-like states in animal 
models [26,86,362,389]. In light of these details, it is plausible to infer that the spontaneously 
active C-fibers described in vivo encompass some proportion of the NA nociceptors that show 
a functional capacity for OA in vitro. 
The specializations that promote the low frequency, irregular OA and SA in NA 
nociceptors were elucidated purely in vitro and found to be intrinsic to isolated DRG neuron 
somata (see also [25,28,377,389]). There are notable concerns about the artificiality of this 
model system, but isolated DRG neuron somata retain their properties observed in vivo 
[17,132,154]. The contusive SCI model was specifically chosen due to previous experiments 
and experimental advantages that make the study of nociceptor OA more feasible 
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[25,28,57,377,389]: 1) most importantly, SCI-induced nociceptor OA has been described as 
being generated in/near the DRGs in vivo and in an excised nerve preparation, 2) a majority of 
nociceptors at and below the level of the injury enter into an hyperexcitable state and generate 
SA, 3) the hyperexcitable state is observable from 3 days to ~6-8 months post-SCI, and 4) the 
model yields a large quantity of DRG tissue that is otherwise not available when using other 
injury models – like SNT or CCI – in which only 3 of the DRGs innervate the injured hindlimb. 
Although the SNT and CCI models were not the focus of my electrophysiological experiments, 
it is very likely that specializations (e.g., large DSFs) for NA nociceptor OA are present in many 
other ongoing pain conditions (unpublished observations of large DSFs in nociceptors taken 
from rats with SNL or chemotherapy-induced peripheral neuropathy, mice with SCI, and 
humans with cancer-related chemotherapy pain). These specializations appear to manifest in 
vitro in multiple conditions, across multiple species (see also nociceptor SA in squid following 
peripheral injury [82]), specifically in putative nociceptors isolated under neuropathic ongoing 
pain conditions. Furthermore, irregular OA with similar firing frequencies is generated by C-
fibers in vivo following SCI [28]. These repeated occurrences suggest the specializations are 
likely to be relevant in vivo rather than purely coincidental, represent generalized mechanisms 
that may have evolved specifically to promote low-level peripheral input to the CNS, and may 
facilitate stimulus-evoked ongoing pain as well as truly spontaneous pain. 
5.3.2. Ongoing pain may not influence avoidance of noxious stimuli in the operant 
mechanical conflict test 
The type of pain being assessed by the sharp probes in the MC test is probably evoked 
by activation of nociceptors that respond to mechanical stimuli, but to what degree does 
ongoing, truly spontaneous pain modulate behavior during the test? Can evoked and ongoing 
pain be distinguished in this test? The recent push for more ethologically relevant, unbiased 
operant measures for pain has begun to reveal the importance of distinguishing spontaneous 
from evoked pain, as spontaneous pain is a more informative translational tool for assessing 
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preclinical neuropathic pain over standard reflex tests [256,286]. One clear, unbiased 
distinction between sham and SCI rats is that SCI promotes the development of chronic, 
spontaneous pain as measured by the operant CPP test [389] (see also Chapter 3). Axotomy 
of the lower lumbar spinal nerve(s) – using the original Kim and Chung procedure [163] or 
modified procedure [101] – also results in spontaneous pain that is detectable in the CPP test 
[19,159,192,291]. The equivalent sham-operated rodents do not exhibit spontaneous pain as 
revealed by the CPP test. Notably, deep plantar incision is sufficient to also produce 
spontaneous pain transiently [85] when incision-induced hypersensitivity and nociceptor SA are 
likely to be present [386]. Despite these distinctions in regards to spontaneous pain, both the 
sham and injured rats tested in Chapter 2 developed a robust aversion to the noxious probes 
likely due to nociceptive sensitization and enhanced evoked pain. 
Although spontaneous pain was not explicitly assessed in Chapter 2, it is likely that at 3 
days post-surgery the sham and SNT rats were experiencing acute, ongoing postsurgical pain 
[85,386]. Unexpectedly, SNT rats exhibited a clear reduction in crossings compared to naïve 
and sham rats when no probes were present. Some SNT rats exhibited hyperalgesic-like 
responses [165] and were observed to guard their injured, allodynic hindpaw when moving 
about the MCS. They also likely had altered gait patterns (see SNI example [326]). This may be 
due to SA in the intact L4 DRG C-fibers that drive pain-related behaviors like spontaneous foot 
lifting [101,386]. Djouhri et al. did not use sham controls and but did posit that C-fiber SA is less 
likely to be present in shams (see [235]), but the study by Xu and Brennan did use the 
appropriate sham control (i.e., skin incision alone without cutting deeper fascia and muscle) for 
their incisional pain model. Although mechanical allodynia is driven by mechanisms of central 
sensitization, including SA originating from axotomized A-fibers in the L5 DRG [224,225], the 
spontaneous pain-related behavior is more likely to be driven by intact C-fiber SA induced by 
Wallerian degeneration of nearby myelinated fibers [101,374]. It cannot be ruled out that 
stepping with the allodynic paw elicits a spontaneous-like evoked response, which may be 
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similar in nature to the “spontaneous” pain evoked by daily routine (see [30]). Regardless, the 
only observations that distinguished the effects of neural injury from sham surgery were of SNT 
rats crossing fewer times without probes. All other notable differences were in sham-operated 
and rats with neural injury compared to naïve, uninjured controls in the presence of noxious 
probes. This suggests that any neuropathic-induced ongoing/spontaneous pain, while likely 
present and contributing to the rats’ pain state, may not be a strong determining factor of pain-
avoidance behavior. 
5.3.3. Possible sensory modalities and pathways for NA nociceptors 
Unfortunately, none of the experiments described directly link the NA nociceptors to any 
particular sensory modality – besides maybe temperature due to the high incidence of 
capsaicin-sensitivity – or with their prospective projection sites in the dorsal horn. However, a 
few reasonable interpretations about potential projections and function can be gleaned from the 
limited marker information. To refresh, a majority of the NA nociceptors responded to capsaicin 
(~70%) and roughly half (~49%) bound IB4, indicating NA nociceptors are primarily comprised 
of TRPV1+ subclasses of nociceptors. There was insufficient data to comment on overlap 
between capsaicin sensitivity and IB4 binding in the NA nociceptors. However, Usoskin et al. 
posit an unbiased classification scheme for primary sensory neurons in mice using single-cell 
RNA sequencing [349]. Species differences aside, they show TRPV1 expression overlaps with 
three distinct populations of unmyelinated DRG sensory neurons, two nonpeptidergic and one 
peptidergic. Gene ontology maps suggest these three populations mediate itch, inflammatory-
related itch, mechanical, heat, neuropeptide function, and pain sensory properties. Here, 
Usoskin et al. define pain as a sensory property using the following descriptions (see 
supplementary data for [349]): 1) sensory perception of pain, 2) response to pain, 3) detection 
of temperature or chemical stimulus involved in sensory perception of pain, and 4) behavioral 
response to pain. As for the NA nociceptors that did not respond to capsaicin, Usokin et al. also 
show there are two distinct populations of unmyelinated TRPV1- DRG sensory neurons, the C-
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type low-threshold mechanoreceptors (LTMRs) that uniquely express tyrosine hydroxylase (see 
also [219]) and neurons that jointly express the Mas-related G protein-coupled receptor 
member D (gene name Mrgprd) and purinergic P2X ligand-gated ion channel 3 receptor (P2X3, 
encoded by the P2rx3 gene). These distinct populations are largely consistent with other 
reported populations of nociceptors and their projections in the dorsal horn (for review 
[279,284]). In light of this information, it is probable that a majority of NA nociceptors that are 
TRPV1+/peptidergic or TRPV1+/non-peptidergic project in the superficial layers, laminae I and 
outer laminae II, and mediate a collection of itch, mechanical, heat, and inflammatory 
sensations. Any NA nociceptors that are C-LTMRs will project into the deeper layer of laminae 
II, and likely not innervate glabrous skin (see [219]). Finally, any NA nociceptors that are 
TRPV1-/Mrgprd+ will project deep within laminae II and mediate mechanical sensations. 
5.3.4. A proposed model for pain-avoidance behavior and postsurgical pain mediated by 
NA/Mrgprd+ nociceptors 
Our current understanding of the Mrgprd+ nociceptors may offer deeper insight into NA 
nociceptor function and pain-avoidance behavior in the MC test. The Mrgprd+ nociceptors 
selectively innervate the skin epidermis, mediate mechanical pain and itch, and are 
topographically organized in deeper regions of laminae II in the dorsal horn 
[26,61,111,176,360,399,406]. The Mrgprd+ nociceptors express the P2X3 receptor [406] and 
are excited by adenosine triphosphate (ATP) in vitro [111]. Activation of keratinocytes 
stimulates ATP release [274,404], suggesting keratinocytes are intermediaries for activation of 
Mrgprd+ nociceptors and mechanical pain (see also [187,342] for review). Ablation of Mrgprd+ 
nociceptors fails to eliminate “spontaneous” pain-related behaviors caused by formalin [328]. 
This is consistent with other studies showing ablation of Mrgprd+ nociceptors leads to specific 
deficits in sensation of mechanical stimuli [61,399]. When optogenetically activated, the 
Mrgprd+ nociceptors that innervate the plantar surface of the paw mediate withdrawal [266]. 
Note, the Mrgprd+ nociceptors in the glabrous skin are innately more sensitive than the Mrgprd+ 
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nociceptors innervating hairy skin in the upper thigh, suggesting some Mrgprd+ nociceptors are 
somatotopically organized for responding to mechanical stimuli encountered during normal 
ambulation. A sizable proportion of Mrgprd+ nociceptors also generate SA in vivo following 
chronic compression injury to the DRG [364] and exhibit enhanced excitability (e.g., 
depolarized RMP, lowered rheobase, more APs when stimulated) in a model of inflammatory 
pain and itch [292]. Deletion of Mrgprd decreases nociceptor sensitivity to cold, heat, and 
mechanical stimuli ex vivo and increases rheobase in vitro in cultured DRG sensory neurons 
[298]. Rau et al. also demonstrate application of an Mrgprd receptor ligand, β-alanine, lowers 
AP threshold and increases firing in Mrgprd+ nociceptors, and posit β-alanine production in the 
skin can tonically activate Mrgprd+ nociceptors. These studies suggest Mrgprd may be 
important for enhancing nociceptor excitability in pain conditions involving epidermal tissue 
damage and peripheral inflammation. The Mrgprd+ nociceptors exhibit injury-induced 
electrophysiological properties similar to some properties observed in the NA nociceptors, and 
the potentiated activity in response to β-alanine is reminiscent of NA nociceptor potentiated OA 
in the presence of 5-HT. Dussor et al. did not measure OA in dissociated Mrgprd+ nociceptors 
treated with ATP [111], so it would be interesting to determine whether ATP potentiates OA like 
β-alanine or like 5-HT in NA nociceptors. Based on referenced studies (mostly in mice) and 
currently available electrophysiological data for NA nociceptors, I think it is reasonable to 
predict Mrgprd+ nociceptors are activated by the sharp probes in the MC test, and that 
NA/Mrgprd+ nociceptors mediate pain-avoidance behavior via mechanisms that promote OA 
(e.g., direct mechanical activation, secreted factors from keratinocytes, other inflammatory 
mediators). While TRPV1+ nociceptors mediate some forms of mechanosensation in rats (e.g., 
pressure; see [44]), they do not appear to mediate pin-prick in naïve rats [44] or movement-
induced pain in rats with bone cancer [158]. Peripheral terminals of Mrgprd+ nociceptors 
innervate more superficial epidermal layers than TRPV1+ terminals in mice [61,176,304,406]; 
TRPV1 is also seen near the dermal-epidermal junction in humans [335] and rats [146]. The 
precise relationships between MCS probe height, rat weight, and degree of skin displacement 
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are still unclear. Activation of TRPV1+ nociceptors may not directly mediate probe-induced 
mechanical transduction, but that does not preclude their contribution should sufficient radial 
pressure activate them. However, based on my observations of forepaw and hindpaw 
placement during crossings it is unlikely rats apply sufficient body weight and pressure on the 
probes. Forepaw withdrawals during initial investigations are exceptionally fast and rats learn to 
raise the heels of their hindpaws and step between probes during crossings. 
Higher-order processing in the pre-frontal cortex and hippocampus have been 
implicated as neurobiological correlates for pain-avoidance behavior in the MC test [271]. 
Whether or not the mechanosensory information is perceived as painful to naïve rats is still 
unclear; naïve rats exhibit longer escape latencies [155,271] but will repeatedly cross over low 
and high probes when given the opportunity, suggesting the experience is not so aversive to 
abolish exploration like in the sham-operated and rats with neural injury. In light of this, evoked 
discharges from NA/Mrgprd+ nociceptors that propagate supraspinally may not take 
precedence during the decision-making process (Fig. 20). Probe avoidance probably becomes 
more advantageous – and exploration decreases – once a rat has undergone a serious 
peripheral injury involving damage to deep tissues (e.g., sham surgery) (Fig. 21). The 
proliferation and circulation of inflammatory mediators and other extracellular signals following 
injury can increase excitability in peripheral nerve terminals and somata of nociceptors [64]. In 
sham-operated rats, NA/Mrgprd+ nociceptors may be sensitized and respond to the probes with 
a burst of OA (higher frequency, prolonged duration). Indeed, NA nociceptors isolated from 
sham-operated rats exhibit signs of increased excitability (e.g., reduced rheobase) and more 
SA. Whether or not OA in NA/Mrgprd+ nociceptors is the sole driving force of the rats’ behavior 
is unclear; the broader ensemble of TRPV1+ NA/Mrgprd- nociceptors likely encodes a larger 
variety of sensory information. They may generate more intrinsic SA and inflammatory 
mediator-activated OA both in the peripheral terminals and somata. This may further enhance 
NA/Mrgprd+ nociceptor activity; signal transmission may be augmented within the DRG and 
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nociceptor somata. Tissue injury and peripheral inflammation can stimulate infiltration of non-
neuronal immune cell types in/near the DRGs (e.g., macrophages [356,358]) and activation of 
satellite glial cells – coupled interactions with satellite glial cells may enhance nociceptor 
excitability (see [34,35,109,168,191,212,388]). Following a more severe neural injury (e.g., 
SCI), the same pain-avoidance behavior is elicited, but the underlying mechanisms are 
possibly more complex (Fig. 22). For example, SCI promotes a hyperexcitable state and OA in 
nociceptor somata [25,28,377,389] and axons [57]. The capsaicin-sensitive, peptidergic 
nociceptors – probable NA/Mrgprd- nociceptors – are more likely to generate SA in their 
somata [28]. They might also generate more extrinsically driven OA. Low frequency SA and 
extrinsically-driven OA generated in NA/Mrgprd- nociceptors and other mechanically insensitive 
nociceptors [195,263,288,323] are probably important for maintenance of central sensitization 
in dorsal horn circuits [369] and strengthening of synaptic connections. Indeed, peptidergic 
DRG sensory neurons show signs of injury-induced growth states [27,229]. Increased sprouting 
and proliferation of post-synaptic elements may allow these nociceptors to infiltrate into deeper 
laminae and increase circuit excitability (see [1,72,200,216,267,365] for sprouting of peptidergic 
primary afferents). This model(s) of NA nociceptor function and pain-avoidance behavior in the 
MC test is merely speculation at this point. It will be interesting to see how future studies map 
NA nociceptors onto current classifications based on molecular markers, function, and anatomy 
in the spinal cord. Future studies that differentially manipulate populations of TRPV1+ and 
Mrgprd+ nociceptors in rodent models of neural injury in combination with using the MC test to 
assess pain-avoidance behavior will further elucidate the functional roles of these nociceptors, 
and possibly identify new therapeutic targets specific to postsurgical and neuropathic pain.  
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Figure 20. Proposed model for NA/Mrgprd+ nociceptor function under naïve conditions. I-IIiv, 
dorsal horn laminae; DRG, dorsal root ganglia; MCS, mechanical conflict system; Mrgprd, Mas-
related G protein-couple receptor D; NA, nonaccommodating; OA, ongoing activity; SB, stratum 
basale; SC, stratum corneum; SG, stratum granulosum; SS, stratum spinosum. Figure 
prepared by Max A. Odem.  
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Figure 21. Proposed model for NA/Mrgprd+ nociceptor function following peripheral injury 
conditions (e.g., sham surgery). I-IIiv, dorsal horn laminae; DRG, dorsal root ganglia; MCS, 
mechanical conflict system; Mrgprd, Mas-related G protein-couple receptor D; NA, 
nonaccommodating; OA, ongoing activity; SB, stratum basale; SC, stratum corneum; SG, 
stratum granulosum; SS, stratum spinosum. Figure prepared by Max A. Odem.  
126 
 
 
Figure 22. Proposed model for NA/Mrgprd+ nociceptor function under severe neural injury 
conditions (e.g., SCI). I-IIiv, dorsal horn laminae; DRG, dorsal root ganglia; MCS, mechanical 
conflict system; Mrgprd, Mas-related G protein-couple receptor D; NA, nonaccommodating; 
OA, ongoing activity; SB, stratum basale; SC, stratum corneum; SCI, spinal cord injury; SG, 
stratum granulosum; SS, stratum spinosum. Figure prepared by Max A. Odem.  
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5.4. Concluding remarks and future directions 
Geoffrey Bove bluntly repudiates the von Frey test as he questions its validity as an 
accurate measure for pain, naming it the “tin standard” in the pain field [38]. In summary, he 
firmly emphasizes the threshold measurements described in many studies are likely not 
comparable due to differences in experimental methods and human bias. By the end of my 
time as a graduate student, I also question the validity of the von Frey and other subjective 
reflex tests for similar reasons. My experiments demonstrate the von Frey test does not reveal 
acute or persistent forms of postsurgical pain in three different neuropathic injury models. This 
is consistent with a large literature base, and not in a good way. In 2004, Mogil and Crager 
suspected the pain field’s exclusive dependence upon reflex tests would be untenable [255]. If 
the results from the MC test are to be believed, then there is a real possibility that prior 
interpretations of some experiments using rodent neural injury models – which were dependent 
upon reflex tests – may be obscured if postsurgical pain in sham control groups was not 
properly taken into account. This includes interpretations of underlying pain-related 
mechanisms and treatment-related effects. Indeed, there are issues concerning the 
reproducibility and replicability of research [29,115,180,290] as well as translational efficacy in 
the pain field [392].  
Increasing emphasis on more descriptive, automated behavioral tests (e.g., MC and 
CPP tests) and recording techniques that provide more natural approximations of nociceptor 
activity in vivo (e.g., dorsal root and nerve recordings; see [28,135,348]) might lessen “death 
valley’s” gap. Future studies that link nociceptor activity in vivo with the negative affective-
motivational components of pain might provide more suitable backdrops for testing 
experimental therapeutics involving cellular and molecular mechanisms predicted to drive 
nociceptor activity and pain behavior.  
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Appendix 
Conditioned place preference methods 
The three compartment conditioned place preference (CPP) device (Med Associates, 
Inc., Fairfax, VT, USA) is comprised of a neutral center grey chamber and two larger, solid 
colored chambers – one white, one black – for contextual pairing of treatments. Manual 
guillotine doors separate each chamber. The white and black chambers were dimly illuminated 
while the grey chamber was brightly lit to discourage rats from preferring it over the other two 
chambers during baseline and post-conditioning tests. The manufacturer provided MED-PC 
v4.34 software automatically tracks rat location and time in each chamber via infrared photo 
beams. Data from two simultaneously running CPP devices were collected and stored on a 
Windows 7 Dell desktop computer. 
 Test procedures were followed as described in [19,192]. Briefly, rats were permitted full 
access to all 3 chambers for 15 minutes to assess innate preference. Rats that spent >80% or 
<20% of their time in any of the 3 chambers were excluded from experiments due to innate 
chamber bias. The next morning, rats were injected with saline vehicle (i.p., 2 mL/kg volume) 
and after 10 minutes placed in the innately preferred chamber for 30 minutes (black chamber 
for majority of rats). That afternoon (~4 hours later) rats were injected with gabapentin (100 
mg/kg, i.p., 2 mL/kg volume dissolved in 0.9% saline; Toronto Research Chemicals, Ontario, 
Canada) and after 10 minutes were placed in the less-preferred chamber for 30 minutes. The 
next day, rats were permitted full access to all 3 chambers for 15 minutes to assess changes in 
chamber preference. No treatments were given at this time. The CPP score (in seconds) is the 
time spent in a chamber in the post-test minus the time spent in the same chamber in the pre-
test.  
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